<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems - Hofmeyr, GJ - 2018 | Cochrane Library</title> <meta content="Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems - Hofmeyr, GJ - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001059.pub5/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems - Hofmeyr, GJ - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001059.pub5/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD001059.pub5" name="dc.identifier" scheme="DOI"/> <meta content="Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems" name="citation_title"/> <meta content="G Justus Hofmeyr" name="citation_author"/> <meta content="Walter Sisulu University, University of Fort Hare, University of the Witwatersrand, Eastern Cape Department of Health" name="citation_author_institution"/> <meta content="justhof@gmail.com" name="citation_author_email"/> <meta content="Theresa A Lawrie" name="citation_author"/> <meta content="1st Floor Education Centre, Royal United Hospital" name="citation_author_institution"/> <meta content="Álvaro N Atallah" name="citation_author"/> <meta content="Centro de Estudos de Saúde Baseada em Evidências e Avaliação Tecnológica em Saúde" name="citation_author_institution"/> <meta content="Maria Regina Torloni" name="citation_author"/> <meta content="Centro de Estudos de Saúde Baseada em Evidências e Avaliação Tecnológica em Saúde" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="10" name="citation_issue"/> <meta content="10.1002/14651858.CD001059.pub5" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/10/01" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001059.pub5/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001059.pub5/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001059.pub5/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Calcium [*administration &amp; dosage]; *Dietary Supplements; Hypertension [mortality, *prevention &amp; control]; Linoleic Acid [administration &amp; dosage]; Pre-Eclampsia [mortality, *prevention &amp; control]; Pregnancy Complications, Cardiovascular [mortality, *prevention &amp; control]; Premature Birth [*prevention &amp; control]; Randomized Controlled Trials as Topic; Vitamin D [administration &amp; dosage]; Vitamins [administration &amp; dosage]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001059.pub5&amp;doi=10.1002/14651858.CD001059.pub5&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001059.pub5&amp;doi=10.1002/14651858.CD001059.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001059.pub5&amp;doi=10.1002/14651858.CD001059.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001059.pub5&amp;doi=10.1002/14651858.CD001059.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001059.pub5&amp;doi=10.1002/14651858.CD001059.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001059.pub5&amp;doi=10.1002/14651858.CD001059.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001059.pub5&amp;doi=10.1002/14651858.CD001059.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001059.pub5&amp;doi=10.1002/14651858.CD001059.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001059.pub5&amp;doi=10.1002/14651858.CD001059.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001059.pub5&amp;doi=10.1002/14651858.CD001059.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001059.pub5&amp;doi=10.1002/14651858.CD001059.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001059.pub5&amp;doi=10.1002/14651858.CD001059.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001059.pub5&amp;doi=10.1002/14651858.CD001059.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001059.pub5&amp;doi=10.1002/14651858.CD001059.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001059.pub5&amp;doi=10.1002/14651858.CD001059.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001059.pub5&amp;doi=10.1002/14651858.CD001059.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001059.pub5&amp;doi=10.1002/14651858.CD001059.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001059.pub5&amp;doi=10.1002/14651858.CD001059.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001059.pub5&amp;doi=10.1002/14651858.CD001059.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001059.pub5&amp;doi=10.1002/14651858.CD001059.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001059.pub5&amp;doi=10.1002/14651858.CD001059.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001059.pub5&amp;doi=10.1002/14651858.CD001059.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001059.pub5&amp;doi=10.1002/14651858.CD001059.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="IYhCEbRn";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD001059\x2epub5\x26doi\x3d10\x2e1002\x2f14651858\x2eCD001059\x2epub5\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001059\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001059\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","de","zh_HANT","ru","ms","ja","fr","pl","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD001059.pub5",title:"Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems",firstPublishedDate:"Oct 1, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pregnancy and Childbirth Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=IYhCEbRn&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001059.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001059.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD001059.pub5/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD001059.pub5/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001059.pub5%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD001059.PUB5" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD001059.pub5/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD001059.PUB5" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD001059.pub5/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD001059.pub5/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>27233 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD001059.pub5" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001059.pub5/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001059.pub5/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001059.pub5/full#CD001059-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001059.pub5/full#CD001059-sec-0147"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001059.pub5/full#CD001059-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001059.pub5/full#CD001059-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001059.pub5/full#CD001059-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001059.pub5/full#CD001059-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001059.pub5/full#CD001059-sec-0080"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001059.pub5/full#CD001059-sec-0138"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001059.pub5/appendices#CD001059-sec-0152"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/table_n/CD001059StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/table_n/CD001059StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001059.pub5/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001059.pub5/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001059.pub5/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001059.pub5/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001059.pub5/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD001059.pub5/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001059.pub5/information#CD001059-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>G Justus Hofmeyr</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001059.pub5/information#CD001059-cr-0003">Theresa A Lawrie</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001059.pub5/information#CD001059-cr-0004">Álvaro N Atallah</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001059.pub5/information#CD001059-cr-0005">Maria Regina Torloni</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/information/en#CD001059-sec-0168">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 01 October 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD001059.pub5">https://doi.org/10.1002/14651858.CD001059.pub5</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD001059-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001059-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001059-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001059-abs-0015">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD001059-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD001059-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD001059-abs-0001" lang="en"> <section id="CD001059-sec-0001"> <h3 class="title" id="CD001059-sec-0001">Background</h3> <p>Pre‐eclampsia and eclampsia are common causes of serious morbidity and death. Calcium supplementation may reduce the risk of pre‐eclampsia, and may help to prevent preterm birth. This is an update of a review last published in 2014. </p> </section> <section id="CD001059-sec-0002"> <h3 class="title" id="CD001059-sec-0002">Objectives</h3> <p>To assess the effects of calcium supplementation during pregnancy on hypertensive disorders of pregnancy and related maternal and child outcomes. </p> </section> <section id="CD001059-sec-0003"> <h3 class="title" id="CD001059-sec-0003">Search methods</h3> <p>We searched Cochrane Pregnancy and Childbirth’s Trials Register, <a href="http://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a>, the WHO International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">ICTRP</a>) (18 September 2017), and reference lists of retrieved studies. </p> </section> <section id="CD001059-sec-0004"> <h3 class="title" id="CD001059-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs), including cluster‐randomised trials, comparing high‐dose calcium supplementation (at least 1 g daily of calcium) during pregnancy with placebo. For low‐dose calcium we included quasi‐randomised trials, trials without placebo, trials with cointerventions and dose comparison trials. </p> </section> <section id="CD001059-sec-0005"> <h3 class="title" id="CD001059-sec-0005">Data collection and analysis</h3> <p>Two researchers independently assessed trials for inclusion and risk of bias, extracted data and checked them for accuracy. Two researchers assessed the evidence using the GRADE approach. </p> </section> <section id="CD001059-sec-0006"> <h3 class="title" id="CD001059-sec-0006">Main results</h3> <p>We included 27 studies (18,064 women). We assessed the included studies as being at low risk of bias, although bias was frequently difficult to assess due to poor reporting and inadequate information on methods. </p> <p><i><b>High‐dose calcium supplementation (</b> </i><b>≥ <i>1 g/day) versus placebo</i> </b> </p> <p>Fourteen studies examined this comparison, however one study contributed no data. The 13 studies contributed data from 15,730 women to our meta‐analyses. The average risk of high blood pressure (BP) was reduced with calcium supplementation compared with placebo (12 trials, 15,470 women: risk ratio (RR) 0.65, 95% confidence interval (CI) 0.53 to 0.81; I² = 74%). There was also a reduction in the risk of pre‐eclampsia associated with calcium supplementation (13 trials, 15,730 women: average RR 0.45, 95% CI 0.31 to 0.65; I² = 70%; low‐quality evidence). This effect was clear for women with low calcium diets (eight trials, 10,678 women: average RR 0.36, 95% CI 0.20 to 0.65; I² = 76%) but not those with adequate calcium diets. The effect appeared to be greater for women at higher risk of pre‐eclampsia, though this may be due to small‐study effects (five trials, 587 women: average RR 0.22, 95% CI 0.12 to 0.42). These data should be interpreted with caution because of the possibility of small‐study effects or publication bias. In the largest trial, the reduction in pre‐eclampsia was modest (8%) and the CI included the possibility of no effect. </p> <p>The composite outcome maternal death or serious morbidity was reduced with calcium supplementation (four trials, 9732 women; RR 0.80, 95% CI 0.66 to 0.98). Maternal deaths were no different (one trial of 8312 women: one death in the calcium group versus six in the placebo group). There was an anomalous increase in the risk of HELLP syndrome in the calcium group (two trials, 12,901 women: RR 2.67, 95% CI 1.05 to 6.82, high‐quality evidence), however, the absolute number of events was low (16 versus six). </p> <p>The average risk of preterm birth was reduced in the calcium supplementation group (11 trials, 15,275 women: RR 0.76, 95% CI 0.60 to 0.97; I² = 60%; low‐quality evidence); this reduction was greatest amongst women at higher risk of developing pre‐eclampsia (four trials, 568 women: average RR 0.45, 95% CI 0.24 to 0.83; I² = 60%). Again, these data should be interpreted with caution because of the possibility of small‐study effects or publication bias. There was no clear effect on admission to neonatal intensive care. There was also no clear effect on the risk of stillbirth or infant death before discharge from hospital (11 trials, 15,665 babies: RR 0.90, 95% CI 0.74 to 1.09). </p> <p>One study showed a reduction in childhood systolic BP greater than 95th percentile among children exposed to calcium supplementation in utero (514 children: RR 0.59, 95% CI 0.39 to 0.91). In a subset of these children, dental caries at 12 years old was also reduced (195 children, RR 0.73, 95% CI 0.62 to 0.87). </p> <p><i><b>Low‐dose calcium supplementation (&lt; 1 g/day) versus placebo or no treatment</b> </i> </p> <p>Twelve trials (2334 women) evaluated low‐dose (usually 500 mg daily) supplementation with calcium alone (four trials) or in association with vitamin D (five trials), linoleic acid (two trials), or antioxidants (one trial). Most studies recruited women at high risk for pre‐eclampsia, and were at high risk of bias, thus the results should be interpreted with caution. Supplementation with low doses of calcium reduced the risk of pre‐eclampsia (nine trials, 2234 women: RR 0.38, 95% CI 0.28 to 0.52). There was also a reduction in high BP (five trials, 665 women: RR 0.53, 95% CI 0.38 to 0.74), admission to neonatal intensive care unit (one trial, 422 women, RR 0.44, 95% CI 0.20 to 0.99), but not preterm birth (six trials, 1290 women, average RR 0.83, 95% CI 0.34 to 2.03), or stillbirth or death before discharge (five trials, 1025 babies, RR 0.48, 95% CI 0.14 to 1.67). </p> <p><i><b>High‐dose (=/&gt; 1 g) versus low‐dose (&lt; 1 g) calcium supplementation</b> </i> </p> <p>We included one trial with 262 women, the results of which should be interpreted with caution due to unclear risk of bias. Risk of pre‐eclampsia appeared to be reduced in the high‐dose group (RR 0.42, 95% CI 0.18 to 0.96). No other differences were found (preterm birth: RR 0.31, 95% CI 0.09 to 1.08; eclampsia: RR 0.32, 95% CI 0.07 to 1.53; stillbirth: RR 0.48, 95% CI 0.13 to 1.83). </p> </section> <section id="CD001059-sec-0007"> <h3 class="title" id="CD001059-sec-0007">Authors' conclusions</h3> <p>High‐dose calcium supplementation (≥ 1 g/day) may reduce the risk of pre‐eclampsia and preterm birth, particularly for women with low calcium diets (low‐quality evidence). The treatment effect may be overestimated due to small‐study effects or publication bias. It reduces the occurrence of the composite outcome 'maternal death or serious morbidity', but not stillbirth or neonatal high care admission. There was an increased risk of HELLP syndrome with calcium supplementation, which was small in absolute numbers. </p> <p>The limited evidence on low‐dose calcium supplementation suggests a reduction in pre‐eclampsia, hypertension and admission to neonatal high care, but needs to be confirmed by larger, high‐quality trials. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD001059-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001059-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD001059-abs-0007">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD001059-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001059-abs-0016">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD001059-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD001059-abs-0011">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD001059-abs-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD001059-abs-0013">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD001059-abs-0009">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD001059-abs-0006">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD001059-abs-0008">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD001059-abs-0005" lang="en"> <h3>Calcium supplementation during pregnancy for preventing blood pressure disorders and related problems </h3> <p><b>What is the issue?</b> </p> <p>Pre‐eclampsia is evident as high blood pressure and protein in the urine. It is a major cause of death in pregnant women and newborn babies worldwide. Preterm birth (birth before 37 weeks) is often caused by high blood pressure and is the leading cause of newborn deaths, particularly in low‐income countries. </p> <p><b>Why is this important?</b> </p> <p>Evidence from randomised controlled trials shows that calcium supplements help prevent pre‐eclampsia and preterm birth and lower the risk of a woman dying or having serious problems related to high blood pressure in pregnancy. This is particularly for women on low calcium diets. </p> <p><b>What evidence did we find?</b> </p> <p>We searched for evidence on 18 September 2017, and found 27 trials. We found evidence from 13 studies (involving 15,730 women) that calcium supplementation in high doses (at least 1 gram (g) daily) during pregnancy may be a safe way of reducing the risk of pre‐eclampsia, especially in women from communities with low dietary calcium and those at increased risk of pre‐eclampsia. Women receiving calcium supplements may also be less likely to die or have serious problems related to pre‐eclampsia (low‐quality evidence) and high blood pressure. Babies may be less likely to be born preterm (low‐quality evidence). The syndrome of haemolysis, elevated liver enzymes and low platelets was increased with calcium, but the absolute numbers were small (high‐quality evidence). High‐dose calcium did not have a clear effect on babies admitted to neonatal intensive care, or the number of stillbirths or deaths before discharge from hospital. </p> <p>Further research is needed into the ideal dosage of supplementation. Limited evidence from 12 trials (2334 women) suggested that a relatively low dose of calcium may be effective in reducing pre‐eclampsia, high blood pressure, and babies admitted to intensive care (however, the quality of the evidence on calcium alone was reduced because eight of the included trials gave other medicines alongside calcium, such as vitamin D, linoleic acid or antioxidants). Low‐dose calcium did not have a clear effect on preterm birth, stillbirth or death before discharge from hospital. </p> <p>One small study compared high‐dose calcium with low‐dose calcium. Pre‐eclampsia appeared to be reduced in the high‐dose group, but no other differences were found in preterm birth, or stillbirth. </p> <p><b>What does this mean?</b> </p> <p>In settings where dietary calcium is low, supplementation is an important strategy to reduce the serious consequences of pre‐eclampsia. Where high‐dose supplementation is not feasible, the option of lower dose supplements (500 milligrams (mg) to 600 mg daily) might be considered in preference to no supplementation. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD001059-sec-0147" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD001059-sec-0147"></div> <h3 class="title" id="CD001059-sec-0148">Implications for practice</h3> <section id="CD001059-sec-0148"> <p>The possible reduction in hypertension, pre‐eclampsia and preterm birth (low‐quality evidence), and the reduction in the composite outcome 'maternal death or severe morbidity' (high‐quality evidence) with high‐dose calcium supplementation should be considered when making decisions about the use of calcium supplementation during pregnancy, particularly for those with low dietary intake or high risk of pre‐eclampsia. Based on evidence included in the previous version of this review, which was limited to high‐dose calcium supplementation, the World Health Organization recommends a calcium dose of 1.5 g to 2 g during pregnancy for women with low dietary calcium intake (<a href="./references#CD001059-bbs2-0123" title="World Health Organization. WHO recommendations for prevention and treatment of pre‐eclampsia and eclampsia. whqlibdoc.who.int/publications/2011/9789241548335_eng.pdf2011. ">WHO 2011</a>). However, this recommendation may be associated with logistical difficulties in low‐income countries: calcium is relatively expensive, and the tablets are bulky and heavy (about 1 kg for a 20‐week supply of calcium carbonate and glycine, providing 1.5 g elemental calcium daily). Implementation may be subject to competing priorities in low‐resource settings. The current updated review adds limited data on the effects of lower calcium dosage, which may guide pragmatic decisions in settings where high‐dose supplementation is unachievable. </p> <p>The increase in the risk of haemolysis, elevated liver enzymes and low platelets (HELLP) syndrome was small in terms of absolute numbers. Therefore, we consider this limitation to be outweighed by the overall reduction in death or severe morbidity which is associated with calcium supplementation. </p> <p>The one study which enrolled women with high risk of pre‐eclampsia and adequate dietary calcium was too small to guide practice. </p> <p>Evidence on the effects of calcium supplementation combined with low‐dose aspirin (not included in this review) should also be considered. </p> </section> <h3 class="title" id="CD001059-sec-0149">Implications for research</h3> <section id="CD001059-sec-0149"> <p>Epidemiological studies have found a difference in dietary calcium intake between high‐ and low‐income settings of about 500 mg. Doses of 1.5 g/day and higher are well above daily recommended dietary calcium intake. Some women find it difficult to swallow or chew three to four large tablets daily, which may affect adherence. Furthermore, doses in excess of 800 mg daily may inhibit iron absorption. Therefore, further research is necessary to determine the optimal dose of calcium supplements in pregnancy. It would also be relevant to assess whether supplementation via dietary modification, for women with low calcium intake, has the same benefits as the tablets administered in these trials. </p> <p>Further research is needed to determine the effectiveness of calcium supplementation in women with high risk of pre‐eclampsia and adequate dietary calcium. </p> <p>Further research is also needed to provide reassurance that calcium supplementation during pregnancy does not have any adverse effects for the children exposed whilst in utero, and to verify whether it reduces childhood hypertension. </p> <p>The increase in the risk of HELLP syndrome identified by this review requires further investigation. Any future trials should also collect information about the use of health service resources, as well as other clinical outcomes. </p> <p>In most of the studies reviewed, supplementation was commenced around 20 weeks of pregnancy. In one small trial of low‐dose calcium supplementation, commencing at eight to 12 weeks in high‐risk women, there was an unanticipated trend to reduced miscarriage. This interesting observation needs to be explored further in prospective research. </p> <p>We have hypothesised, based on the finding in this review of no effect of calcium supplementation on proteinuria, that the benefits of calcium supplementation in the second half of pregnancy may be the result of a direct lowering effect on blood pressure, and that supplementation may be needed from before pregnancy to affect the genesis of pre‐eclampsia during placental development. This hypothesis is addressed in a separate review (<a href="./references#CD001059-bbs2-0098" title="HofmeyrGJ , ManyameS . Calcium supplementation commencing before or early in pregnancy, or food fortification with calcium, for preventing hypertensive disorders of pregnancy. Cochrane Database of Systematic Reviews2017, Issue 9. [DOI: 10.1002/14651858.CD011192.pub2] ">Hofmeyr 2017</a>). </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD001059-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD001059-sec-0029"></div> <div class="table" id="CD001059-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Calcium supplementation compared with placebo for preventing hypertensive disorders and related problems in pregnancy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population: pregnant women</b> </p> <p><b>Settings: outpatient</b> </p> <p><b>Intervention: high‐dose calcium (≥ 1 g/day)</b> </p> <p><b>Comparison: placebo</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>No calcium</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Calcium</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Pre‐eclampsia</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Overall</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 0.45</b> (0.31 to 0.65) </p> <p><b>RR 0.36</b> (0.20 to 0.65) </p> <p><b>RR 0.22</b> (0.12 to 0.42) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>15,730<br/> (13) </p> <p>10,678</p> <p>(8)</p> <p>587</p> <p>(5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>1</sup> </p> <p>⊕⊕⊝⊝<br/> low<sup>1</sup> </p> <p>⊕⊕⊝⊝<br/> low<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>65 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>29 per 1000</b><br/> (20 to 42) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Low‐calcium diet</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>57 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>21 per 1000</b><br/> (11 to 37) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High‐risk women</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>176 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>38 per 1000</b><br/> (21 to 74) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Preterm birth</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Overall</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.76</b> (0.60 to 0.97) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>15,275<br/> (11) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>104 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>79 per 1000</b><br/> (62 to 101) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>HELLP syndrome</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>1 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>3 per 1000</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 2.67</b> (1.05 to 6.82) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12,901</p> <p>(2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊕<br/> high </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded two levels due to heterogeneity and small study effects (‐2) </p> <p>CI: confidence interval<br/> HELLP: haemolysis, elevated liver enzymes and low platelets<br/> RR: risk ratio </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD001059-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD001059-sec-0030"></div> <section id="CD001059-sec-0031"> <h3 class="title" id="CD001059-sec-0031">Description of the condition</h3> <p>High blood pressure, with or without proteinuria, is a major cause of maternal death and morbidity (<a href="./references#CD001059-bbs2-0081" title="BetránAP , WojdylaD , PosnerSF , GülmezogluAM . National estimates for maternal mortality: an analysis based on the WHO systematic review of maternal mortality and morbidity. BMC Public Health2005;5:131. ">Betrán 2005</a>; <a href="./references#CD001059-bbs2-0085" title="ClarkSL , BelfortMA , DildyGA , HerbstMA , MeyersJA , HankinsGD . Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery. American Journal of Obstetrics and Gynecology2008;199(1):36.e1‐e5. ">Clark 2008</a>; <a href="./references#CD001059-bbs2-0095" title="HMSO . Report on confidential enquiries into maternal deaths in the United Kingdom 1988‐1990. Department of Health Welsh Office, Scottish Office Home and Health Department, Department of Health and Social Security, Northern Ireland. London: HMSO, 1994. ">HMSO 1994</a>; <a href="./references#CD001059-bbs2-0102" title="KhanKS , WojdylaD , SayL , GulmezogluAM , VanLookPF . WHO analysis of causes of maternal death: a systematic review. Lancet2006;367:1066–74. ">Khan 2006</a>; <a href="./references#CD001059-bbs2-0109" title="NHMRC . NHMRC Report on Maternal Deaths in Australia 1988‐1990. Canberra: Government Publishing Service, 1993. ">NHMRC 1993</a>), and perinatal morbidity and mortality (<a href="./references#CD001059-bbs2-0105" title="LangenveldJ , RavelliAC , vanKaamAH , van derHamDP , vanPampusMG , PorathM , et al. Neonatal outcome of pregnancies complicated by hypertensive disorders between 34 and 37 weeks of gestation: a 7 year retrospective analysis of a national registry. American Journal of Obstetrics and Gynecology2011;205(6):540.e1‐540.e7. ">Langenveld 2011</a>; <a href="./references#CD001059-bbs2-0110" title="OzkanH , CetinkayaM , KoksalN , OzmenA , YıldızM . Maternal preeclampsia is associated with an increased risk of retinopathy of prematurity. Journal of Perinatal Medicine2011;39(5):523‐7. ">Ozkan 2011</a>), worldwide. Hypertension has been estimated to complicate 5% of all pregnancies and 11% of first pregnancies, half associated with pre‐eclampsia, and to account for up to 40,000 maternal deaths annually (<a href="./references#CD001059-bbs2-0121" title="VillarJ , SayL , ShennanA , LindheimerM , DuleyL , Conde‐AgudeloA , et al. Methodological and technical issues related to the diagnosis, screening, prevention and treatment of pre‐eclampsia and eclampsia. International Journal of Gynecology &amp; Obstetrics2004;85(Suppl 1):S28‐S41. ">Villar 2004</a>). For this reason, strategies to reduce the risk of hypertensive disorders of pregnancy have received considerable attention (<a href="./references#CD001059-bbs2-0082" title="BucherHC , GuyattGH , CookRJ . Effect of calcium supplementation on pregnancy‐induced hypertension and preeclampsia: a meta‐analysis of randomized controlled trials. JAMA1996;275:1113‐7. ">Bucher 1996</a>; <a href="./references#CD001059-bbs2-0083" title="CarroliG , DuleyL , BelizanJM , VillarJ . Calcium supplementation during pregnancy: a systematic review of randomised controlled trials. British Journal of Obstetrics and Gynaecology1994;101(9):753‐8. ">Carroli 1994</a>; <a href="./references#CD001059-bbs2-0086" title="CLASP (Collaborative Low‐dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomised trial of low‐dose aspirin for the prevention and treatment of pre‐eclampsia among 9364 pregnant woman. Lancet1994;343:619‐29. ">CLASP 1994</a>; <a href="./references#CD001059-bbs2-0089" title="ECPPA (Estudo Collaborativo para Prevenção da Pre‐eclampsia com Aspirina) Collaborative Group. ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant woman. British Journal of Obstetrics and Gynaecology1996;103:39‐47. ">ECCPA 1996</a>). </p> <p>Spontaneous and medically induced preterm birth is commonly associated with hypertensive disorders. It is the leading cause of early neonatal death and infant mortality, particularly in low‐income countries (<a href="./references#CD001059-bbs2-0118" title="VillarJ , EzcurraEJ , Gurtner de la FuenteV , CampodonicoL . Preterm delivery syndrome: the unmet need. Research and Clinical Forums1994;16:9‐39. ">Villar 1994</a>). Preterm survivors are at high risk of significant morbidity, especially respiratory disease and its sequelae, and long‐term neurological morbidity (<a href="./references#CD001059-bbs2-0100" title="JohnsonA , TownshendP , YudkinP , BullD , WilkinsonAR . Functional abilities at age 4 years of children born before 29 weeks gestation. BMJ1993;306:1715‐8. ">Johnson 1993</a>). Interventions to reduce preterm birth have been reviewed by Villar and colleagues (<a href="./references#CD001059-bbs2-0119" title="VillarJ , GulmezogluAM , deOnisM . Nutritional and antimicrobial interventions to prevent preterm birth: an overview of randomized controlled trials. Obstetrical and Gynecological Survey1998;53(9):575‐85. ">Villar 1998</a>). </p> <p>During early pregnancy, blood pressure normally falls; it then climbs slowly in later pregnancy to reach pre‐pregnancy levels at term (<a href="./references#CD001059-bbs2-0116" title="VillarJ , RepkeJ , MarkushL , CalvertW , RhoadsG . The measuring of blood pressure during pregnancy. American Journal of Obstetrics and Gynecology1989;161:1019‐24. ">Villar 1989</a>). These normal changes in blood pressure make the diagnosis of hypertension during pregnancy difficult. Clinical methods of measuring blood pressure are also subject to considerable inaccuracy (<a href="./references#CD001059-bbs2-0121" title="VillarJ , SayL , ShennanA , LindheimerM , DuleyL , Conde‐AgudeloA , et al. Methodological and technical issues related to the diagnosis, screening, prevention and treatment of pre‐eclampsia and eclampsia. International Journal of Gynecology &amp; Obstetrics2004;85(Suppl 1):S28‐S41. ">Villar 2004</a>). A widely accepted definition, however, is a diastolic blood pressure equal to or greater than 90 millimetres of mercury (mmHg) or systolic pressure equal to or greater than 140 mmHg before the onset of labour (<a href="./references#CD001059-bbs2-0108" title="National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. American Journal of Obstetrics and Gynecology2000;183:S1‐S22. ">NHBPEP 2000</a>). The consequences of high blood pressure are more serious if there is associated proteinuria. Hypertension and significant proteinuria (1+ by dipstick testing, equal to or greater than 300 mg per 24 hours, or equal to or greater than 30 mg per decilitre (dL)) (<a href="./references#CD001059-bbs2-0108" title="National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. American Journal of Obstetrics and Gynecology2000;183:S1‐S22. ">NHBPEP 2000</a>), usually indicate the presence of pre‐eclampsia. The urine protein to creatinine ratio has been used increasingly as a measure of proteinuria (<a href="./references#CD001059-bbs2-0124" title="YamasmitW , ChaithongwongwatthanaS , CharoenvidhyaD , UerpairojkitB , TolosaJ . Random urinary protein‐to‐creatinine ratio for prediction of significant proteinuria in women with preeclampsia. Journal of Maternal‐Fetal &amp; Neonatal Medicine2004;16:275‐9. ">Yamasmit 2004</a>). Predictors of poor outcome include low gestational age and high levels of proteinuria (<a href="./references#CD001059-bbs2-0122" title="vonDadelszenP , MageeLA , DevarakondaRM , HamiltonT , AinsworthLM , YinR , et al. The prediction of adverse maternal outcomes in pre‐eclampsia. Journal of Obstetrics and Gynaecology Canada: JOGC2004;26:871‐9. ">von Dadelszen 2004</a>). </p> </section> <section id="CD001059-sec-0032"> <h3 class="title" id="CD001059-sec-0032">Description of the intervention</h3> <p>Calcium supplementation is an oral dietary supplement, usually in the form of calcium carbonate or calcium gluconate. The dose is expressed in terms of the amount of elemental calcium in the preparation. </p> </section> <section id="CD001059-sec-0033"> <h3 class="title" id="CD001059-sec-0033">How the intervention might work</h3> <p>An inverse relationship between calcium intake and hypertensive disorders of pregnancy was first described in 1980 (<a href="./references#CD001059-bbs2-0077" title="BelizanJM , VillarJ . The relationship between calcium intake and edema, proteinuria, and hypertension‐gestosis: an hypothesis. American Journal of Clinical Nutrition1980;33:2202‐10. ">Belizan 1980</a>). This was based on the observation that Mayan Indians in Guatemala, who traditionally soak their corn in lime before cooking, had a high calcium intake and a low incidence of pre‐eclampsia and eclampsia. A very low prevalence of pre‐eclampsia had been reported from Ethiopia where the diet, among other features, contained high levels of calcium (<a href="./references#CD001059-bbs2-0091" title="HamlinRHJ . Prevention of pre‐eclampsia. Lancet1962;1:864‐5. ">Hamlin 1962</a>). These observations were supported by other epidemiological and clinical studies (<a href="./references#CD001059-bbs2-0078" title="BelizanJM , VillarJ , RepkeJ . The relationship between calcium intake and pregnancy‐induced hypertension: up‐to‐date evidence. American Journal of Obstetrics and Gynecology1988;158:898‐902. ">Belizan 1988</a>; <a href="./references#CD001059-bbs2-0090" title="HamlinRHJ . The prevention of eclampsia and pre‐eclampsia. Lancet1952;i:64‐8. ">Hamlin 1952</a>; <a href="./references#CD001059-bbs2-0111" title="RepkeJT , VillarJ . Pregnancy‐induced hypertension and low birth weight: the role of calcium. American Journal of Clinical Nutrition1991;54:237S‐241S. ">Repke 1991</a>; <a href="./references#CD001059-bbs2-0115" title="VillarJ , BelizanJM , FischerPJ . Epidemiologic observations on the relationship between calcium intake and eclampsia. International Journal of Gynecology &amp; Obstetrics1983;21:271‐8. ">Villar 1983</a>; <a href="./references#CD001059-bbs2-0025" title="RepkeJT , VillarJ , AndersonC , ParejaG , DubinN , BelizanJM . Biochemical changes associated with blood pressure reduction induced by calcium supplementation during pregnancy. American Journal of Obstetrics and Gynecology1989;160:684‐90. VillarJ , RepkeJ , BelizanJM , ParejaG . Calcium supplementation reduces blood pressure during pregnancy: results of a randomized controlled clinical trial. Obstetrics &amp; Gynecology1987;70:317‐22. ">Villar 1987</a>; <a href="./references#CD001059-bbs2-0117" title="VillarJ , BelizanJM , FisherPJ . Epidemiologic observation on the relationship between calcium intake and eclampsia. International Journal of Gynecology &amp; Obstetrics1993;21:271‐8. ">Villar 1993</a>), and led to the hypothesis that an increase in calcium intake during pregnancy might reduce the incidence of high blood pressure and pre‐eclampsia among women with low calcium intake. An association has been found between pre‐eclampsia and hypocalciuria (<a href="./references#CD001059-bbs2-0114" title="SegoviaBL , VegaIT , VillarrealEC , LiconaNA . Hypocalciuria during pregnancy as a risk factor of preeclampsia. Ginecologia y Obstetricia de Mexico2004;72:570‐4. ">Segovia 2004</a>); lower urine calcium to creatinine ratio (<a href="./references#CD001059-bbs2-0101" title="KazerooniT , Hamze‐NejadiS , KazerooniT , Hamze‐NejadiS . Calcium to creatinine ratio in a spot sample of urine for early prediction of pre‐eclampsia. International Journal of Gynecology &amp; Obstetrics2003;80:279‐83. ">Kazerooni 2003</a>); hypocalcaemia (<a href="./references#CD001059-bbs2-0104" title="KumruS , AydinS , SimsekM , SahinK , YamanM , AyG . Comparison of serum copper, zinc, calcium, and magnesium levels in preeclamptic and healthy pregnant women. Biological Trace Element Research2003;94:105‐12. ">Kumru 2003</a>); lower plasma and higher membranous calcium (<a href="./references#CD001059-bbs2-0103" title="KistersK , BarenbrockM , LouwenF , HausbergM , RahnKH , KoschM . Membrane, intracellular, and plasma magnesium and calcium concentrations in preeclampsia. American Journal of Hypertension2000;13:765‐9. ">Kisters 2000</a>); lower dietary milk intake (<a href="./references#CD001059-bbs2-0088" title="DuvekotEJ , deGrootCJ , BloemenkampKW , OeiSG . Pregnant women with a low milk intake have an increased risk of developing preeclampsia. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2002;105:11‐4. ">Duvekot 2002</a>); and between eclampsia and hypocalcaemia (<a href="./references#CD001059-bbs2-0099" title="IsezuoSA , EkeleBA . Eclampsia and abnormal QTc. West African Journal of Medicine2004;23:123‐7. ">Isezuo 2004</a>). </p> <p>Low calcium intake may cause high blood pressure by stimulating either parathyroid hormone or renin release, thereby increasing intracellular calcium in vascular smooth muscle (<a href="./references#CD001059-bbs2-0078" title="BelizanJM , VillarJ , RepkeJ . The relationship between calcium intake and pregnancy‐induced hypertension: up‐to‐date evidence. American Journal of Obstetrics and Gynecology1988;158:898‐902. ">Belizan 1988</a>), and leading to vasoconstriction. A possible mode of action for calcium supplementation is that it reduces parathyroid release and intracellular calcium, and so reduces smooth muscle contractility. By a similar mechanism, calcium supplementation could also reduce uterine smooth muscle contractility and prevent preterm labour and delivery (<a href="./references#CD001059-bbs2-0026" title="VillarJ , BelizanJM , RepkeJ . The effect of calcium supplementation on the incidence of hypertensive disorders of pregnancy and prematurity. 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy. 1990:54. VillarJ , BelizanJM , RepkeJT . Does calcium supplementation reduce pregnancy‐induced hypertension and prematurity?. Advances in the prevention of low birthweight; 1988 May 8‐11; Cape Cod, Massachusetts. 1998:187‐95. VillarJ , RepkeJT . Calcium supplementation during pregnancy may reduce preterm delivery in high‐risk populations. American Journal of Obstetrics and Gynecology1990;163:1124‐31. ">Villar 1990</a>). Calcium might also have an indirect effect on smooth muscle function by increasing magnesium levels (<a href="./references#CD001059-bbs2-0061" title="RepkeJ , VillarJ , BergelE , BelizanJM . The effect of iron absorption in patients receiving calcium supplementation. 9th Annual Meeting of the Society of Perinatal Obstetricians; 1989 February 1‐4; New Orleans, Louisiana, USA. 1989:512. ">Repke 1989</a>). Recent evidence indicates that calcium supplementation affects uteroplacental blood flow (it lowers the resistance index in uterine and umbilical arteries) (<a href="./references#CD001059-bbs2-0084" title="CarroliG , MerialdiM , WojdylaD , AbalosE , CampodonicoL , YaoSE , et al. Effects of calcium supplementation on uteroplacental and fetoplacental blood flow in low‐calcium‐intake mothers: a randomized controlled trial. American Journal of Obstetrics and Gynecology2010; Vol. 202:45.e1‐45.e9. ">Carroli 2010</a>). Supplementation in the second half of pregnancy appears to reduce blood pressure directly, rather than preventing the endothelial damage associated with pre‐eclampsia (<a href="./references#CD001059-bbs2-0097" title="HofmeyrGJ , MlokotiZ , NikodemVC , MangesiL , FerreiraS , SingataM , et al. Calcium supplementation during pregnancy for preventing hypertensive disorders is not associated with changes in platelet count, urate, and urinary protein: a randomized control trial. Hypertension in Pregnancy2008;27(3):299‐304. ">Hofmeyr 2008</a>). </p> <p>Calcium supplementation is attractive as a potential intervention to reduce the risk of a woman developing pre‐eclampsia as it is readily available, and is likely to be safe for the woman and her child. In addition, there is a possibility that it may have a preventative effect on the risk of hypertension in offspring (<a href="./references#CD001059-bbs2-0079" title="BelizanJM , VillarJ , BergelE , delPinoA , DiFulvioS , GallianoSV , et al. Long term effect of calcium supplementation during pregnancy on the blood pressure of offspring: follow up of a randomised controlled trial. BMJ1997;315:281‐5. ">Belizan 1997</a>). A theoretical risk of increased renal tract stone formation, or the occurrence of other adverse effects associated with calcium supplementation, has not been substantiated. </p> </section> <section id="CD001059-sec-0034"> <h3 class="title" id="CD001059-sec-0034">Why it is important to do this review</h3> <p>Calcium supplementation was tested in several randomised trials, commencing in the late 1980s, which suggested a promising beneficial effect on hypertensive disorders and related problems. The first systematic reviews highlighted the need for larger trials to assess the effects on important clinical outcomes in addition to pre‐eclampsia and preterm delivery, such as perinatal mortality (<a href="./references#CD001059-bbs2-0083" title="CarroliG , DuleyL , BelizanJM , VillarJ . Calcium supplementation during pregnancy: a systematic review of randomised controlled trials. British Journal of Obstetrics and Gynaecology1994;101(9):753‐8. ">Carroli 1994</a>; <a href="./references#CD001059-bbs2-0126" title="DuleyL . Routine calcium supplementation in pregnancy. [revised 23 June 1993] In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM]. The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995. ">Duley 1995</a>). A subsequent systematic review came to more promising conclusions (<a href="./references#CD001059-bbs2-0082" title="BucherHC , GuyattGH , CookRJ . Effect of calcium supplementation on pregnancy‐induced hypertension and preeclampsia: a meta‐analysis of randomized controlled trials. JAMA1996;275:1113‐7. ">Bucher 1996</a>), but these findings were not confirmed by a large trial in the USA (<a href="./references#CD001059-bbs2-0007" title="HabliM , LevineRJ , QianC , SibaiB . Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. American Journal of Obstetrics and Gynecology2007;197(4):406.e1‐406.e7. HattonDC , Harrison‐HohnerJ , CosteS , RellerM , McCarronD . Gestational calcium supplementation and blood pressure in the offspring. American Journal of Hypertension2003;16:801‐5. Levine RJ for the CPEP Study Group. Calcium for preeclampsia prevention (CPEP): a double‐blind, placebo‐controlled trial in healthy nulliparas. American Journal of Obstetrics and Gynecology1997;176:S2. Levine RJ for the CPEP Study Group. The trial of calcium for preeclampsia prevention (CPEP). 8th World Congress on Hypertension in Pregnancy ‐ Protagonists and Presentations; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. LevineRJ , EsterlitzJR , RaymondEG , DerSimonianR , HauthJC , Ben CuretL , et al. Trial of calcium for preeclampsia prevention (CPEP): rationale, design, and methods. Controlled Clinical Trials1996;17:442‐69. LevineRJ , HauthJC , CuretLB , SibaiBM , CatalanoPM , MorrisCD , et al. Trial of calcium to prevent preeclampsia. New England Journal of Medicine1997;337(2):69‐76. NCT00000534 . Calcium for pre‐eclampsia prevention (CPEP). clinicaltrials.gov/ct2/show/record/NCT00000534 (first received 27 October 1999). ">CPEP 1997</a>), and the discrepancy elicited discussion (<a href="./references#CD001059-bbs2-0120" title="VillarJ , BelizanJM . Same nutrient, different hypotheses: disparities in trials of calcium supplementation during pregnancy. American Journal of Clinical Nutrition2000;71 Suppl:1375S‐1379S. ">Villar 2000</a>). Subsequently, a large trial conducted in communities with low dietary calcium intake has been reported (<a href="./references#CD001059-bbs2-0027" title="AbalosE , MerialdiM , WojdylaD , CarroliG , CampodónicoL , YaoSE , et al. Effects of calcium supplementation on fetal growth in mothers with deficient calcium intake: a randomised controlled trial. Paediatric and Perinatal Epidemiology2010;24(1):53‐62. Abdel‐AleemH , MerialdiM , ElsnosyED , ElsedfyGO , Abdel‐AleemMA , VillarJ . The effect of calcium supplementation during pregnancy on fetal and infant growth: a nested randomized controlled trial within WHO calcium supplementation trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2009;22(2):94‐100. CarroliG , MerialdiM , WojdylaD , AbalosE , CampodonicoL , YaoSE , et al. Effects of calcium supplementation on uteroplacental and fetoplacental blood flow in low‐calcium‐intake mothers: a randomized controlled trial. American Journal of Obstetrics and Gynecology2010;202(1):45.e1‐45.e9. HofmeyrGJ , MlokotiZ , NikodemVC , MangesiL , FerreiraS , SingataM , et al. Calcium supplementation during pregnancy for preventing hypertensive disorders is not associated with changes in platelet count, urate, and urinary protein: a randomized control trial. Hypertension in Pregnancy2008;27(3):299‐304. VillarJ , Abdel‐AleemH , MerialdiM , MathaiM , AliM , ZavaletaN , et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. American Journal of Obstetrics and Gynecology2006;194:639‐49. VillarJ , AleemHA , MerialdiM , MathaiM , AliM , ZavaletaN , et al. WHO randomized trial of calcium supplementation among low calcium intake pregnant women [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S2. VillarJ , ISRCTN37214165 . Calcium supplementation during pregnancy in low‐intake populations. isrctn.com/ISRCTN37214165 (first received 19 March 2014). ZhangJ , VillarJ , SunW , MerialdiM , Abdel‐AleemH , MathaiM , et al. Blood pressure dynamics during pregnancy and spontaneous preterm birth. American Journal of Obstetrics and Gynecology2007;197(2):162.e1‐6. ">WHO 2006</a>). In 2012 the World Health Organization (WHO) published guidelines recommending calcium supplementation with 1.5 g to 2 g elemental calcium daily for pregnant women with low dietary calcium. This recommendation has raised questions regarding the optimum dosage of calcium. </p> <p> <ol id="CD001059-list-0001"> <li> <p>The WHO recommendation was based on available data from randomised trials. Most of the high‐quality trials reviewed used 1.5 g to 2 g of calcium daily, and there was little robust evidence regarding smaller dosages. </p> </li> <li> <p>The dosage of 1.5 g to 2 g calcium daily is well above the daily recommended dietary calcium of 1 g to 1.2 g. </p> </li> <li> <p>Logistically, calcium in this dosage is heavy to transport. Calcium carbonate plus glycine tablets containing 1.5 g elemental calcium and glycine daily (= 3750 mg calcium carbonate plus glycine) weigh about 200 g for a four‐week supply (84 tablets). This would amount to about 1 kg of tablets for 20 weeks, therefore, a clinic seeing 1000 pregnant women per year would need to receive 1000 kg of tablets each year. </p> </li> <li> <p>The cost of calcium is moderately high (compared with supplements such as iron and folate), and the dosage thus has important cost implications. </p> </li> <li> <p>A 2010 report from the Gambia study (<a href="./references#CD001059-bbs2-0011" title='GoldbergG , YinJ , JarjouL , PrenticeA . Maternal calcium supplementation during pregnancy and blood pressure in rural Gambian children at 3 and 9 years old. Annals of Nutrition &amp; Metabolism2013;63(Suppl 1):728, Abstract no: PO982. GoldbergGR , JarjouLM , ColeTJ , PrenticeA . Randomized, placebo‐controlled, calcium supplementation trial in pregnant Gambian women accustomed to a low calcium intake: effects on maternal blood pressure and infant growth. American Journal of Clinical Nutrition2013;98(4):972‐82. HawkesworthS , SawoY , FulfordAJ , GoldbergGR , JarjouLM , PrenticeA , et al. Effect of maternal calcium supplementation on offspring blood pressure in 5‐ to 10‐y‐old rural Gambian children. American Journal of Clinical Nutrition2010;92(4):741‐7. HawkesworthS , WalkerCG , SawoY , FulfordAJ , JarjouLM , GoldbergGR , et al. Nutritional supplementation during pregnancy and offspring cardiovascular disease risk in The Gambia. American Journal of Clinical Nutrition2011;94(6 Suppl):1853S‐1860S. JarjouLM , LaskeyMA , SawoY , GoldbergGR , ColeTJ , PrenticeA . Effect of calcium supplementation in pregnancy on maternal bone outcomes in women with a low calcium intake. American Journal of Clinical Nutrition2010;92(2):450‐7. JarjouLM , PrenticeA , BennettJ . Impact of calcium supplementation in the preceding pregnancy on the human milk calcium concentration of Gambian women. Advances in Experimental Medicine and Biology2004;54:347‐9. JarjouLM , PrenticeA , SawoY , LaskeyMA , BennettJ , GoldbergGR , et al. Randomized, placebo‐controlled, calcium supplementation study in pregnant Gambian women: effects on breast‐milk calcium concentrations and infant birth weight, growth, and bone mineral accretion in the first year of life. American Journal of Clinical Nutrition2006;83(3):657‐66. JarjouLMA , BennettJ , LaidlawA , GoldbergGR , PrenticeA . Changes in bone turnover and calcitrophic hormones in lactating Gambian women supplemented with calcium during pregnancy. Journal of Human Lactation2007;23(1):86‐7. JarjouLMA , SawoY , GoldbergGR , LaskeyMA , ColeTJ , PrenticeA . Persistent effects of calcium supplementation during pregnancy on maternal bone mineral content: a follow‐up study in Gambian women. Proceedings of the 16th ISRHML Conference "Breastfeeding and the Use of Human Milk. Science and Practice"; 2012 September 27th ‐ October 1st; Trieste, Italy. 2012:Abstract no.:105. JarjouMA , YankubaS , GoldbergR , LaskeyMA , ColeJ , PrenticeA . Unexpected long‐term effects of calcium supplementation in pregnancy on maternal bone outcomes in women with a low calcium intake: a follow‐up study. American Journal of Clinical Nutrition2013;98(3):723‐30. PrenticeA , GoldbergGR , JarjouLMA . The effects of pregnancy calcium supplementation on calcium metabolism after lactation in Gambian women with a low calcium intake. Breastfeeding Medicine2016;11(2):A‐20‐A‐21, Abstract no: P‐8. PrenticeA , ISRCTN72582014 . Effects on birth weight and perinatal mortality of maternal dietary supplements in rural Gambia: 5 year randomised controlled trial. isrctn.com/ISRCTN72582014 (first received 27 March 2013). PrenticeA , ISRCTN96502494 . Calcium requirements of pregnant women in The Gambia. isrctn.com/ISRCTN96502494 (first received 6 November 2007). PrenticeA , JarjouLM , GoldbergGR , BennettJ , ColeTJ , SchoenmakersI . Maternal plasma 25‐hydroxyvitamin D concentration and birthweight, growth and bone mineral accretion of Gambian infants. Acta Paediatrica2009;98(8):1360‐2. WardKA , JarjouL , PrenticeA . Maternal calcium supplementation and offspring growth. Osteoporosis International2016;27(1 Suppl 1):S327‐8. WardKA , PrenticeA , JarjouL . Long‐term effects of maternal calcium supplementation on childhood growth differ between males and females in a population accustomed to a low calcium intake. Bone2017;103:31‐8. '>Jarjou 2004</a>) has suggested that calcium at the dosage of 1.5 g daily during pregnancy may impair the mother's ability to conserve calcium, causing rebound bone demineralisation following pregnancy. Although there are limitations to this study (conclusions were based on a sub‐set of women from the original trial; the hypothesis was not prespecified; multiple end‐point testing), the possibility of adverse effects due to the interruption of high‐dose calcium supplementation in women who have previously adapted to low dietary calcium intake is reason for caution. </p> </li> </ol> </p> <p>For these reasons, when updating this review, we considered it important to systematically review the evidence on lower dosages of calcium supplementation in pregnancy. Originally, we had specified that randomised controlled trials with dosages below 1 g daily would be reviewed in subsequent updates of this review. However, in view of the lack of high‐quality trials of lower dosages, we revised the review to include lower quality studies (e.g. quasi‐randomised trials) of lower dosage studies only. </p> <p>This is an update of a review last published in 2014.</p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD001059-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD001059-sec-0035"></div> <p>To assess the effects of calcium supplementation during pregnancy on hypertensive disorders of pregnancy and related maternal and child outcomes. </p> <p>Subgroup analyses tested whether these effects were influenced by whether:</p> <p> <ol id="CD001059-list-0002"> <li> <p>women had low or adequate dietary calcium intake prior to trial entry;</p> </li> <li> <p>women were at low or average risk of hypertensive disorders, or at high risk.</p> </li> </ol> </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD001059-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD001059-sec-0036"></div> <section id="CD001059-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD001059-sec-0038"> <h4 class="title">Types of studies</h4> <p>All published, unpublished and ongoing randomised controlled trials. We included trials that were presented only as abstracts if there was sufficient detail (published and unpublished) to confirm eligibility. For the original review of high‐dose calcium supplementation we excluded quasi‐random designs. However, for the 2012 update we included trials employing these weaker study designs (e.g. quasi‐randomisation by alternation, unstated or other methods), only for the subgroup of trials of calcium supplementation less than 1 g daily (low dose), with appropriate caution in the interpretation of the results. The reason for the discrepancy between high‐dose and low‐dose trials is that there are adequate data from appropriately randomised, placebo controlled trials of high‐dose but not low‐dose calcium supplementation for review. Cluster‐randomised trials were also eligible for inclusion. </p> <p>Because of the addition of a comparison of trials of low‐dose calcium supplementation, it was also of interest to include trials comparing high‐ with low‐dose supplementation. Please see <a href="#CD001059-sec-0172">Differences between protocol and review</a> for details. </p> </section> <section id="CD001059-sec-0039"> <h4 class="title">Types of participants</h4> <p>Pregnant women, regardless of the risk of hypertensive disorders of pregnancy. We excluded women with diagnosed hypertensive disorders of pregnancy. We did not exclude women with multiple pregnancy. </p> <p>Prespecified subgroups to be compared were as follows.</p> <p> <ol id="CD001059-list-0003"> <li> <p>Women at low or average risk of hypertensive disorders of pregnancy (unselected)</p> </li> <li> <p>Women at above average risk of hypertensive disorders of pregnancy. These included women selected by the trial authors on the basis of an increased risk of hypertensive disorders of pregnancy (e.g. teenagers or women older than 40 years, women with previous pre‐eclampsia, women with increased sensitivity to angiotensin II, women with pre‐existing hypertension). Primiparity alone was not regarded as a high‐risk factor. </p> </li> <li> <p>Women or populations with low baseline dietary calcium intake (as defined by trial authors, or if not defined, mean intake of less than 900 mg per day) </p> </li> <li> <p>Women or populations with adequate dietary calcium intake (as defined by trial authors, or if not defined, mean intake equal to or greater than 900 mg per day) </p> </li> </ol> </p> </section> <section id="CD001059-sec-0040"> <h4 class="title">Types of interventions</h4> <p>1. High‐dose supplementation (&gt; 1 g elemental calcium daily)</p> <p>Supplementation with calcium from 34 weeks of pregnancy at the latest, compared with placebo treatment. We excluded studies with no placebo. </p> <p>2. Low‐dose supplementation (&lt; 1 g elemental calcium daily)</p> <p>Supplementation with calcium from 34 weeks of pregnancy at the latest, with or without cointerventions (e.g. vitamin D, linoleic acid, anti‐oxidants or anti‐platelet agents), compared with placebo or no treatment. We prespecified the inclusion criteria to be less restrictive than for the high‐dose calcium comparisons because of the relatively small number of studies of low‐dose calcium supplementation; we subgrouped the outcomes by the cointerventions. This was added in the 2013 revision of this review. </p> <p>3. Comparison of different dosages of calcium, added in the 2018 revision of this review. </p> </section> <section id="CD001059-sec-0041"> <h4 class="title">Types of outcome measures</h4> <p>In the original protocol we prespecified 15 clinical measures of maternal and fetal or neonatal morbidity and mortality. In October 2004 we added seven additional outcomes (marked * below). For the 2013 update we added two outcome measures, marked ** below, in order to include newly published data. As such, these should be regarded as post‐hoc analyses, and interpreted with caution. </p> <section id="CD001059-sec-0042"> <h5 class="title">Primary outcomes</h5> <section id="CD001059-sec-0043"> <h6 class="title">For the woman</h6> <p> <ol id="CD001059-list-0004"> <li> <p>High blood pressure as defined by trial authors, with or without proteinuria. Ideally, high blood pressure would be defined as diastolic blood pressure equal to or greater than 90 mmHg, or an increase in systolic blood pressure of 30 mmHg or more, or in diastolic blood pressure of 15 mmHg or more. </p> </li> <li> <p>High blood pressure with significant proteinuria, as defined by trial authors. Ideally, proteinuria would be defined as 2+ by dipstick testing, equal to or greater than 300 mg per 24 hours, or equal to or greater than 500 mg per litre. Although the strict definition of pre‐eclampsia includes confirmation of no hypertension or proteinuria outside pregnancy, for convenience the above definition is referred to in this review as <b>pre‐eclampsia</b>. </p> </li> </ol> </p> </section> <section id="CD001059-sec-0044"> <h6 class="title">For the child</h6> <p> <ol id="CD001059-list-0005"> <li> <p>Preterm birth (birth before 37 weeks of estimated gestation)</p> </li> <li> <p>Admission to a neonatal intensive care unit</p> </li> <li> <p>Stillbirth or death before discharge from hospital</p> </li> </ol> </p> </section> </section> <section id="CD001059-sec-0045"> <h5 class="title">Secondary outcomes</h5> <section id="CD001059-sec-0046"> <h6 class="title">For the woman</h6> <p> <ol id="CD001059-list-0006"> <li> <p>Maternal death or serious morbidity. Serious morbidity includes eclampsia; renal failure; syndrome of haemolysis, elevated liver enzymes and low platelets (HELLP syndrome); and admission to intensive care. This is a composite outcome of death or at least one measure of serious morbidity; in addition we planned to present each individual outcome. </p> </li> <li> <p>Placental abruption</p> </li> <li> <p>Caesarean section</p> </li> <li> <p>*Proteinuria</p> </li> <li> <p>*Severe pre‐eclampsia as defined by trial authors</p> </li> <li> <p>*Eclampsia</p> </li> <li> <p>*HELLP syndrome</p> </li> <li> <p>*Intensive care unit admission</p> </li> <li> <p>*Maternal death</p> </li> <li> <p>Mother's hospital stay of seven days or more</p> </li> <li> <p>**Miscarriage</p> </li> </ol> </p> </section> <section id="CD001059-sec-0047"> <h6 class="title">For the child</h6> <p> <ol id="CD001059-list-0007"> <li> <p>Low birthweight (the first weight obtained after birth less than 2500 g)</p> </li> <li> <p>Neonate small‐for‐gestational age as defined by trial authors</p> </li> <li> <p>Neonate in intensive care unit for seven days or more</p> </li> <li> <p>*Death or severe neonatal morbidity</p> </li> <li> <p>Childhood disability</p> </li> <li> <p>Systolic blood pressure greater than 95th percentile during childhood</p> </li> <li> <p>Diastolic blood pressure greater than 95th percentile during childhood</p> </li> <li> <p>**Dental caries in childhood (one or more decayed, missing or filled teeth, or as defined by trial authors) </p> </li> </ol> </p> <p>Only those outcomes with data appear in the analysis table.</p> </section> <section id="CD001059-sec-0048"> <h6 class="title">Outcomes for 'Summary of findings' table</h6> <p>We included the following GRADE outcomes in the 'Summary of findings' table.</p> <p> <ol id="CD001059-list-0008"> <li> <p>Pre‐eclampsia</p> </li> <li> <p>Preterm birth</p> </li> <li> <p>HELLP syndrome</p> </li> </ol> </p> </section> </section> </section> </section> <section id="CD001059-sec-0049"> <h3 class="title">Search methods for identification of studies</h3> <p>The following methods section of this review is based on a standard template used by Cochrane Pregnancy and Childbirth. </p> <section id="CD001059-sec-0050"> <h4 class="title">Electronic searches</h4> <p>We searched Cochrane Pregnancy and Childbirth’s Trials Register by contacting their Information Specialist (18 September 2017). </p> <p>The Register is a database containing over 24,000 reports of controlled trials in the field of pregnancy and childbirth. For full search methods used to populate Pregnancy and Childbirth’s Trials Register including the detailed search strategies for CENTRAL, MEDLINE, Embase and CINAHL; the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service, please follow this link to the editorial information about the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html" target="_blank">Cochrane Pregnancy and Childbirth</a> in the Cochrane Library and select the 'Specialized Register' section from the options on the left side of the screen. </p> <p>Briefly, Cochrane Pregnancy and Childbirth’s Trials Register is maintained by their Information Specialist and contains trials identified from: </p> <p> <ol id="CD001059-list-0009"> <li> <p>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</p> </li> <li> <p>weekly searches of MEDLINE (Ovid);</p> </li> <li> <p>weekly searches of Embase (Ovid);</p> </li> <li> <p>monthly searches of CINAHL (EBSCO);</p> </li> <li> <p>handsearches of 30 journals and the proceedings of major conferences;</p> </li> <li> <p>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts. </p> </li> </ol> </p> <p>Search results are screened by two people and the full text of all relevant trial reports identified through the searching activities described above is reviewed. Based on the intervention described, each trial report is assigned a number that corresponds to a specific Pregnancy and Childbirth review topic (or topics), and is then added to the Register. The Information Specialist searches the Register for each review using this topic number rather than keywords. This results in a more specific search set that has been fully accounted for in the relevant review sections (<a href="./references#CD001059-bbs1-0001" title="">Included studies</a>; <a href="./references#CD001059-bbs1-0002" title="">Excluded studies</a>; <a href="./references#CD001059-bbs1-0003" title="">Studies awaiting classification</a>; <a href="./references#CD001059-bbs1-0004" title="">Ongoing studies</a>). </p> <p>In addition, we searched <a href="http://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a> and the WHO International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">ICTRP</a>) (18 September 2017) for unpublished, planned and ongoing trial reports using the terms given in <a href="./appendices#CD001059-sec-0153">Appendix 1</a>. </p> </section> <section id="CD001059-sec-0051"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists of retrieved studies.</p> <p>We did not apply any language or date restrictions.</p> </section> </section> <section id="CD001059-sec-0052"> <h3 class="title" id="CD001059-sec-0052">Data collection and analysis</h3> <p>For methods used in the previous version of this review, see <a href="./references#CD001059-bbs2-0130" title="HofmeyrGJ , LawrieTA , AtallahÁN , DuleyL , TorloniMR . Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database of Systematic Reviews2014, Issue 6. [DOI: 10.1002/14651858.CD001059.pub4] ">Hofmeyr 2014</a>. </p> <p>For this update, the following methods were used for assessing the reports that were identified as a result of the updated search. </p> <p>The following methods section of this review is based on a standard template used by Cochrane Pregnancy and Childbirth. </p> <section id="CD001059-sec-0053"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently assessed for inclusion all the potential studies identified as a result of the search strategy. We resolved any disagreement through discussion or, if required, we consulted the third review author. </p> </section> <section id="CD001059-sec-0054"> <h4 class="title">Data extraction and management</h4> <p>We designed a form to extract data. For eligible studies, two review authors extracted the data using the agreed form. We resolved discrepancies through discussion or, if required, we consulted the third review author. Data were entered into Review Manager 5 software (<a href="./references#CD001059-bbs2-0112" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) and checked for accuracy. </p> <p>When information regarding any of the above was unclear, we planned to contact authors of the original reports to provide further details. </p> </section> <section id="CD001059-sec-0055"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD001059-bbs2-0093" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). Any disagreement was resolved by discussion or by involving a third assessor. </p> <section id="CD001059-sec-0056"> <h5 class="title">(1) Random sequence generation (checking for possible selection bias)</h5> <p>We described the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. </p> <p>For each included study we assessed the method as being at:</p> <p> <ol id="CD001059-list-0010"> <li> <p>low risk of bias (any truly random process, e.g. random number table; computer random number generator); </p> </li> <li> <p>high risk of bias (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ol> </p> </section> <section id="CD001059-sec-0057"> <h5 class="title">(2) Allocation concealment (checking for possible selection bias)</h5> <p>For each included study we described the method used to conceal allocation to interventions prior to assignment and assessed whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. </p> <p>We assessed the methods as being at:</p> <p> <ol id="CD001059-list-0011"> <li> <p>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes); </p> </li> <li> <p>high risk of bias (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ol> </p> </section> <section id="CD001059-sec-0058"> <h5 class="title">(3.1) Blinding of participants and personnel (checking for possible performance bias)</h5> <p>For each included study we described the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We considered that studies were at low risk of bias if they were blinded, or if we judged that the lack of blinding was unlikely to affect results. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed the methods as being at:</p> <p> <ol id="CD001059-list-0012"> <li> <p>low, high or unclear risk of bias for participants;</p> </li> <li> <p>low, high or unclear risk of bias for personnel.</p> </li> </ol> </p> </section> <section id="CD001059-sec-0059"> <h5 class="title">(3.2) Blinding of outcome assessment (checking for possible detection bias)</h5> <p>For each included study we described the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed methods used to blind outcome assessment as being at:</p> <p> <ol id="CD001059-list-0013"> <li> <p>low, high or unclear risk of bias.</p> </li> </ol> </p> </section> <section id="CD001059-sec-0060"> <h5 class="title">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data) </h5> <p>For each included study, and for each outcome or class of outcomes, we described the completeness of data including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or could be supplied by the trial authors, we planned to re‐include missing data in the analyses that we undertook. </p> <p>We assessed methods as being at:</p> <p> <ol id="CD001059-list-0014"> <li> <p>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups); </p> </li> <li> <p>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; ‘as treated’ analysis done with substantial departure of intervention received from that assigned at randomisation); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ol> </p> </section> <section id="CD001059-sec-0061"> <h5 class="title">(5) Selective reporting (checking for reporting bias)</h5> <p>For each included study we described how we investigated the possibility of selective outcome reporting bias and what we found. </p> <p>We assessed the methods as being at:</p> <p> <ol id="CD001059-list-0015"> <li> <p>low risk of bias (where it was clear that all of the study’s prespecified outcomes and all expected outcomes of interest to the review have been reported); </p> </li> <li> <p>high risk of bias (where not all the study’s prespecified outcomes were reported; one or more reported primary outcomes were not prespecified; outcomes of interest were reported incompletely and so could not be used; study failed to include results of a key outcome that would have been expected to have been reported); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ol> </p> </section> <section id="CD001059-sec-0062"> <h5 class="title">(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)</h5> <p>For each included study we described any important concerns we had about other possible sources of bias. </p> </section> <section id="CD001059-sec-0063"> <h5 class="title">(7) Overall risk of bias</h5> <p>We made explicit judgements about whether studies were at high risk of bias, according to the criteria given in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD001059-bbs2-0093" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). With reference to (1) to (6) above, we planned to assess the likely magnitude and direction of the bias and whether we considered it was likely to have an impact on the findings. In future updates, we will explore the impact of the level of bias through undertaking sensitivity analyses (<a href="#CD001059-sec-0079">Sensitivity analysis</a>). </p> </section> <section id="CD001059-sec-0064"> <h5 class="title">Assessment of the quality of the evidence using the GRADE approach</h5> <p>For this update we assessed the quality of the evidence using the GRADE approach, as outlined in the <a href="http://gdt.guidelinedevelopment.org/central_prod/_design/client/handbook/handbook.html" target="_blank">GRADE handbook</a>, in order to assess the quality of the body of evidence relating to the following outcomes for our main comparison. </p> <p> <ol id="CD001059-list-0016"> <li> <p>Pre‐eclampsia</p> </li> <li> <p>Preterm birth</p> </li> <li> <p>HELLP syndrome</p> </li> </ol> </p> <p>We used the <a href="http://www.guidelinedevelopment.org/" target="_blank">GRADEpro</a> Guideline Development Tool to import data from Review Manager 5.3 (<a href="./references#CD001059-bbs2-0112" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>), in order to create 'Summary of findings' tables. A summary of the intervention effect and a measure of quality for each of the above outcomes was produced using the GRADE approach. The GRADE approach uses five considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence for each outcome. The evidence can be downgraded from 'high quality' by one level for serious (or by two levels for very serious) limitations, depending on assessments for risk of bias, indirectness of evidence, serious inconsistency, imprecision of effect estimates or potential publication bias. </p> </section> </section> <section id="CD001059-sec-0065"> <h4 class="title">Measures of treatment effect</h4> <section id="CD001059-sec-0066"> <h5 class="title">Dichotomous data</h5> <p>For dichotomous data, we presented results as summary risk ratio with 95% confidence intervals. </p> </section> <section id="CD001059-sec-0067"> <h5 class="title">Continuous data</h5> <p>We used the mean difference if outcomes were measured in the same way between trials. In future updates, as appropriate, we will use the standardised mean difference to combine trials that measure the same outcome, but use different methods. </p> </section> </section> <section id="CD001059-sec-0068"> <h4 class="title">Unit of analysis issues</h4> <section id="CD001059-sec-0069"> <h5 class="title">Cluster‐randomised trials</h5> <p>We have not identified any cluster‐randomised trials to date. We will include any future cluster‐randomised trials in the analyses along with individually randomised trials. We will adjust their sample sizes using the methods described in the <i>Cochrane Handbook</i> using an estimate of the intracluster correlation co‐efficient (ICC) derived from the trial (if possible), from a similar trial or from a study of a similar population. If we use ICCs from other sources, we will report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. If we identify cluster‐randomised trials in addition to the individually‐randomised trials, we plan to synthesise the relevant information. We will consider it reasonable to combine the results from both if there is little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomisation unit is considered to be unlikely. </p> <p>We will also acknowledge heterogeneity in the randomisation unit and perform a sensitivity analysis to investigate the effects of the randomisation unit. </p> </section> <section id="CD001059-sec-0070"> <h5 class="title">Cross‐over trials</h5> <p>Cross‐over trials are not relevant to this review.</p> </section> <section id="CD001059-sec-0071"> <h5 class="title">Other unit of analysis issues</h5> <p>For multiple‐arm trials we have included only the two arms relevant to the review comparisons. We expect inclusion of multiple pregnancies to be rare. If multiple pregnancies are included in future updates of this review, we will analyse the neonates as individual participants. We will make adjustments for cluster effects only if the numbers of multiples are sufficient to justify statistical adjustment. </p> </section> </section> <section id="CD001059-sec-0072"> <h4 class="title">Dealing with missing data</h4> <p>For included studies, we noted levels of attrition. In future updates, if more eligible studies are included, we will use sensitivity analyses to explore the impact of including studies with high levels of missing data in the overall assessment of treatment effect. </p> <p>For all outcomes, analyses were carried out, as far as possible, on an intention‐to‐treat basis, i.e. we attempted to include all participants randomised to each group in the analyses. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing. </p> </section> <section id="CD001059-sec-0073"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity in each meta‐analysis using the Tau², I² and Chi² statistics. We regarded heterogeneity as substantial if I² was greater than 30% and either Tau² was greater than zero, or there was a low P value (less than 0.10) in the Chi² test for heterogeneity. If we identified substantial heterogeneity (above 30%), we planned to explore it by prespecified subgroup analysis. </p> </section> <section id="CD001059-sec-0074"> <h4 class="title">Assessment of reporting biases</h4> <p>We investigated reporting biases (such as publication bias) using funnel plots. We assessed funnel plot asymmetry visually. If asymmetry was suggested by a visual assessment, we performed exploratory analyses to investigate it. </p> </section> <section id="CD001059-sec-0075"> <h4 class="title">Data synthesis</h4> <p>We carried out statistical analysis using Review Manager 5 software (<a href="./references#CD001059-bbs2-0112" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We used fixed‐effect meta‐analysis for combining data where it was reasonable to assume that studies were estimating the same underlying treatment effect, i.e. where trials were examining the same intervention, and the trials’ populations and methods were judged sufficiently similar. </p> <p>If there was clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials, or if substantial statistical heterogeneity was detected, we used random‐effects meta‐analysis to produce an overall summary if an average treatment effect across trials was considered clinically meaningful. The random‐effects summary will be treated as the average of the range of possible treatment effects and we discuss the clinical implications of treatment effects differing between trials. If the average treatment effect is not clinically meaningful, we planned not to combine trials. If we used random‐effects analyses, the results were presented as the average treatment effect with 95% confidence intervals, and the estimates of Tau² and I². </p> </section> <section id="CD001059-sec-0076"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If we identified substantial heterogeneity, we investigated it using subgroup analyses and sensitivity analyses. We considered whether an overall summary was meaningful, and if it was, we used random‐effects analysis to produce it. </p> <section id="CD001059-sec-0077"> <h5 class="title">High‐dose calcium supplementation</h5> <p>We carried out the following subgroup analyses.</p> <p> <ol id="CD001059-list-0017"> <li> <p>Trials in populations with low versus adequate dietary calcium intake</p> </li> <li> <p>Trials in participants with low/average versus high hypertensive risk</p> </li> <li> <p>Trials with small versus larger sample size</p> </li> <li> <p>We also subgrouped the trials by both dietary calcium intake and trial size, to distinguish the differences between the two subgroups more clearly (not prespecified in the original protocol). </p> </li> </ol> </p> <p>We used only primary outcomes in subgroup analyses 2, 3 and 4 above.</p> </section> <section id="CD001059-sec-0078"> <h5 class="title">Low‐dose calcium supplementation</h5> <p>We carried out subgroup analysis by cointerventions (comparison 6). This was not done for the high‐dose calcium comparisons because cointerventions were not included. </p> <p>We assessed subgroup differences by interaction tests available within Review Manager (<a href="./references#CD001059-bbs2-0112" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We reported the results of subgroup analyses quoting the Chi² statistic and P value, and the interaction test I² value. </p> </section> </section> <section id="CD001059-sec-0079"> <h4 class="title">Sensitivity analysis</h4> <p>We carried out a planned sensitivity analyses to explore the effect of risk of bias assessed by concealment of allocation, high attrition rates, or both, with studies at high risk of bias being excluded from the analyses in order to assess whether this makes any difference to the overall result. This sensitivity analysis was only possible for the comparison of high‐dose calcium versus placebo (there were too few studies in the comparison of low‐dose calcium versus no supplementation). </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD001059-sec-0080" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD001059-sec-0080"></div> <section id="CD001059-sec-0081"> <h3 class="title">Description of studies</h3> <section id="CD001059-sec-0082"> <h4 class="title">Results of the search</h4> <p>See: <a href="#CD001059-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD001059-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD001059-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>The 2017 search retrieved 46 reports; we also reassessed seven reports awaiting further classification and one ongoing study from the previous version of the review (<a href="./references#CD001059-bbs2-0130" title="HofmeyrGJ , LawrieTA , AtallahÁN , DuleyL , TorloniMR . Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database of Systematic Reviews2014, Issue 6. [DOI: 10.1002/14651858.CD001059.pub4] ">Hofmeyr 2014</a>). In this version of the review, one study is awaiting further assessment and there are now four ongoing studies (five reports). There were five additional reports relating to two studies already excluded from the review (<a href="./references#CD001059-bbs2-0040" title="BezerraFF , NCT01732328 . Calcium plus vitamin D supplementation during pregnancy of adolescent mothers: effects on maternal and infant bone mass, calcium and bone metabolism and breast milk composition. clinicaltrials.gov/show/NCT01732328 (first received 19 November 2012). DiogenesME , BezerraFF , RezendeEP , DonangeloCM . Calcium plus vitamin D supplementation during third trimester of pregnancy in adolescents accustomed to low calcium diets did not affect infant bone mass at early lactation in a randomized controlled trial. Journal of Nutrition2015;145:1515‐23. DiogenesME , BezerraFF , RezendeEP , TaveiraMF , PinhalI , DonangeloCM . Effect of calcium plus vitamin D supplementation during pregnancy in Brazilian adolescent mothers: a randomized, placebo‐controlled trial. American Journal of Clinical Nutrition2013;98(1):82‐91. DiogenesMEL , BezerraFF , RezendeEP , TaveiraMF , PinhalI , DonangeloCM . Maternal vitamin D status of adolescent mothers at mid‐pregnancy influence bone mineral content of their newborns. FASEB Journal2011;25:603.19. NormandoP , DiogenesME , CabelloPH , CabelloGM , DonangeloCM , BezerraFF . Calcium plus vitamin D supplementation during pregnancy interacts with polymorphisms in the promoter region of the VDR gene to affect postpartum bone mass of Brazilian adolescent mothers: a randomized controlled trial. Nutrition2016;32(10):1068‐74. ">Diogenes 2011</a>; <a href="./references#CD001059-bbs2-0042" title="EttingerAS , LamadridH , MercadoA , KordasK , PetersonK , HuH , et al. Effect of calcium on bone resorption and bone mineral density in pregnancy: A randomized control trial. American Journal of Epidemiology2011;173(Suppl):S236. HuH , Hernandez‐AvilaM , NCT00558623 . Controlled trial in pregnancy of dietary supplements for suppression of bone resorption and mobilization of lead into plasma. clinicaltrials.gov/show/NCT00558623 (first received 14 November 2007). ">Ettinger 2011</a>), and 10 additional reports relating to three studies already included in the review. We have included three new studies (four reports) in the review (<a href="./references#CD001059-bbs2-0002" title="AsemiZ , IRCT201212105623N3 . Comparison of effectiveness of multivitamin, multivitamin‐mineral supplements, probiotic and normal Gaz on pregnancy outcomes in pregnant women. en.search.irct.ir/view/11730 (first received 26 December 2012). AsemiZ , TabassiZ , HeidarzadehZ , KhorammianH , SabihiSS , SamimiM . Effect of calcium‐vitamin D supplementation on metabolic profiles in pregnant women at risk for pre‐eclampsia: a randomized placebo‐controlled trial. Pakistan Journal of Biological Sciences2012;15(7):316‐24. ">Asemi 2012</a>; <a href="./references#CD001059-bbs2-0003" title="AsemiZ , SamimiM , SiavashaniMA , MazloomiM , TabassiZ , KaramaliM , et al. Calcium‐vitamin D co‐supplementation affects metabolic profiles, but not pregnancy outcomes, in healthy pregnant women. International Journal of Preventive Medicine2016;7:49. ">Asemi 2016</a>; <a href="./references#CD001059-bbs2-0012" title="KhanA , MandalSK , PalA . Role of high dose calcium in the prevention of preeclampsia. Bangladesh Journal of Obstetrics and Gynecology2013;28(2):66‐70. ">Khan 2013</a>) and have excluded a further 19 further studies (29 reports). In total, the review now includes 27 studies and 44 are excluded. </p> </section> <section id="CD001059-sec-0083"> <h4 class="title">Included studies</h4> <p>The studies were carried out in countries across the world: Philippines (<a href="./references#CD001059-bbs2-0001" title="AlmiranteCY . Calcium supplementation during pregnancy in the prevention of EPH gestosis. Prenatal and Neonatal Medicine1998;3 Suppl 1:24. ">Almirante 1998</a>); Iran (<a href="./references#CD001059-bbs2-0002" title="AsemiZ , IRCT201212105623N3 . Comparison of effectiveness of multivitamin, multivitamin‐mineral supplements, probiotic and normal Gaz on pregnancy outcomes in pregnant women. en.search.irct.ir/view/11730 (first received 26 December 2012). AsemiZ , TabassiZ , HeidarzadehZ , KhorammianH , SabihiSS , SamimiM . Effect of calcium‐vitamin D supplementation on metabolic profiles in pregnant women at risk for pre‐eclampsia: a randomized placebo‐controlled trial. Pakistan Journal of Biological Sciences2012;15(7):316‐24. ">Asemi 2012</a>; <a href="./references#CD001059-bbs2-0003" title="AsemiZ , SamimiM , SiavashaniMA , MazloomiM , TabassiZ , KaramaliM , et al. Calcium‐vitamin D co‐supplementation affects metabolic profiles, but not pregnancy outcomes, in healthy pregnant women. International Journal of Preventive Medicine2016;7:49. ">Asemi 2016</a>; <a href="./references#CD001059-bbs2-0019" title="NiromaneshS , LaghaiiS , Mosavi‐JarrahiA . Supplementary calcium in prevention of pre‐eclampsia. International Journal of Gynecology &amp; Obstetrics2001;74:17‐21. ">Niromanesh 2001</a>; <a href="./references#CD001059-bbs2-0024" title="TaherianAA , TaherianA , ShirvaniA . Prevention of pre‐eclampsia with low‐dose aspirin or calcium supplementation. Archives of Iranian Medicine2002;5(3):151‐6. ">Taherian 2002</a>); Trinidad (<a href="./references#CD001059-bbs2-0004" title="BassawB , RoopnarinesinghS , RoopnarinesinghA , HomerH . Prevention of hypertensive disorders of pregnancy. Journal of Obstetrics and Gynaecology1998;18(2):123‐6. ">Bassaw 1998</a>); Argentina (<a href="./references#CD001059-bbs2-0005" title="BelizanJM . Prevention of hypertensive disorders of pregnancy with calcium supplementation. 8th World Congress on Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires. 1992:93. BelizanJM , VillarJ , BergelE , delPinoA , DiFulvioS , GallianoSV , et al. Long term effect of calcium supplementation during pregnancy on the blood pressure of offspring: follow up of a randomised controlled trial. BMJ1997;315:281‐5. BelizanJM , VillarJ , GonzalezL , CampodonicoL , BergelE . Calcium supplementation to prevent hypertensive disorders of pregnancy. New England Journal of Medicine1991;325:1399‐405. BergelE , GibbonsL , RasinesMG , LuetichA , BelizanJM . Maternal calcium supplementation during pregnancy and dental caries of children at 12 years of age: follow‐up of a randomized controlled trial. Acta Obstetricia et Gynecologica Scandinavica2010;89(11):1396‐402. StephensIF . Effect of calcium supplementation during pregnancy on blood pressure of offspring. Authors cannot be sure of effect's generalisability to all children aged 5‐9 [letter; comment]. BMJ1998;316(7126):234. VillarJ , BelizanJM , RepkeJ . The effect of calcium supplementation on the incidence of hypertensive disorders of pregnancy and prematurity. 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy. 1990:54. VillarJ , BelizanJM , RepkeJT . Does calcium supplementation reduce pregnancy‐induced hypertension and prematurity?. Proceedings of the International Symposium on advances in the prevention of low birthweight; 1988 May 8‐11; Cape Cod, Massachusetts. 1988:187‐95. ">Belizan 1991</a>); China (<a href="./references#CD001059-bbs2-0006" title="CongKJ , ChiSL , LiuGR . Calcium and pregnancy induced hypertension. Chinese Journal of Obstetrics and Gynecology1993;28:657‐9. CongKJ , ChiSL , LiuGR . Calcium supplementation during pregnancy for reducing pregnancy induced hypertension. Chinese Medical Journal1995;108:57‐9. CongKJ , ChiSL , LiuGR . Calcium supplementation during pregnancy to reduce pregnancy induced hypertension. Beijing Medical Journal1992;5:268. ">Cong 1995</a>; <a href="./references#CD001059-bbs2-0014" title="LiX , GouW . Study on prevention of pregnancy induced hypertension and effect of platelet intracellular free ca˜(2+) by calcium supplementation. Journal of Xi'an Medical University2000;21(1):46‐8. ">Li 2000</a>); Australia (<a href="./references#CD001059-bbs2-0008" title="CrowtherC , HillerJ , PridmoreB , BryceR , DugganP , HagueW , et al. Calcium supplementation in nulliparous women for the prevention of pregnancy included hypertension, pre‐eclampsia and preterm birth: an Australian randomised trial. 2nd Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. 1998:101. CrowtherCA , HillerJE , PridmoreB , BryceR , DugganP , HagueWM , et al. Calcium supplementation in nulliparous women for the prevention of pregnancy‐induced hypertension, preeclampsia and preterm birth: an Australian randomized trial. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(1):12‐8. HillerJE , CrowtherCA , MooreVA , WillsonK , RobinsonJS . Calcium supplementation in pregnancy and its impact on blood pressure in children and women: follow up of a randomised controlled trial. Australian and New Zealand Journal of Obstetrics and Gynaecology2007;47(2):115‐21. ">Crowther 1999</a>); Colombia (<a href="./references#CD001059-bbs2-0009" title="HerreraJA , Arevalo‐HerreraM , HerreraS . Prevention of preeclampsia by linoleic acid and calcium supplementation: a randomized controlled trial. Obstetrics &amp; Gynecology1998;91(4):585‐90. ">Herrera 1998</a>); Gambia (<a href="./references#CD001059-bbs2-0011" title='GoldbergG , YinJ , JarjouL , PrenticeA . Maternal calcium supplementation during pregnancy and blood pressure in rural Gambian children at 3 and 9 years old. Annals of Nutrition &amp; Metabolism2013;63(Suppl 1):728, Abstract no: PO982. GoldbergGR , JarjouLM , ColeTJ , PrenticeA . Randomized, placebo‐controlled, calcium supplementation trial in pregnant Gambian women accustomed to a low calcium intake: effects on maternal blood pressure and infant growth. American Journal of Clinical Nutrition2013;98(4):972‐82. HawkesworthS , SawoY , FulfordAJ , GoldbergGR , JarjouLM , PrenticeA , et al. Effect of maternal calcium supplementation on offspring blood pressure in 5‐ to 10‐y‐old rural Gambian children. American Journal of Clinical Nutrition2010;92(4):741‐7. HawkesworthS , WalkerCG , SawoY , FulfordAJ , JarjouLM , GoldbergGR , et al. Nutritional supplementation during pregnancy and offspring cardiovascular disease risk in The Gambia. American Journal of Clinical Nutrition2011;94(6 Suppl):1853S‐1860S. JarjouLM , LaskeyMA , SawoY , GoldbergGR , ColeTJ , PrenticeA . Effect of calcium supplementation in pregnancy on maternal bone outcomes in women with a low calcium intake. American Journal of Clinical Nutrition2010;92(2):450‐7. JarjouLM , PrenticeA , BennettJ . Impact of calcium supplementation in the preceding pregnancy on the human milk calcium concentration of Gambian women. Advances in Experimental Medicine and Biology2004;54:347‐9. JarjouLM , PrenticeA , SawoY , LaskeyMA , BennettJ , GoldbergGR , et al. Randomized, placebo‐controlled, calcium supplementation study in pregnant Gambian women: effects on breast‐milk calcium concentrations and infant birth weight, growth, and bone mineral accretion in the first year of life. American Journal of Clinical Nutrition2006;83(3):657‐66. JarjouLMA , BennettJ , LaidlawA , GoldbergGR , PrenticeA . Changes in bone turnover and calcitrophic hormones in lactating Gambian women supplemented with calcium during pregnancy. Journal of Human Lactation2007;23(1):86‐7. JarjouLMA , SawoY , GoldbergGR , LaskeyMA , ColeTJ , PrenticeA . Persistent effects of calcium supplementation during pregnancy on maternal bone mineral content: a follow‐up study in Gambian women. Proceedings of the 16th ISRHML Conference "Breastfeeding and the Use of Human Milk. Science and Practice"; 2012 September 27th ‐ October 1st; Trieste, Italy. 2012:Abstract no.:105. JarjouMA , YankubaS , GoldbergR , LaskeyMA , ColeJ , PrenticeA . Unexpected long‐term effects of calcium supplementation in pregnancy on maternal bone outcomes in women with a low calcium intake: a follow‐up study. American Journal of Clinical Nutrition2013;98(3):723‐30. PrenticeA , GoldbergGR , JarjouLMA . The effects of pregnancy calcium supplementation on calcium metabolism after lactation in Gambian women with a low calcium intake. Breastfeeding Medicine2016;11(2):A‐20‐A‐21, Abstract no: P‐8. PrenticeA , ISRCTN72582014 . Effects on birth weight and perinatal mortality of maternal dietary supplements in rural Gambia: 5 year randomised controlled trial. isrctn.com/ISRCTN72582014 (first received 27 March 2013). PrenticeA , ISRCTN96502494 . Calcium requirements of pregnant women in The Gambia. isrctn.com/ISRCTN96502494 (first received 6 November 2007). PrenticeA , JarjouLM , GoldbergGR , BennettJ , ColeTJ , SchoenmakersI . Maternal plasma 25‐hydroxyvitamin D concentration and birthweight, growth and bone mineral accretion of Gambian infants. Acta Paediatrica2009;98(8):1360‐2. WardKA , JarjouL , PrenticeA . Maternal calcium supplementation and offspring growth. Osteoporosis International2016;27(1 Suppl 1):S327‐8. WardKA , PrenticeA , JarjouL . Long‐term effects of maternal calcium supplementation on childhood growth differ between males and females in a population accustomed to a low calcium intake. Bone2017;103:31‐8. '>Jarjou 2004</a>); India (<a href="./references#CD001059-bbs2-0012" title="KhanA , MandalSK , PalA . Role of high dose calcium in the prevention of preeclampsia. Bangladesh Journal of Obstetrics and Gynecology2013;28(2):66‐70. ">Khan 2013</a>; <a href="./references#CD001059-bbs2-0013" title="KumarA , DeviSG , BatraS , SinghC , ShuklaDK . Calcium supplementation for the prevention of pre‐eclampsia. International Journal of Gynecology &amp; Obstetrics2009;104(1):32‐6. ">Kumar 2009</a>; <a href="./references#CD001059-bbs2-0018" title="MaryaRK , RatheeS , ManrowM . Effect of calcium and vitamin D supplementation on toxaemia of pregnancy. Gynecologic and Obstetric Investigation1987;24:38‐42. ">Marya 1987</a>; <a href="./references#CD001059-bbs2-0020" title="PurwarM , KulkarniH , MotghareV , DholeS . Calcium supplementation and prevention of pregnancy induced hypertension. Journal of Obstetrics and Gynaecology Research1996;22(5):425‐30. PurwarM , MotghareV , KulkarniH . Calcium supplementation and prevention of pregnancy induced hypertension: randomized double blind controlled trial. Journal of Clinical Epidemiology1996; Vol. 49, issue Suppl 1:28S. ">Purwar 1996</a>); Ecuador (<a href="./references#CD001059-bbs2-0015" title="Lopez‐JaramilloP , NarvaezM , WeigelRM , YepezR . Calcium supplementation reduces the risk of pregnancy‐induced hypertension in an Andes population. British Journal of Obstetrics and Gynaecology1989;96:648‐55. Lopez‐JaramilloP , NarvaezM , YepezR . Effect of calcium supplementation on the vascular sensitivity to angiotensin II in pregnant women. American Journal of Obstetrics and Gynecology1987;156:261‐2. NarvaezM , Lopez‐JaramilloP , WeigelM . Calcium (Ca++) supplementation reduces the risk for pregnancy induced hypertension (PIH). World Congress of Gynecology and Obstetrics; 1988 October 23‐28; Brazil. 1988:180‐1. ">L‐Jaramillo 1989</a>; <a href="./references#CD001059-bbs2-0016" title="Lopez‐JaramilloP , NarvaezM , FelixC , LopezA . Dietary calcium supplementation and prevention of pregnancy hypertension. Lancet1990;335:293. NarvaezM , Lopez‐JaramilloP , WeigelM . Calcium (Ca++) supplementation reduces the risk for pregnancy induced hypertension (PIH). World Congress of Gynecology and Obstetrics; 1988 October 23‐28; Brazil. 1988:180‐1. ">L‐Jaramillo 1990</a>; <a href="./references#CD001059-bbs2-0017" title="Lopez‐JaramilloP , DelgadoF , JacomeP , TeranE , RuanoC , RiveraJ . Calcium supplementation and the risk of preeclampsia in Ecuadorian pregnant teenagers. Obstetrics &amp; Gynecology1997;90:162‐7. ">L‐Jaramillo 1997</a>); Hong Kong (<a href="./references#CD001059-bbs2-0021" title="RogersMS , FungHYM , HungCY . Calcium and low‐dose aspirin prophylaxis in women at high risk of pregnancy‐induced hypertension. Hypertension in Pregnancy1999;18(2):165‐72. ">Rogers 1999</a>); Indonesia (<a href="./references#CD001059-bbs2-0022" title="RumirisD , PurwosunuY , WibowoN , FarinaA , SekizawaA . Lower rate of preeclampsia after antioxidant supplementation in pregnant women with low antioxidant status. Hypertension in Pregnancy2006;25:241–53. ">Rumiris 2006</a>); and the USA (<a href="./references#CD001059-bbs2-0007" title="HabliM , LevineRJ , QianC , SibaiB . Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. American Journal of Obstetrics and Gynecology2007;197(4):406.e1‐406.e7. HattonDC , Harrison‐HohnerJ , CosteS , RellerM , McCarronD . Gestational calcium supplementation and blood pressure in the offspring. American Journal of Hypertension2003;16:801‐5. Levine RJ for the CPEP Study Group. Calcium for preeclampsia prevention (CPEP): a double‐blind, placebo‐controlled trial in healthy nulliparas. American Journal of Obstetrics and Gynecology1997;176:S2. Levine RJ for the CPEP Study Group. The trial of calcium for preeclampsia prevention (CPEP). 8th World Congress on Hypertension in Pregnancy ‐ Protagonists and Presentations; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. LevineRJ , EsterlitzJR , RaymondEG , DerSimonianR , HauthJC , Ben CuretL , et al. Trial of calcium for preeclampsia prevention (CPEP): rationale, design, and methods. Controlled Clinical Trials1996;17:442‐69. LevineRJ , HauthJC , CuretLB , SibaiBM , CatalanoPM , MorrisCD , et al. Trial of calcium to prevent preeclampsia. New England Journal of Medicine1997;337(2):69‐76. NCT00000534 . Calcium for pre‐eclampsia prevention (CPEP). clinicaltrials.gov/ct2/show/record/NCT00000534 (first received 27 October 1999). ">CPEP 1997</a>; <a href="./references#CD001059-bbs2-0023" title="Sanchez‐RamosL , BrionesDK , KaunitzAM , DelvalleGO , GaudierFL , WalkerKD . Prevention of pregnancy‐induced hypertension by calcium supplementation in angiotensin II‐sensitive patients. Obstetrics &amp; Gynecology1994;84:349‐53. Sanchez‐RamosL , DelvalleGO , BrionesD , WalkerC , DelkeI , GaudierF . Prevention of preeclampsia by calcium supplementation in angiotensin‐sensitive patients. American Journal of Obstetrics and Gynecology1994;170:408. ">S‐Ramos 1994</a>; <a href="./references#CD001059-bbs2-0026" title="VillarJ , BelizanJM , RepkeJ . The effect of calcium supplementation on the incidence of hypertensive disorders of pregnancy and prematurity. 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy. 1990:54. VillarJ , BelizanJM , RepkeJT . Does calcium supplementation reduce pregnancy‐induced hypertension and prematurity?. Advances in the prevention of low birthweight; 1988 May 8‐11; Cape Cod, Massachusetts. 1998:187‐95. VillarJ , RepkeJT . Calcium supplementation during pregnancy may reduce preterm delivery in high‐risk populations. American Journal of Obstetrics and Gynecology1990;163:1124‐31. ">Villar 1990</a>). In addition there were multicentre studies carried out in more than one country (<a href="./references#CD001059-bbs2-0010" title="HerreraJA , Arevalo‐HerreraM , ShahabuddinAK , ErshengG , HerreraS , GarciaRG , et al. Calcium and conjugated linoleic acid reduces pregnancy‐induced hypertension and decreases intracellular calcium in lymphocytes. American Journal of Hypertension2006;19(4):381‐7. HerreraJA , ShahabuddinAK , ErshengG , WeiY , GarciaRG , Lopez‐JaramilloP . Calcium plus linoleic acid therapy for pregnancy‐induced hypertension. International Journal of Gynecology &amp; Obstetrics2005;91(3):221‐7. HerreraJA , ShahabuddinAKM , FaisalM , ErshengG , WeiY , LixiaD , et al. Effects of supplementation with oral calcium and linoleic acid in primigravidas at high risk [Efectos de la supplementacion oral con calcio y acido linoleico conjugado en primigravidas de alto riesgo]. Colombia Medica2004;35(1):31‐7. ">Herrera 2006</a>; <a href="./references#CD001059-bbs2-0025" title="RepkeJT , VillarJ , AndersonC , ParejaG , DubinN , BelizanJM . Biochemical changes associated with blood pressure reduction induced by calcium supplementation during pregnancy. American Journal of Obstetrics and Gynecology1989;160:684‐90. VillarJ , RepkeJ , BelizanJM , ParejaG . Calcium supplementation reduces blood pressure during pregnancy: results of a randomized controlled clinical trial. Obstetrics &amp; Gynecology1987;70:317‐22. ">Villar 1987</a>; <a href="./references#CD001059-bbs2-0027" title="AbalosE , MerialdiM , WojdylaD , CarroliG , CampodónicoL , YaoSE , et al. Effects of calcium supplementation on fetal growth in mothers with deficient calcium intake: a randomised controlled trial. Paediatric and Perinatal Epidemiology2010;24(1):53‐62. Abdel‐AleemH , MerialdiM , ElsnosyED , ElsedfyGO , Abdel‐AleemMA , VillarJ . The effect of calcium supplementation during pregnancy on fetal and infant growth: a nested randomized controlled trial within WHO calcium supplementation trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2009;22(2):94‐100. CarroliG , MerialdiM , WojdylaD , AbalosE , CampodonicoL , YaoSE , et al. Effects of calcium supplementation on uteroplacental and fetoplacental blood flow in low‐calcium‐intake mothers: a randomized controlled trial. American Journal of Obstetrics and Gynecology2010;202(1):45.e1‐45.e9. HofmeyrGJ , MlokotiZ , NikodemVC , MangesiL , FerreiraS , SingataM , et al. Calcium supplementation during pregnancy for preventing hypertensive disorders is not associated with changes in platelet count, urate, and urinary protein: a randomized control trial. Hypertension in Pregnancy2008;27(3):299‐304. VillarJ , Abdel‐AleemH , MerialdiM , MathaiM , AliM , ZavaletaN , et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. American Journal of Obstetrics and Gynecology2006;194:639‐49. VillarJ , AleemHA , MerialdiM , MathaiM , AliM , ZavaletaN , et al. WHO randomized trial of calcium supplementation among low calcium intake pregnant women [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S2. VillarJ , ISRCTN37214165 . Calcium supplementation during pregnancy in low‐intake populations. isrctn.com/ISRCTN37214165 (first received 19 March 2014). ZhangJ , VillarJ , SunW , MerialdiM , Abdel‐AleemH , MathaiM , et al. Blood pressure dynamics during pregnancy and spontaneous preterm birth. American Journal of Obstetrics and Gynecology2007;197(2):162.e1‐6. ">WHO 2006</a>). </p> <p>In six of the studies the dates of recruitment were not clear or not stated (<a href="./references#CD001059-bbs2-0001" title="AlmiranteCY . Calcium supplementation during pregnancy in the prevention of EPH gestosis. Prenatal and Neonatal Medicine1998;3 Suppl 1:24. ">Almirante 1998</a>; <a href="./references#CD001059-bbs2-0006" title="CongKJ , ChiSL , LiuGR . Calcium and pregnancy induced hypertension. Chinese Journal of Obstetrics and Gynecology1993;28:657‐9. CongKJ , ChiSL , LiuGR . Calcium supplementation during pregnancy for reducing pregnancy induced hypertension. Chinese Medical Journal1995;108:57‐9. CongKJ , ChiSL , LiuGR . Calcium supplementation during pregnancy to reduce pregnancy induced hypertension. Beijing Medical Journal1992;5:268. ">Cong 1995</a>; <a href="./references#CD001059-bbs2-0007" title="HabliM , LevineRJ , QianC , SibaiB . Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. American Journal of Obstetrics and Gynecology2007;197(4):406.e1‐406.e7. HattonDC , Harrison‐HohnerJ , CosteS , RellerM , McCarronD . Gestational calcium supplementation and blood pressure in the offspring. American Journal of Hypertension2003;16:801‐5. Levine RJ for the CPEP Study Group. Calcium for preeclampsia prevention (CPEP): a double‐blind, placebo‐controlled trial in healthy nulliparas. American Journal of Obstetrics and Gynecology1997;176:S2. Levine RJ for the CPEP Study Group. The trial of calcium for preeclampsia prevention (CPEP). 8th World Congress on Hypertension in Pregnancy ‐ Protagonists and Presentations; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. LevineRJ , EsterlitzJR , RaymondEG , DerSimonianR , HauthJC , Ben CuretL , et al. Trial of calcium for preeclampsia prevention (CPEP): rationale, design, and methods. Controlled Clinical Trials1996;17:442‐69. LevineRJ , HauthJC , CuretLB , SibaiBM , CatalanoPM , MorrisCD , et al. Trial of calcium to prevent preeclampsia. New England Journal of Medicine1997;337(2):69‐76. NCT00000534 . Calcium for pre‐eclampsia prevention (CPEP). clinicaltrials.gov/ct2/show/record/NCT00000534 (first received 27 October 1999). ">CPEP 1997</a>; <a href="./references#CD001059-bbs2-0016" title="Lopez‐JaramilloP , NarvaezM , FelixC , LopezA . Dietary calcium supplementation and prevention of pregnancy hypertension. Lancet1990;335:293. NarvaezM , Lopez‐JaramilloP , WeigelM . Calcium (Ca++) supplementation reduces the risk for pregnancy induced hypertension (PIH). World Congress of Gynecology and Obstetrics; 1988 October 23‐28; Brazil. 1988:180‐1. ">L‐Jaramillo 1990</a>; <a href="./references#CD001059-bbs2-0018" title="MaryaRK , RatheeS , ManrowM . Effect of calcium and vitamin D supplementation on toxaemia of pregnancy. Gynecologic and Obstetric Investigation1987;24:38‐42. ">Marya 1987</a>; <a href="./references#CD001059-bbs2-0019" title="NiromaneshS , LaghaiiS , Mosavi‐JarrahiA . Supplementary calcium in prevention of pre‐eclampsia. International Journal of Gynecology &amp; Obstetrics2001;74:17‐21. ">Niromanesh 2001</a>). Recruitment started in the 1980s in five studies (<a href="./references#CD001059-bbs2-0005" title="BelizanJM . Prevention of hypertensive disorders of pregnancy with calcium supplementation. 8th World Congress on Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires. 1992:93. BelizanJM , VillarJ , BergelE , delPinoA , DiFulvioS , GallianoSV , et al. Long term effect of calcium supplementation during pregnancy on the blood pressure of offspring: follow up of a randomised controlled trial. BMJ1997;315:281‐5. BelizanJM , VillarJ , GonzalezL , CampodonicoL , BergelE . Calcium supplementation to prevent hypertensive disorders of pregnancy. New England Journal of Medicine1991;325:1399‐405. BergelE , GibbonsL , RasinesMG , LuetichA , BelizanJM . Maternal calcium supplementation during pregnancy and dental caries of children at 12 years of age: follow‐up of a randomized controlled trial. Acta Obstetricia et Gynecologica Scandinavica2010;89(11):1396‐402. StephensIF . Effect of calcium supplementation during pregnancy on blood pressure of offspring. Authors cannot be sure of effect's generalisability to all children aged 5‐9 [letter; comment]. BMJ1998;316(7126):234. VillarJ , BelizanJM , RepkeJ . The effect of calcium supplementation on the incidence of hypertensive disorders of pregnancy and prematurity. 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy. 1990:54. VillarJ , BelizanJM , RepkeJT . Does calcium supplementation reduce pregnancy‐induced hypertension and prematurity?. Proceedings of the International Symposium on advances in the prevention of low birthweight; 1988 May 8‐11; Cape Cod, Massachusetts. 1988:187‐95. ">Belizan 1991</a>; <a href="./references#CD001059-bbs2-0015" title="Lopez‐JaramilloP , NarvaezM , WeigelRM , YepezR . Calcium supplementation reduces the risk of pregnancy‐induced hypertension in an Andes population. British Journal of Obstetrics and Gynaecology1989;96:648‐55. Lopez‐JaramilloP , NarvaezM , YepezR . Effect of calcium supplementation on the vascular sensitivity to angiotensin II in pregnant women. American Journal of Obstetrics and Gynecology1987;156:261‐2. NarvaezM , Lopez‐JaramilloP , WeigelM . Calcium (Ca++) supplementation reduces the risk for pregnancy induced hypertension (PIH). World Congress of Gynecology and Obstetrics; 1988 October 23‐28; Brazil. 1988:180‐1. ">L‐Jaramillo 1989</a>; <a href="./references#CD001059-bbs2-0023" title="Sanchez‐RamosL , BrionesDK , KaunitzAM , DelvalleGO , GaudierFL , WalkerKD . Prevention of pregnancy‐induced hypertension by calcium supplementation in angiotensin II‐sensitive patients. Obstetrics &amp; Gynecology1994;84:349‐53. Sanchez‐RamosL , DelvalleGO , BrionesD , WalkerC , DelkeI , GaudierF . Prevention of preeclampsia by calcium supplementation in angiotensin‐sensitive patients. American Journal of Obstetrics and Gynecology1994;170:408. ">S‐Ramos 1994</a>; <a href="./references#CD001059-bbs2-0025" title="RepkeJT , VillarJ , AndersonC , ParejaG , DubinN , BelizanJM . Biochemical changes associated with blood pressure reduction induced by calcium supplementation during pregnancy. American Journal of Obstetrics and Gynecology1989;160:684‐90. VillarJ , RepkeJ , BelizanJM , ParejaG . Calcium supplementation reduces blood pressure during pregnancy: results of a randomized controlled clinical trial. Obstetrics &amp; Gynecology1987;70:317‐22. ">Villar 1987</a>; <a href="./references#CD001059-bbs2-0026" title="VillarJ , BelizanJM , RepkeJ . The effect of calcium supplementation on the incidence of hypertensive disorders of pregnancy and prematurity. 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy. 1990:54. VillarJ , BelizanJM , RepkeJT . Does calcium supplementation reduce pregnancy‐induced hypertension and prematurity?. Advances in the prevention of low birthweight; 1988 May 8‐11; Cape Cod, Massachusetts. 1998:187‐95. VillarJ , RepkeJT . Calcium supplementation during pregnancy may reduce preterm delivery in high‐risk populations. American Journal of Obstetrics and Gynecology1990;163:1124‐31. ">Villar 1990</a>); in the 1990s in nine studies (<a href="./references#CD001059-bbs2-0004" title="BassawB , RoopnarinesinghS , RoopnarinesinghA , HomerH . Prevention of hypertensive disorders of pregnancy. Journal of Obstetrics and Gynaecology1998;18(2):123‐6. ">Bassaw 1998</a>; <a href="./references#CD001059-bbs2-0008" title="CrowtherC , HillerJ , PridmoreB , BryceR , DugganP , HagueW , et al. Calcium supplementation in nulliparous women for the prevention of pregnancy included hypertension, pre‐eclampsia and preterm birth: an Australian randomised trial. 2nd Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. 1998:101. CrowtherCA , HillerJE , PridmoreB , BryceR , DugganP , HagueWM , et al. Calcium supplementation in nulliparous women for the prevention of pregnancy‐induced hypertension, preeclampsia and preterm birth: an Australian randomized trial. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(1):12‐8. HillerJE , CrowtherCA , MooreVA , WillsonK , RobinsonJS . Calcium supplementation in pregnancy and its impact on blood pressure in children and women: follow up of a randomised controlled trial. Australian and New Zealand Journal of Obstetrics and Gynaecology2007;47(2):115‐21. ">Crowther 1999</a>; <a href="./references#CD001059-bbs2-0009" title="HerreraJA , Arevalo‐HerreraM , HerreraS . Prevention of preeclampsia by linoleic acid and calcium supplementation: a randomized controlled trial. Obstetrics &amp; Gynecology1998;91(4):585‐90. ">Herrera 1998</a>; <a href="./references#CD001059-bbs2-0011" title='GoldbergG , YinJ , JarjouL , PrenticeA . Maternal calcium supplementation during pregnancy and blood pressure in rural Gambian children at 3 and 9 years old. Annals of Nutrition &amp; Metabolism2013;63(Suppl 1):728, Abstract no: PO982. GoldbergGR , JarjouLM , ColeTJ , PrenticeA . Randomized, placebo‐controlled, calcium supplementation trial in pregnant Gambian women accustomed to a low calcium intake: effects on maternal blood pressure and infant growth. American Journal of Clinical Nutrition2013;98(4):972‐82. HawkesworthS , SawoY , FulfordAJ , GoldbergGR , JarjouLM , PrenticeA , et al. Effect of maternal calcium supplementation on offspring blood pressure in 5‐ to 10‐y‐old rural Gambian children. American Journal of Clinical Nutrition2010;92(4):741‐7. HawkesworthS , WalkerCG , SawoY , FulfordAJ , JarjouLM , GoldbergGR , et al. Nutritional supplementation during pregnancy and offspring cardiovascular disease risk in The Gambia. American Journal of Clinical Nutrition2011;94(6 Suppl):1853S‐1860S. JarjouLM , LaskeyMA , SawoY , GoldbergGR , ColeTJ , PrenticeA . Effect of calcium supplementation in pregnancy on maternal bone outcomes in women with a low calcium intake. American Journal of Clinical Nutrition2010;92(2):450‐7. JarjouLM , PrenticeA , BennettJ . Impact of calcium supplementation in the preceding pregnancy on the human milk calcium concentration of Gambian women. Advances in Experimental Medicine and Biology2004;54:347‐9. JarjouLM , PrenticeA , SawoY , LaskeyMA , BennettJ , GoldbergGR , et al. Randomized, placebo‐controlled, calcium supplementation study in pregnant Gambian women: effects on breast‐milk calcium concentrations and infant birth weight, growth, and bone mineral accretion in the first year of life. American Journal of Clinical Nutrition2006;83(3):657‐66. JarjouLMA , BennettJ , LaidlawA , GoldbergGR , PrenticeA . Changes in bone turnover and calcitrophic hormones in lactating Gambian women supplemented with calcium during pregnancy. Journal of Human Lactation2007;23(1):86‐7. JarjouLMA , SawoY , GoldbergGR , LaskeyMA , ColeTJ , PrenticeA . Persistent effects of calcium supplementation during pregnancy on maternal bone mineral content: a follow‐up study in Gambian women. Proceedings of the 16th ISRHML Conference "Breastfeeding and the Use of Human Milk. Science and Practice"; 2012 September 27th ‐ October 1st; Trieste, Italy. 2012:Abstract no.:105. JarjouMA , YankubaS , GoldbergR , LaskeyMA , ColeJ , PrenticeA . Unexpected long‐term effects of calcium supplementation in pregnancy on maternal bone outcomes in women with a low calcium intake: a follow‐up study. American Journal of Clinical Nutrition2013;98(3):723‐30. PrenticeA , GoldbergGR , JarjouLMA . The effects of pregnancy calcium supplementation on calcium metabolism after lactation in Gambian women with a low calcium intake. Breastfeeding Medicine2016;11(2):A‐20‐A‐21, Abstract no: P‐8. PrenticeA , ISRCTN72582014 . Effects on birth weight and perinatal mortality of maternal dietary supplements in rural Gambia: 5 year randomised controlled trial. isrctn.com/ISRCTN72582014 (first received 27 March 2013). PrenticeA , ISRCTN96502494 . Calcium requirements of pregnant women in The Gambia. isrctn.com/ISRCTN96502494 (first received 6 November 2007). PrenticeA , JarjouLM , GoldbergGR , BennettJ , ColeTJ , SchoenmakersI . Maternal plasma 25‐hydroxyvitamin D concentration and birthweight, growth and bone mineral accretion of Gambian infants. Acta Paediatrica2009;98(8):1360‐2. WardKA , JarjouL , PrenticeA . Maternal calcium supplementation and offspring growth. Osteoporosis International2016;27(1 Suppl 1):S327‐8. WardKA , PrenticeA , JarjouL . Long‐term effects of maternal calcium supplementation on childhood growth differ between males and females in a population accustomed to a low calcium intake. Bone2017;103:31‐8. '>Jarjou 2004</a>; <a href="./references#CD001059-bbs2-0014" title="LiX , GouW . Study on prevention of pregnancy induced hypertension and effect of platelet intracellular free ca˜(2+) by calcium supplementation. Journal of Xi'an Medical University2000;21(1):46‐8. ">Li 2000</a>; <a href="./references#CD001059-bbs2-0017" title="Lopez‐JaramilloP , DelgadoF , JacomeP , TeranE , RuanoC , RiveraJ . Calcium supplementation and the risk of preeclampsia in Ecuadorian pregnant teenagers. Obstetrics &amp; Gynecology1997;90:162‐7. ">L‐Jaramillo 1997</a>; <a href="./references#CD001059-bbs2-0020" title="PurwarM , KulkarniH , MotghareV , DholeS . Calcium supplementation and prevention of pregnancy induced hypertension. Journal of Obstetrics and Gynaecology Research1996;22(5):425‐30. PurwarM , MotghareV , KulkarniH . Calcium supplementation and prevention of pregnancy induced hypertension: randomized double blind controlled trial. Journal of Clinical Epidemiology1996; Vol. 49, issue Suppl 1:28S. ">Purwar 1996</a>; <a href="./references#CD001059-bbs2-0021" title="RogersMS , FungHYM , HungCY . Calcium and low‐dose aspirin prophylaxis in women at high risk of pregnancy‐induced hypertension. Hypertension in Pregnancy1999;18(2):165‐72. ">Rogers 1999</a>; <a href="./references#CD001059-bbs2-0024" title="TaherianAA , TaherianA , ShirvaniA . Prevention of pre‐eclampsia with low‐dose aspirin or calcium supplementation. Archives of Iranian Medicine2002;5(3):151‐6. ">Taherian 2002</a>); and in the 2000s in seven studies (<a href="./references#CD001059-bbs2-0002" title="AsemiZ , IRCT201212105623N3 . Comparison of effectiveness of multivitamin, multivitamin‐mineral supplements, probiotic and normal Gaz on pregnancy outcomes in pregnant women. en.search.irct.ir/view/11730 (first received 26 December 2012). AsemiZ , TabassiZ , HeidarzadehZ , KhorammianH , SabihiSS , SamimiM . Effect of calcium‐vitamin D supplementation on metabolic profiles in pregnant women at risk for pre‐eclampsia: a randomized placebo‐controlled trial. Pakistan Journal of Biological Sciences2012;15(7):316‐24. ">Asemi 2012</a>; <a href="./references#CD001059-bbs2-0003" title="AsemiZ , SamimiM , SiavashaniMA , MazloomiM , TabassiZ , KaramaliM , et al. Calcium‐vitamin D co‐supplementation affects metabolic profiles, but not pregnancy outcomes, in healthy pregnant women. International Journal of Preventive Medicine2016;7:49. ">Asemi 2016</a>; <a href="./references#CD001059-bbs2-0010" title="HerreraJA , Arevalo‐HerreraM , ShahabuddinAK , ErshengG , HerreraS , GarciaRG , et al. Calcium and conjugated linoleic acid reduces pregnancy‐induced hypertension and decreases intracellular calcium in lymphocytes. American Journal of Hypertension2006;19(4):381‐7. HerreraJA , ShahabuddinAK , ErshengG , WeiY , GarciaRG , Lopez‐JaramilloP . Calcium plus linoleic acid therapy for pregnancy‐induced hypertension. International Journal of Gynecology &amp; Obstetrics2005;91(3):221‐7. HerreraJA , ShahabuddinAKM , FaisalM , ErshengG , WeiY , LixiaD , et al. Effects of supplementation with oral calcium and linoleic acid in primigravidas at high risk [Efectos de la supplementacion oral con calcio y acido linoleico conjugado en primigravidas de alto riesgo]. Colombia Medica2004;35(1):31‐7. ">Herrera 2006</a>; <a href="./references#CD001059-bbs2-0012" title="KhanA , MandalSK , PalA . Role of high dose calcium in the prevention of preeclampsia. Bangladesh Journal of Obstetrics and Gynecology2013;28(2):66‐70. ">Khan 2013</a>; <a href="./references#CD001059-bbs2-0013" title="KumarA , DeviSG , BatraS , SinghC , ShuklaDK . Calcium supplementation for the prevention of pre‐eclampsia. International Journal of Gynecology &amp; Obstetrics2009;104(1):32‐6. ">Kumar 2009</a>; <a href="./references#CD001059-bbs2-0022" title="RumirisD , PurwosunuY , WibowoN , FarinaA , SekizawaA . Lower rate of preeclampsia after antioxidant supplementation in pregnant women with low antioxidant status. Hypertension in Pregnancy2006;25:241–53. ">Rumiris 2006</a>; <a href="./references#CD001059-bbs2-0027" title="AbalosE , MerialdiM , WojdylaD , CarroliG , CampodónicoL , YaoSE , et al. Effects of calcium supplementation on fetal growth in mothers with deficient calcium intake: a randomised controlled trial. Paediatric and Perinatal Epidemiology2010;24(1):53‐62. Abdel‐AleemH , MerialdiM , ElsnosyED , ElsedfyGO , Abdel‐AleemMA , VillarJ . The effect of calcium supplementation during pregnancy on fetal and infant growth: a nested randomized controlled trial within WHO calcium supplementation trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2009;22(2):94‐100. CarroliG , MerialdiM , WojdylaD , AbalosE , CampodonicoL , YaoSE , et al. Effects of calcium supplementation on uteroplacental and fetoplacental blood flow in low‐calcium‐intake mothers: a randomized controlled trial. American Journal of Obstetrics and Gynecology2010;202(1):45.e1‐45.e9. HofmeyrGJ , MlokotiZ , NikodemVC , MangesiL , FerreiraS , SingataM , et al. Calcium supplementation during pregnancy for preventing hypertensive disorders is not associated with changes in platelet count, urate, and urinary protein: a randomized control trial. Hypertension in Pregnancy2008;27(3):299‐304. VillarJ , Abdel‐AleemH , MerialdiM , MathaiM , AliM , ZavaletaN , et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. American Journal of Obstetrics and Gynecology2006;194:639‐49. VillarJ , AleemHA , MerialdiM , MathaiM , AliM , ZavaletaN , et al. WHO randomized trial of calcium supplementation among low calcium intake pregnant women [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S2. VillarJ , ISRCTN37214165 . Calcium supplementation during pregnancy in low‐intake populations. isrctn.com/ISRCTN37214165 (first received 19 March 2014). ZhangJ , VillarJ , SunW , MerialdiM , Abdel‐AleemH , MathaiM , et al. Blood pressure dynamics during pregnancy and spontaneous preterm birth. American Journal of Obstetrics and Gynecology2007;197(2):162.e1‐6. ">WHO 2006</a>). </p> <p>Many of these studies were conducted before it was required for sources of funding and conflict of interest declarations to be reported in published reports. Ten studies did not mention sources of funding. In two studies trial funding was not reported, but it was stated that study drugs were provided by pharmaceutical companies (<a href="./references#CD001059-bbs2-0019" title="NiromaneshS , LaghaiiS , Mosavi‐JarrahiA . Supplementary calcium in prevention of pre‐eclampsia. International Journal of Gynecology &amp; Obstetrics2001;74:17‐21. ">Niromanesh 2001</a>; <a href="./references#CD001059-bbs2-0020" title="PurwarM , KulkarniH , MotghareV , DholeS . Calcium supplementation and prevention of pregnancy induced hypertension. Journal of Obstetrics and Gynaecology Research1996;22(5):425‐30. PurwarM , MotghareV , KulkarniH . Calcium supplementation and prevention of pregnancy induced hypertension: randomized double blind controlled trial. Journal of Clinical Epidemiology1996; Vol. 49, issue Suppl 1:28S. ">Purwar 1996</a>); pharmaceutical companies also provided drugs for other trials that were otherwise government, health service or university funded (<a href="./references#CD001059-bbs2-0002" title="AsemiZ , IRCT201212105623N3 . Comparison of effectiveness of multivitamin, multivitamin‐mineral supplements, probiotic and normal Gaz on pregnancy outcomes in pregnant women. en.search.irct.ir/view/11730 (first received 26 December 2012). AsemiZ , TabassiZ , HeidarzadehZ , KhorammianH , SabihiSS , SamimiM . Effect of calcium‐vitamin D supplementation on metabolic profiles in pregnant women at risk for pre‐eclampsia: a randomized placebo‐controlled trial. Pakistan Journal of Biological Sciences2012;15(7):316‐24. ">Asemi 2012</a>; <a href="./references#CD001059-bbs2-0003" title="AsemiZ , SamimiM , SiavashaniMA , MazloomiM , TabassiZ , KaramaliM , et al. Calcium‐vitamin D co‐supplementation affects metabolic profiles, but not pregnancy outcomes, in healthy pregnant women. International Journal of Preventive Medicine2016;7:49. ">Asemi 2016</a>; <a href="./references#CD001059-bbs2-0007" title="HabliM , LevineRJ , QianC , SibaiB . Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. American Journal of Obstetrics and Gynecology2007;197(4):406.e1‐406.e7. HattonDC , Harrison‐HohnerJ , CosteS , RellerM , McCarronD . Gestational calcium supplementation and blood pressure in the offspring. American Journal of Hypertension2003;16:801‐5. Levine RJ for the CPEP Study Group. Calcium for preeclampsia prevention (CPEP): a double‐blind, placebo‐controlled trial in healthy nulliparas. American Journal of Obstetrics and Gynecology1997;176:S2. Levine RJ for the CPEP Study Group. The trial of calcium for preeclampsia prevention (CPEP). 8th World Congress on Hypertension in Pregnancy ‐ Protagonists and Presentations; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. LevineRJ , EsterlitzJR , RaymondEG , DerSimonianR , HauthJC , Ben CuretL , et al. Trial of calcium for preeclampsia prevention (CPEP): rationale, design, and methods. Controlled Clinical Trials1996;17:442‐69. LevineRJ , HauthJC , CuretLB , SibaiBM , CatalanoPM , MorrisCD , et al. Trial of calcium to prevent preeclampsia. New England Journal of Medicine1997;337(2):69‐76. NCT00000534 . Calcium for pre‐eclampsia prevention (CPEP). clinicaltrials.gov/ct2/show/record/NCT00000534 (first received 27 October 1999). ">CPEP 1997</a>; <a href="./references#CD001059-bbs2-0011" title='GoldbergG , YinJ , JarjouL , PrenticeA . Maternal calcium supplementation during pregnancy and blood pressure in rural Gambian children at 3 and 9 years old. Annals of Nutrition &amp; Metabolism2013;63(Suppl 1):728, Abstract no: PO982. GoldbergGR , JarjouLM , ColeTJ , PrenticeA . Randomized, placebo‐controlled, calcium supplementation trial in pregnant Gambian women accustomed to a low calcium intake: effects on maternal blood pressure and infant growth. American Journal of Clinical Nutrition2013;98(4):972‐82. HawkesworthS , SawoY , FulfordAJ , GoldbergGR , JarjouLM , PrenticeA , et al. Effect of maternal calcium supplementation on offspring blood pressure in 5‐ to 10‐y‐old rural Gambian children. American Journal of Clinical Nutrition2010;92(4):741‐7. HawkesworthS , WalkerCG , SawoY , FulfordAJ , JarjouLM , GoldbergGR , et al. Nutritional supplementation during pregnancy and offspring cardiovascular disease risk in The Gambia. American Journal of Clinical Nutrition2011;94(6 Suppl):1853S‐1860S. JarjouLM , LaskeyMA , SawoY , GoldbergGR , ColeTJ , PrenticeA . Effect of calcium supplementation in pregnancy on maternal bone outcomes in women with a low calcium intake. American Journal of Clinical Nutrition2010;92(2):450‐7. JarjouLM , PrenticeA , BennettJ . Impact of calcium supplementation in the preceding pregnancy on the human milk calcium concentration of Gambian women. Advances in Experimental Medicine and Biology2004;54:347‐9. JarjouLM , PrenticeA , SawoY , LaskeyMA , BennettJ , GoldbergGR , et al. Randomized, placebo‐controlled, calcium supplementation study in pregnant Gambian women: effects on breast‐milk calcium concentrations and infant birth weight, growth, and bone mineral accretion in the first year of life. American Journal of Clinical Nutrition2006;83(3):657‐66. JarjouLMA , BennettJ , LaidlawA , GoldbergGR , PrenticeA . Changes in bone turnover and calcitrophic hormones in lactating Gambian women supplemented with calcium during pregnancy. Journal of Human Lactation2007;23(1):86‐7. JarjouLMA , SawoY , GoldbergGR , LaskeyMA , ColeTJ , PrenticeA . Persistent effects of calcium supplementation during pregnancy on maternal bone mineral content: a follow‐up study in Gambian women. Proceedings of the 16th ISRHML Conference "Breastfeeding and the Use of Human Milk. Science and Practice"; 2012 September 27th ‐ October 1st; Trieste, Italy. 2012:Abstract no.:105. JarjouMA , YankubaS , GoldbergR , LaskeyMA , ColeJ , PrenticeA . Unexpected long‐term effects of calcium supplementation in pregnancy on maternal bone outcomes in women with a low calcium intake: a follow‐up study. American Journal of Clinical Nutrition2013;98(3):723‐30. PrenticeA , GoldbergGR , JarjouLMA . The effects of pregnancy calcium supplementation on calcium metabolism after lactation in Gambian women with a low calcium intake. Breastfeeding Medicine2016;11(2):A‐20‐A‐21, Abstract no: P‐8. PrenticeA , ISRCTN72582014 . Effects on birth weight and perinatal mortality of maternal dietary supplements in rural Gambia: 5 year randomised controlled trial. isrctn.com/ISRCTN72582014 (first received 27 March 2013). PrenticeA , ISRCTN96502494 . Calcium requirements of pregnant women in The Gambia. isrctn.com/ISRCTN96502494 (first received 6 November 2007). PrenticeA , JarjouLM , GoldbergGR , BennettJ , ColeTJ , SchoenmakersI . Maternal plasma 25‐hydroxyvitamin D concentration and birthweight, growth and bone mineral accretion of Gambian infants. Acta Paediatrica2009;98(8):1360‐2. WardKA , JarjouL , PrenticeA . Maternal calcium supplementation and offspring growth. Osteoporosis International2016;27(1 Suppl 1):S327‐8. WardKA , PrenticeA , JarjouL . Long‐term effects of maternal calcium supplementation on childhood growth differ between males and females in a population accustomed to a low calcium intake. Bone2017;103:31‐8. '>Jarjou 2004</a>). Other trialists also stated that studies were supported by university, government or hospital funding (<a href="./references#CD001059-bbs2-0008" title="CrowtherC , HillerJ , PridmoreB , BryceR , DugganP , HagueW , et al. Calcium supplementation in nulliparous women for the prevention of pregnancy included hypertension, pre‐eclampsia and preterm birth: an Australian randomised trial. 2nd Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. 1998:101. CrowtherCA , HillerJE , PridmoreB , BryceR , DugganP , HagueWM , et al. Calcium supplementation in nulliparous women for the prevention of pregnancy‐induced hypertension, preeclampsia and preterm birth: an Australian randomized trial. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(1):12‐8. HillerJE , CrowtherCA , MooreVA , WillsonK , RobinsonJS . Calcium supplementation in pregnancy and its impact on blood pressure in children and women: follow up of a randomised controlled trial. Australian and New Zealand Journal of Obstetrics and Gynaecology2007;47(2):115‐21. ">Crowther 1999</a>; <a href="./references#CD001059-bbs2-0009" title="HerreraJA , Arevalo‐HerreraM , HerreraS . Prevention of preeclampsia by linoleic acid and calcium supplementation: a randomized controlled trial. Obstetrics &amp; Gynecology1998;91(4):585‐90. ">Herrera 1998</a>; <a href="./references#CD001059-bbs2-0010" title="HerreraJA , Arevalo‐HerreraM , ShahabuddinAK , ErshengG , HerreraS , GarciaRG , et al. Calcium and conjugated linoleic acid reduces pregnancy‐induced hypertension and decreases intracellular calcium in lymphocytes. American Journal of Hypertension2006;19(4):381‐7. HerreraJA , ShahabuddinAK , ErshengG , WeiY , GarciaRG , Lopez‐JaramilloP . Calcium plus linoleic acid therapy for pregnancy‐induced hypertension. International Journal of Gynecology &amp; Obstetrics2005;91(3):221‐7. HerreraJA , ShahabuddinAKM , FaisalM , ErshengG , WeiY , LixiaD , et al. Effects of supplementation with oral calcium and linoleic acid in primigravidas at high risk [Efectos de la supplementacion oral con calcio y acido linoleico conjugado en primigravidas de alto riesgo]. Colombia Medica2004;35(1):31‐7. ">Herrera 2006</a>; <a href="./references#CD001059-bbs2-0011" title='GoldbergG , YinJ , JarjouL , PrenticeA . Maternal calcium supplementation during pregnancy and blood pressure in rural Gambian children at 3 and 9 years old. Annals of Nutrition &amp; Metabolism2013;63(Suppl 1):728, Abstract no: PO982. GoldbergGR , JarjouLM , ColeTJ , PrenticeA . Randomized, placebo‐controlled, calcium supplementation trial in pregnant Gambian women accustomed to a low calcium intake: effects on maternal blood pressure and infant growth. American Journal of Clinical Nutrition2013;98(4):972‐82. HawkesworthS , SawoY , FulfordAJ , GoldbergGR , JarjouLM , PrenticeA , et al. Effect of maternal calcium supplementation on offspring blood pressure in 5‐ to 10‐y‐old rural Gambian children. American Journal of Clinical Nutrition2010;92(4):741‐7. HawkesworthS , WalkerCG , SawoY , FulfordAJ , JarjouLM , GoldbergGR , et al. Nutritional supplementation during pregnancy and offspring cardiovascular disease risk in The Gambia. American Journal of Clinical Nutrition2011;94(6 Suppl):1853S‐1860S. JarjouLM , LaskeyMA , SawoY , GoldbergGR , ColeTJ , PrenticeA . Effect of calcium supplementation in pregnancy on maternal bone outcomes in women with a low calcium intake. American Journal of Clinical Nutrition2010;92(2):450‐7. JarjouLM , PrenticeA , BennettJ . Impact of calcium supplementation in the preceding pregnancy on the human milk calcium concentration of Gambian women. Advances in Experimental Medicine and Biology2004;54:347‐9. JarjouLM , PrenticeA , SawoY , LaskeyMA , BennettJ , GoldbergGR , et al. Randomized, placebo‐controlled, calcium supplementation study in pregnant Gambian women: effects on breast‐milk calcium concentrations and infant birth weight, growth, and bone mineral accretion in the first year of life. American Journal of Clinical Nutrition2006;83(3):657‐66. JarjouLMA , BennettJ , LaidlawA , GoldbergGR , PrenticeA . Changes in bone turnover and calcitrophic hormones in lactating Gambian women supplemented with calcium during pregnancy. Journal of Human Lactation2007;23(1):86‐7. JarjouLMA , SawoY , GoldbergGR , LaskeyMA , ColeTJ , PrenticeA . Persistent effects of calcium supplementation during pregnancy on maternal bone mineral content: a follow‐up study in Gambian women. Proceedings of the 16th ISRHML Conference "Breastfeeding and the Use of Human Milk. Science and Practice"; 2012 September 27th ‐ October 1st; Trieste, Italy. 2012:Abstract no.:105. JarjouMA , YankubaS , GoldbergR , LaskeyMA , ColeJ , PrenticeA . Unexpected long‐term effects of calcium supplementation in pregnancy on maternal bone outcomes in women with a low calcium intake: a follow‐up study. American Journal of Clinical Nutrition2013;98(3):723‐30. PrenticeA , GoldbergGR , JarjouLMA . The effects of pregnancy calcium supplementation on calcium metabolism after lactation in Gambian women with a low calcium intake. Breastfeeding Medicine2016;11(2):A‐20‐A‐21, Abstract no: P‐8. PrenticeA , ISRCTN72582014 . Effects on birth weight and perinatal mortality of maternal dietary supplements in rural Gambia: 5 year randomised controlled trial. isrctn.com/ISRCTN72582014 (first received 27 March 2013). PrenticeA , ISRCTN96502494 . Calcium requirements of pregnant women in The Gambia. isrctn.com/ISRCTN96502494 (first received 6 November 2007). PrenticeA , JarjouLM , GoldbergGR , BennettJ , ColeTJ , SchoenmakersI . Maternal plasma 25‐hydroxyvitamin D concentration and birthweight, growth and bone mineral accretion of Gambian infants. Acta Paediatrica2009;98(8):1360‐2. WardKA , JarjouL , PrenticeA . Maternal calcium supplementation and offspring growth. Osteoporosis International2016;27(1 Suppl 1):S327‐8. WardKA , PrenticeA , JarjouL . Long‐term effects of maternal calcium supplementation on childhood growth differ between males and females in a population accustomed to a low calcium intake. Bone2017;103:31‐8. '>Jarjou 2004</a>; <a href="./references#CD001059-bbs2-0013" title="KumarA , DeviSG , BatraS , SinghC , ShuklaDK . Calcium supplementation for the prevention of pre‐eclampsia. International Journal of Gynecology &amp; Obstetrics2009;104(1):32‐6. ">Kumar 2009</a>; <a href="./references#CD001059-bbs2-0015" title="Lopez‐JaramilloP , NarvaezM , WeigelRM , YepezR . Calcium supplementation reduces the risk of pregnancy‐induced hypertension in an Andes population. British Journal of Obstetrics and Gynaecology1989;96:648‐55. Lopez‐JaramilloP , NarvaezM , YepezR . Effect of calcium supplementation on the vascular sensitivity to angiotensin II in pregnant women. American Journal of Obstetrics and Gynecology1987;156:261‐2. NarvaezM , Lopez‐JaramilloP , WeigelM . Calcium (Ca++) supplementation reduces the risk for pregnancy induced hypertension (PIH). World Congress of Gynecology and Obstetrics; 1988 October 23‐28; Brazil. 1988:180‐1. ">L‐Jaramillo 1989</a>; <a href="./references#CD001059-bbs2-0024" title="TaherianAA , TaherianA , ShirvaniA . Prevention of pre‐eclampsia with low‐dose aspirin or calcium supplementation. Archives of Iranian Medicine2002;5(3):151‐6. ">Taherian 2002</a>). Two studies were WHO funded (<a href="./references#CD001059-bbs2-0017" title="Lopez‐JaramilloP , DelgadoF , JacomeP , TeranE , RuanoC , RiveraJ . Calcium supplementation and the risk of preeclampsia in Ecuadorian pregnant teenagers. Obstetrics &amp; Gynecology1997;90:162‐7. ">L‐Jaramillo 1997</a>; <a href="./references#CD001059-bbs2-0027" title="AbalosE , MerialdiM , WojdylaD , CarroliG , CampodónicoL , YaoSE , et al. Effects of calcium supplementation on fetal growth in mothers with deficient calcium intake: a randomised controlled trial. Paediatric and Perinatal Epidemiology2010;24(1):53‐62. Abdel‐AleemH , MerialdiM , ElsnosyED , ElsedfyGO , Abdel‐AleemMA , VillarJ . The effect of calcium supplementation during pregnancy on fetal and infant growth: a nested randomized controlled trial within WHO calcium supplementation trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2009;22(2):94‐100. CarroliG , MerialdiM , WojdylaD , AbalosE , CampodonicoL , YaoSE , et al. Effects of calcium supplementation on uteroplacental and fetoplacental blood flow in low‐calcium‐intake mothers: a randomized controlled trial. American Journal of Obstetrics and Gynecology2010;202(1):45.e1‐45.e9. HofmeyrGJ , MlokotiZ , NikodemVC , MangesiL , FerreiraS , SingataM , et al. Calcium supplementation during pregnancy for preventing hypertensive disorders is not associated with changes in platelet count, urate, and urinary protein: a randomized control trial. Hypertension in Pregnancy2008;27(3):299‐304. VillarJ , Abdel‐AleemH , MerialdiM , MathaiM , AliM , ZavaletaN , et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. American Journal of Obstetrics and Gynecology2006;194:639‐49. VillarJ , AleemHA , MerialdiM , MathaiM , AliM , ZavaletaN , et al. WHO randomized trial of calcium supplementation among low calcium intake pregnant women [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S2. VillarJ , ISRCTN37214165 . Calcium supplementation during pregnancy in low‐intake populations. isrctn.com/ISRCTN37214165 (first received 19 March 2014). ZhangJ , VillarJ , SunW , MerialdiM , Abdel‐AleemH , MathaiM , et al. Blood pressure dynamics during pregnancy and spontaneous preterm birth. American Journal of Obstetrics and Gynecology2007;197(2):162.e1‐6. ">WHO 2006</a>) and two were funded by national dairy food organisations (<a href="./references#CD001059-bbs2-0025" title="RepkeJT , VillarJ , AndersonC , ParejaG , DubinN , BelizanJM . Biochemical changes associated with blood pressure reduction induced by calcium supplementation during pregnancy. American Journal of Obstetrics and Gynecology1989;160:684‐90. VillarJ , RepkeJ , BelizanJM , ParejaG . Calcium supplementation reduces blood pressure during pregnancy: results of a randomized controlled clinical trial. Obstetrics &amp; Gynecology1987;70:317‐22. ">Villar 1987</a>; <a href="./references#CD001059-bbs2-0026" title="VillarJ , BelizanJM , RepkeJ . The effect of calcium supplementation on the incidence of hypertensive disorders of pregnancy and prematurity. 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy. 1990:54. VillarJ , BelizanJM , RepkeJT . Does calcium supplementation reduce pregnancy‐induced hypertension and prematurity?. Advances in the prevention of low birthweight; 1988 May 8‐11; Cape Cod, Massachusetts. 1998:187‐95. VillarJ , RepkeJT . Calcium supplementation during pregnancy may reduce preterm delivery in high‐risk populations. American Journal of Obstetrics and Gynecology1990;163:1124‐31. ">Villar 1990</a>). </p> <p>Only two of the studies explicitly stated that authors had no known conflict of interest (<a href="./references#CD001059-bbs2-0003" title="AsemiZ , SamimiM , SiavashaniMA , MazloomiM , TabassiZ , KaramaliM , et al. Calcium‐vitamin D co‐supplementation affects metabolic profiles, but not pregnancy outcomes, in healthy pregnant women. International Journal of Preventive Medicine2016;7:49. ">Asemi 2016</a>; <a href="./references#CD001059-bbs2-0011" title='GoldbergG , YinJ , JarjouL , PrenticeA . Maternal calcium supplementation during pregnancy and blood pressure in rural Gambian children at 3 and 9 years old. Annals of Nutrition &amp; Metabolism2013;63(Suppl 1):728, Abstract no: PO982. GoldbergGR , JarjouLM , ColeTJ , PrenticeA . Randomized, placebo‐controlled, calcium supplementation trial in pregnant Gambian women accustomed to a low calcium intake: effects on maternal blood pressure and infant growth. American Journal of Clinical Nutrition2013;98(4):972‐82. HawkesworthS , SawoY , FulfordAJ , GoldbergGR , JarjouLM , PrenticeA , et al. Effect of maternal calcium supplementation on offspring blood pressure in 5‐ to 10‐y‐old rural Gambian children. American Journal of Clinical Nutrition2010;92(4):741‐7. HawkesworthS , WalkerCG , SawoY , FulfordAJ , JarjouLM , GoldbergGR , et al. Nutritional supplementation during pregnancy and offspring cardiovascular disease risk in The Gambia. American Journal of Clinical Nutrition2011;94(6 Suppl):1853S‐1860S. JarjouLM , LaskeyMA , SawoY , GoldbergGR , ColeTJ , PrenticeA . Effect of calcium supplementation in pregnancy on maternal bone outcomes in women with a low calcium intake. American Journal of Clinical Nutrition2010;92(2):450‐7. JarjouLM , PrenticeA , BennettJ . Impact of calcium supplementation in the preceding pregnancy on the human milk calcium concentration of Gambian women. Advances in Experimental Medicine and Biology2004;54:347‐9. JarjouLM , PrenticeA , SawoY , LaskeyMA , BennettJ , GoldbergGR , et al. Randomized, placebo‐controlled, calcium supplementation study in pregnant Gambian women: effects on breast‐milk calcium concentrations and infant birth weight, growth, and bone mineral accretion in the first year of life. American Journal of Clinical Nutrition2006;83(3):657‐66. JarjouLMA , BennettJ , LaidlawA , GoldbergGR , PrenticeA . Changes in bone turnover and calcitrophic hormones in lactating Gambian women supplemented with calcium during pregnancy. Journal of Human Lactation2007;23(1):86‐7. JarjouLMA , SawoY , GoldbergGR , LaskeyMA , ColeTJ , PrenticeA . Persistent effects of calcium supplementation during pregnancy on maternal bone mineral content: a follow‐up study in Gambian women. Proceedings of the 16th ISRHML Conference "Breastfeeding and the Use of Human Milk. Science and Practice"; 2012 September 27th ‐ October 1st; Trieste, Italy. 2012:Abstract no.:105. JarjouMA , YankubaS , GoldbergR , LaskeyMA , ColeJ , PrenticeA . Unexpected long‐term effects of calcium supplementation in pregnancy on maternal bone outcomes in women with a low calcium intake: a follow‐up study. American Journal of Clinical Nutrition2013;98(3):723‐30. PrenticeA , GoldbergGR , JarjouLMA . The effects of pregnancy calcium supplementation on calcium metabolism after lactation in Gambian women with a low calcium intake. Breastfeeding Medicine2016;11(2):A‐20‐A‐21, Abstract no: P‐8. PrenticeA , ISRCTN72582014 . Effects on birth weight and perinatal mortality of maternal dietary supplements in rural Gambia: 5 year randomised controlled trial. isrctn.com/ISRCTN72582014 (first received 27 March 2013). PrenticeA , ISRCTN96502494 . Calcium requirements of pregnant women in The Gambia. isrctn.com/ISRCTN96502494 (first received 6 November 2007). PrenticeA , JarjouLM , GoldbergGR , BennettJ , ColeTJ , SchoenmakersI . Maternal plasma 25‐hydroxyvitamin D concentration and birthweight, growth and bone mineral accretion of Gambian infants. Acta Paediatrica2009;98(8):1360‐2. WardKA , JarjouL , PrenticeA . Maternal calcium supplementation and offspring growth. Osteoporosis International2016;27(1 Suppl 1):S327‐8. WardKA , PrenticeA , JarjouL . Long‐term effects of maternal calcium supplementation on childhood growth differ between males and females in a population accustomed to a low calcium intake. Bone2017;103:31‐8. '>Jarjou 2004</a>). </p> <p>Compliance, where reported, was generally more than 80% (84% and 86% for calcium and placebo in <a href="./references#CD001059-bbs2-0005" title="BelizanJM . Prevention of hypertensive disorders of pregnancy with calcium supplementation. 8th World Congress on Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires. 1992:93. BelizanJM , VillarJ , BergelE , delPinoA , DiFulvioS , GallianoSV , et al. Long term effect of calcium supplementation during pregnancy on the blood pressure of offspring: follow up of a randomised controlled trial. BMJ1997;315:281‐5. BelizanJM , VillarJ , GonzalezL , CampodonicoL , BergelE . Calcium supplementation to prevent hypertensive disorders of pregnancy. New England Journal of Medicine1991;325:1399‐405. BergelE , GibbonsL , RasinesMG , LuetichA , BelizanJM . Maternal calcium supplementation during pregnancy and dental caries of children at 12 years of age: follow‐up of a randomized controlled trial. Acta Obstetricia et Gynecologica Scandinavica2010;89(11):1396‐402. StephensIF . Effect of calcium supplementation during pregnancy on blood pressure of offspring. Authors cannot be sure of effect's generalisability to all children aged 5‐9 [letter; comment]. BMJ1998;316(7126):234. VillarJ , BelizanJM , RepkeJ . The effect of calcium supplementation on the incidence of hypertensive disorders of pregnancy and prematurity. 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy. 1990:54. VillarJ , BelizanJM , RepkeJT . Does calcium supplementation reduce pregnancy‐induced hypertension and prematurity?. Proceedings of the International Symposium on advances in the prevention of low birthweight; 1988 May 8‐11; Cape Cod, Massachusetts. 1988:187‐95. ">Belizan 1991</a>; 84.5% and 86.2% in <a href="./references#CD001059-bbs2-0027" title="AbalosE , MerialdiM , WojdylaD , CarroliG , CampodónicoL , YaoSE , et al. Effects of calcium supplementation on fetal growth in mothers with deficient calcium intake: a randomised controlled trial. Paediatric and Perinatal Epidemiology2010;24(1):53‐62. Abdel‐AleemH , MerialdiM , ElsnosyED , ElsedfyGO , Abdel‐AleemMA , VillarJ . The effect of calcium supplementation during pregnancy on fetal and infant growth: a nested randomized controlled trial within WHO calcium supplementation trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2009;22(2):94‐100. CarroliG , MerialdiM , WojdylaD , AbalosE , CampodonicoL , YaoSE , et al. Effects of calcium supplementation on uteroplacental and fetoplacental blood flow in low‐calcium‐intake mothers: a randomized controlled trial. American Journal of Obstetrics and Gynecology2010;202(1):45.e1‐45.e9. HofmeyrGJ , MlokotiZ , NikodemVC , MangesiL , FerreiraS , SingataM , et al. Calcium supplementation during pregnancy for preventing hypertensive disorders is not associated with changes in platelet count, urate, and urinary protein: a randomized control trial. Hypertension in Pregnancy2008;27(3):299‐304. VillarJ , Abdel‐AleemH , MerialdiM , MathaiM , AliM , ZavaletaN , et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. American Journal of Obstetrics and Gynecology2006;194:639‐49. VillarJ , AleemHA , MerialdiM , MathaiM , AliM , ZavaletaN , et al. WHO randomized trial of calcium supplementation among low calcium intake pregnant women [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S2. VillarJ , ISRCTN37214165 . Calcium supplementation during pregnancy in low‐intake populations. isrctn.com/ISRCTN37214165 (first received 19 March 2014). ZhangJ , VillarJ , SunW , MerialdiM , Abdel‐AleemH , MathaiM , et al. Blood pressure dynamics during pregnancy and spontaneous preterm birth. American Journal of Obstetrics and Gynecology2007;197(2):162.e1‐6. ">WHO 2006</a>; 79% and 81% in <a href="./references#CD001059-bbs2-0023" title="Sanchez‐RamosL , BrionesDK , KaunitzAM , DelvalleGO , GaudierFL , WalkerKD . Prevention of pregnancy‐induced hypertension by calcium supplementation in angiotensin II‐sensitive patients. Obstetrics &amp; Gynecology1994;84:349‐53. Sanchez‐RamosL , DelvalleGO , BrionesD , WalkerC , DelkeI , GaudierF . Prevention of preeclampsia by calcium supplementation in angiotensin‐sensitive patients. American Journal of Obstetrics and Gynecology1994;170:408. ">S‐Ramos 1994</a>). However, in one study compliance was 64% and 67% in the respective groups (<a href="./references#CD001059-bbs2-0007" title="HabliM , LevineRJ , QianC , SibaiB . Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. American Journal of Obstetrics and Gynecology2007;197(4):406.e1‐406.e7. HattonDC , Harrison‐HohnerJ , CosteS , RellerM , McCarronD . Gestational calcium supplementation and blood pressure in the offspring. American Journal of Hypertension2003;16:801‐5. Levine RJ for the CPEP Study Group. Calcium for preeclampsia prevention (CPEP): a double‐blind, placebo‐controlled trial in healthy nulliparas. American Journal of Obstetrics and Gynecology1997;176:S2. Levine RJ for the CPEP Study Group. The trial of calcium for preeclampsia prevention (CPEP). 8th World Congress on Hypertension in Pregnancy ‐ Protagonists and Presentations; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. LevineRJ , EsterlitzJR , RaymondEG , DerSimonianR , HauthJC , Ben CuretL , et al. Trial of calcium for preeclampsia prevention (CPEP): rationale, design, and methods. Controlled Clinical Trials1996;17:442‐69. LevineRJ , HauthJC , CuretLB , SibaiBM , CatalanoPM , MorrisCD , et al. Trial of calcium to prevent preeclampsia. New England Journal of Medicine1997;337(2):69‐76. NCT00000534 . Calcium for pre‐eclampsia prevention (CPEP). clinicaltrials.gov/ct2/show/record/NCT00000534 (first received 27 October 1999). ">CPEP 1997</a>), and in another, 31% and 24% of women from each group stopped taking the tablets before the end of the trial (<a href="./references#CD001059-bbs2-0008" title="CrowtherC , HillerJ , PridmoreB , BryceR , DugganP , HagueW , et al. Calcium supplementation in nulliparous women for the prevention of pregnancy included hypertension, pre‐eclampsia and preterm birth: an Australian randomised trial. 2nd Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. 1998:101. CrowtherCA , HillerJE , PridmoreB , BryceR , DugganP , HagueWM , et al. Calcium supplementation in nulliparous women for the prevention of pregnancy‐induced hypertension, preeclampsia and preterm birth: an Australian randomized trial. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(1):12‐8. HillerJE , CrowtherCA , MooreVA , WillsonK , RobinsonJS . Calcium supplementation in pregnancy and its impact on blood pressure in children and women: follow up of a randomised controlled trial. Australian and New Zealand Journal of Obstetrics and Gynaecology2007;47(2):115‐21. ">Crowther 1999</a>). In <a href="./references#CD001059-bbs2-0017" title="Lopez‐JaramilloP , DelgadoF , JacomeP , TeranE , RuanoC , RiveraJ . Calcium supplementation and the risk of preeclampsia in Ecuadorian pregnant teenagers. Obstetrics &amp; Gynecology1997;90:162‐7. ">L‐Jaramillo 1997</a>, two women were withdrawn for non‐compliance. </p> <section id="CD001059-sec-0084"> <h5 class="title">High‐dose calcium supplementation (1 g/day or more)</h5> <p>We included 14 studies examining high‐dose supplements in the review. One study contributed no data, although authors have been contacted and data may be available for the next update (<a href="./references#CD001059-bbs2-0011" title='GoldbergG , YinJ , JarjouL , PrenticeA . Maternal calcium supplementation during pregnancy and blood pressure in rural Gambian children at 3 and 9 years old. Annals of Nutrition &amp; Metabolism2013;63(Suppl 1):728, Abstract no: PO982. GoldbergGR , JarjouLM , ColeTJ , PrenticeA . Randomized, placebo‐controlled, calcium supplementation trial in pregnant Gambian women accustomed to a low calcium intake: effects on maternal blood pressure and infant growth. American Journal of Clinical Nutrition2013;98(4):972‐82. HawkesworthS , SawoY , FulfordAJ , GoldbergGR , JarjouLM , PrenticeA , et al. Effect of maternal calcium supplementation on offspring blood pressure in 5‐ to 10‐y‐old rural Gambian children. American Journal of Clinical Nutrition2010;92(4):741‐7. HawkesworthS , WalkerCG , SawoY , FulfordAJ , JarjouLM , GoldbergGR , et al. Nutritional supplementation during pregnancy and offspring cardiovascular disease risk in The Gambia. American Journal of Clinical Nutrition2011;94(6 Suppl):1853S‐1860S. JarjouLM , LaskeyMA , SawoY , GoldbergGR , ColeTJ , PrenticeA . Effect of calcium supplementation in pregnancy on maternal bone outcomes in women with a low calcium intake. American Journal of Clinical Nutrition2010;92(2):450‐7. JarjouLM , PrenticeA , BennettJ . Impact of calcium supplementation in the preceding pregnancy on the human milk calcium concentration of Gambian women. Advances in Experimental Medicine and Biology2004;54:347‐9. JarjouLM , PrenticeA , SawoY , LaskeyMA , BennettJ , GoldbergGR , et al. Randomized, placebo‐controlled, calcium supplementation study in pregnant Gambian women: effects on breast‐milk calcium concentrations and infant birth weight, growth, and bone mineral accretion in the first year of life. American Journal of Clinical Nutrition2006;83(3):657‐66. JarjouLMA , BennettJ , LaidlawA , GoldbergGR , PrenticeA . Changes in bone turnover and calcitrophic hormones in lactating Gambian women supplemented with calcium during pregnancy. Journal of Human Lactation2007;23(1):86‐7. JarjouLMA , SawoY , GoldbergGR , LaskeyMA , ColeTJ , PrenticeA . Persistent effects of calcium supplementation during pregnancy on maternal bone mineral content: a follow‐up study in Gambian women. Proceedings of the 16th ISRHML Conference "Breastfeeding and the Use of Human Milk. Science and Practice"; 2012 September 27th ‐ October 1st; Trieste, Italy. 2012:Abstract no.:105. JarjouMA , YankubaS , GoldbergR , LaskeyMA , ColeJ , PrenticeA . Unexpected long‐term effects of calcium supplementation in pregnancy on maternal bone outcomes in women with a low calcium intake: a follow‐up study. American Journal of Clinical Nutrition2013;98(3):723‐30. PrenticeA , GoldbergGR , JarjouLMA . The effects of pregnancy calcium supplementation on calcium metabolism after lactation in Gambian women with a low calcium intake. Breastfeeding Medicine2016;11(2):A‐20‐A‐21, Abstract no: P‐8. PrenticeA , ISRCTN72582014 . Effects on birth weight and perinatal mortality of maternal dietary supplements in rural Gambia: 5 year randomised controlled trial. isrctn.com/ISRCTN72582014 (first received 27 March 2013). PrenticeA , ISRCTN96502494 . Calcium requirements of pregnant women in The Gambia. isrctn.com/ISRCTN96502494 (first received 6 November 2007). PrenticeA , JarjouLM , GoldbergGR , BennettJ , ColeTJ , SchoenmakersI . Maternal plasma 25‐hydroxyvitamin D concentration and birthweight, growth and bone mineral accretion of Gambian infants. Acta Paediatrica2009;98(8):1360‐2. WardKA , JarjouL , PrenticeA . Maternal calcium supplementation and offspring growth. Osteoporosis International2016;27(1 Suppl 1):S327‐8. WardKA , PrenticeA , JarjouL . Long‐term effects of maternal calcium supplementation on childhood growth differ between males and females in a population accustomed to a low calcium intake. Bone2017;103:31‐8. '>Jarjou 2004</a>). Of the remaining 13 studies, four were multicentre studies: one was conducted in Argentina (<a href="./references#CD001059-bbs2-0005" title="BelizanJM . Prevention of hypertensive disorders of pregnancy with calcium supplementation. 8th World Congress on Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires. 1992:93. BelizanJM , VillarJ , BergelE , delPinoA , DiFulvioS , GallianoSV , et al. Long term effect of calcium supplementation during pregnancy on the blood pressure of offspring: follow up of a randomised controlled trial. BMJ1997;315:281‐5. BelizanJM , VillarJ , GonzalezL , CampodonicoL , BergelE . Calcium supplementation to prevent hypertensive disorders of pregnancy. New England Journal of Medicine1991;325:1399‐405. BergelE , GibbonsL , RasinesMG , LuetichA , BelizanJM . Maternal calcium supplementation during pregnancy and dental caries of children at 12 years of age: follow‐up of a randomized controlled trial. Acta Obstetricia et Gynecologica Scandinavica2010;89(11):1396‐402. StephensIF . Effect of calcium supplementation during pregnancy on blood pressure of offspring. Authors cannot be sure of effect's generalisability to all children aged 5‐9 [letter; comment]. BMJ1998;316(7126):234. VillarJ , BelizanJM , RepkeJ . The effect of calcium supplementation on the incidence of hypertensive disorders of pregnancy and prematurity. 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy. 1990:54. VillarJ , BelizanJM , RepkeJT . Does calcium supplementation reduce pregnancy‐induced hypertension and prematurity?. Proceedings of the International Symposium on advances in the prevention of low birthweight; 1988 May 8‐11; Cape Cod, Massachusetts. 1988:187‐95. ">Belizan 1991</a>), one in the USA (<a href="./references#CD001059-bbs2-0007" title="HabliM , LevineRJ , QianC , SibaiB . Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. American Journal of Obstetrics and Gynecology2007;197(4):406.e1‐406.e7. HattonDC , Harrison‐HohnerJ , CosteS , RellerM , McCarronD . Gestational calcium supplementation and blood pressure in the offspring. American Journal of Hypertension2003;16:801‐5. Levine RJ for the CPEP Study Group. Calcium for preeclampsia prevention (CPEP): a double‐blind, placebo‐controlled trial in healthy nulliparas. American Journal of Obstetrics and Gynecology1997;176:S2. Levine RJ for the CPEP Study Group. The trial of calcium for preeclampsia prevention (CPEP). 8th World Congress on Hypertension in Pregnancy ‐ Protagonists and Presentations; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. LevineRJ , EsterlitzJR , RaymondEG , DerSimonianR , HauthJC , Ben CuretL , et al. Trial of calcium for preeclampsia prevention (CPEP): rationale, design, and methods. Controlled Clinical Trials1996;17:442‐69. LevineRJ , HauthJC , CuretLB , SibaiBM , CatalanoPM , MorrisCD , et al. Trial of calcium to prevent preeclampsia. New England Journal of Medicine1997;337(2):69‐76. NCT00000534 . Calcium for pre‐eclampsia prevention (CPEP). clinicaltrials.gov/ct2/show/record/NCT00000534 (first received 27 October 1999). ">CPEP 1997</a>), another in Australia (<a href="./references#CD001059-bbs2-0008" title="CrowtherC , HillerJ , PridmoreB , BryceR , DugganP , HagueW , et al. Calcium supplementation in nulliparous women for the prevention of pregnancy included hypertension, pre‐eclampsia and preterm birth: an Australian randomised trial. 2nd Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. 1998:101. CrowtherCA , HillerJE , PridmoreB , BryceR , DugganP , HagueWM , et al. Calcium supplementation in nulliparous women for the prevention of pregnancy‐induced hypertension, preeclampsia and preterm birth: an Australian randomized trial. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(1):12‐8. HillerJE , CrowtherCA , MooreVA , WillsonK , RobinsonJS . Calcium supplementation in pregnancy and its impact on blood pressure in children and women: follow up of a randomised controlled trial. Australian and New Zealand Journal of Obstetrics and Gynaecology2007;47(2):115‐21. ">Crowther 1999</a>), and the fourth was international (<a href="./references#CD001059-bbs2-0027" title="AbalosE , MerialdiM , WojdylaD , CarroliG , CampodónicoL , YaoSE , et al. Effects of calcium supplementation on fetal growth in mothers with deficient calcium intake: a randomised controlled trial. Paediatric and Perinatal Epidemiology2010;24(1):53‐62. Abdel‐AleemH , MerialdiM , ElsnosyED , ElsedfyGO , Abdel‐AleemMA , VillarJ . The effect of calcium supplementation during pregnancy on fetal and infant growth: a nested randomized controlled trial within WHO calcium supplementation trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2009;22(2):94‐100. CarroliG , MerialdiM , WojdylaD , AbalosE , CampodonicoL , YaoSE , et al. Effects of calcium supplementation on uteroplacental and fetoplacental blood flow in low‐calcium‐intake mothers: a randomized controlled trial. American Journal of Obstetrics and Gynecology2010;202(1):45.e1‐45.e9. HofmeyrGJ , MlokotiZ , NikodemVC , MangesiL , FerreiraS , SingataM , et al. Calcium supplementation during pregnancy for preventing hypertensive disorders is not associated with changes in platelet count, urate, and urinary protein: a randomized control trial. Hypertension in Pregnancy2008;27(3):299‐304. VillarJ , Abdel‐AleemH , MerialdiM , MathaiM , AliM , ZavaletaN , et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. American Journal of Obstetrics and Gynecology2006;194:639‐49. VillarJ , AleemHA , MerialdiM , MathaiM , AliM , ZavaletaN , et al. WHO randomized trial of calcium supplementation among low calcium intake pregnant women [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S2. VillarJ , ISRCTN37214165 . Calcium supplementation during pregnancy in low‐intake populations. isrctn.com/ISRCTN37214165 (first received 19 March 2014). ZhangJ , VillarJ , SunW , MerialdiM , Abdel‐AleemH , MathaiM , et al. Blood pressure dynamics during pregnancy and spontaneous preterm birth. American Journal of Obstetrics and Gynecology2007;197(2):162.e1‐6. ">WHO 2006</a>). Most of the 15,730 women recruited to these studies were low risk (15,143 women) and had a low dietary intake of calcium (10,678). Most studies only recruited women who were nulliparous or primiparous. One study did not state the parity of women recruited (<a href="./references#CD001059-bbs2-0019" title="NiromaneshS , LaghaiiS , Mosavi‐JarrahiA . Supplementary calcium in prevention of pre‐eclampsia. International Journal of Gynecology &amp; Obstetrics2001;74:17‐21. ">Niromanesh 2001</a>), and another commented that most women were nulliparous (<a href="./references#CD001059-bbs2-0026" title="VillarJ , BelizanJM , RepkeJ . The effect of calcium supplementation on the incidence of hypertensive disorders of pregnancy and prematurity. 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy. 1990:54. VillarJ , BelizanJM , RepkeJT . Does calcium supplementation reduce pregnancy‐induced hypertension and prematurity?. Advances in the prevention of low birthweight; 1988 May 8‐11; Cape Cod, Massachusetts. 1998:187‐95. VillarJ , RepkeJT . Calcium supplementation during pregnancy may reduce preterm delivery in high‐risk populations. American Journal of Obstetrics and Gynecology1990;163:1124‐31. ">Villar 1990</a>). For most studies the intervention was 1.5 g to 2 g per day of calcium. All of these studies compared high‐dose supplementation with a placebo. </p> <p>Five studies enrolled women considered to be at high risk of pre‐eclampsia. The definitions of high risk and the actual risk (rate of pre‐eclampsia in the placebo group) were variable: positive 'roll‐over' test at 28 to 30 weeks (8/34) (<a href="./references#CD001059-bbs2-0016" title="Lopez‐JaramilloP , NarvaezM , FelixC , LopezA . Dietary calcium supplementation and prevention of pregnancy hypertension. Lancet1990;335:293. NarvaezM , Lopez‐JaramilloP , WeigelM . Calcium (Ca++) supplementation reduces the risk for pregnancy induced hypertension (PIH). World Congress of Gynecology and Obstetrics; 1988 October 23‐28; Brazil. 1988:180‐1. ">L‐Jaramillo 1990</a>); teenagers 17 years or younger (3/88) (<a href="./references#CD001059-bbs2-0026" title="VillarJ , BelizanJM , RepkeJ . The effect of calcium supplementation on the incidence of hypertensive disorders of pregnancy and prematurity. 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy. 1990:54. VillarJ , BelizanJM , RepkeJT . Does calcium supplementation reduce pregnancy‐induced hypertension and prematurity?. Advances in the prevention of low birthweight; 1988 May 8‐11; Cape Cod, Massachusetts. 1998:187‐95. VillarJ , RepkeJT . Calcium supplementation during pregnancy may reduce preterm delivery in high‐risk populations. American Journal of Obstetrics and Gynecology1990;163:1124‐31. ">Villar 1990</a>); positive 'roll‐over' test at 28 to 32 weeks plus one clinical risk factor (7/15) (<a href="./references#CD001059-bbs2-0019" title="NiromaneshS , LaghaiiS , Mosavi‐JarrahiA . Supplementary calcium in prevention of pre‐eclampsia. International Journal of Gynecology &amp; Obstetrics2001;74:17‐21. ">Niromanesh 2001</a>); positive 'roll‐over' and positive angiotensin II infusion test (15/34) (<a href="./references#CD001059-bbs2-0023" title="Sanchez‐RamosL , BrionesDK , KaunitzAM , DelvalleGO , GaudierFL , WalkerKD . Prevention of pregnancy‐induced hypertension by calcium supplementation in angiotensin II‐sensitive patients. Obstetrics &amp; Gynecology1994;84:349‐53. Sanchez‐RamosL , DelvalleGO , BrionesD , WalkerC , DelkeI , GaudierF . Prevention of preeclampsia by calcium supplementation in angiotensin‐sensitive patients. American Journal of Obstetrics and Gynecology1994;170:408. ">S‐Ramos 1994</a>); and nulliparous teenagers 17.5 years or younger (21/135) (<a href="./references#CD001059-bbs2-0017" title="Lopez‐JaramilloP , DelgadoF , JacomeP , TeranE , RuanoC , RiveraJ . Calcium supplementation and the risk of preeclampsia in Ecuadorian pregnant teenagers. Obstetrics &amp; Gynecology1997;90:162‐7. ">L‐Jaramillo 1997</a>). The clinical usefulness of the pooled results in this subgroup is therefore limited. </p> <p>Two included studies conducted long‐term follow‐up of the children whose mothers were recruited to these trials (<a href="./references#CD001059-bbs2-0005" title="BelizanJM . Prevention of hypertensive disorders of pregnancy with calcium supplementation. 8th World Congress on Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires. 1992:93. BelizanJM , VillarJ , BergelE , delPinoA , DiFulvioS , GallianoSV , et al. Long term effect of calcium supplementation during pregnancy on the blood pressure of offspring: follow up of a randomised controlled trial. BMJ1997;315:281‐5. BelizanJM , VillarJ , GonzalezL , CampodonicoL , BergelE . Calcium supplementation to prevent hypertensive disorders of pregnancy. New England Journal of Medicine1991;325:1399‐405. BergelE , GibbonsL , RasinesMG , LuetichA , BelizanJM . Maternal calcium supplementation during pregnancy and dental caries of children at 12 years of age: follow‐up of a randomized controlled trial. Acta Obstetricia et Gynecologica Scandinavica2010;89(11):1396‐402. StephensIF . Effect of calcium supplementation during pregnancy on blood pressure of offspring. Authors cannot be sure of effect's generalisability to all children aged 5‐9 [letter; comment]. BMJ1998;316(7126):234. VillarJ , BelizanJM , RepkeJ . The effect of calcium supplementation on the incidence of hypertensive disorders of pregnancy and prematurity. 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy. 1990:54. VillarJ , BelizanJM , RepkeJT . Does calcium supplementation reduce pregnancy‐induced hypertension and prematurity?. Proceedings of the International Symposium on advances in the prevention of low birthweight; 1988 May 8‐11; Cape Cod, Massachusetts. 1988:187‐95. ">Belizan 1991</a>; <a href="./references#CD001059-bbs2-0094" title="HillerJE , CrowtherCA , MooreVA , WillsonK , RobinsonJS . Calcium supplementation in pregnancy and its impact on blood pressure in children and women: follow up of a randomised controlled trial. Australian and New Zealand Journal of Obstetrics and Gynaecology2007;47(2):115‐21. ">Hiller 2007</a>). In <a href="./references#CD001059-bbs2-0005" title="BelizanJM . Prevention of hypertensive disorders of pregnancy with calcium supplementation. 8th World Congress on Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires. 1992:93. BelizanJM , VillarJ , BergelE , delPinoA , DiFulvioS , GallianoSV , et al. Long term effect of calcium supplementation during pregnancy on the blood pressure of offspring: follow up of a randomised controlled trial. BMJ1997;315:281‐5. BelizanJM , VillarJ , GonzalezL , CampodonicoL , BergelE . Calcium supplementation to prevent hypertensive disorders of pregnancy. New England Journal of Medicine1991;325:1399‐405. BergelE , GibbonsL , RasinesMG , LuetichA , BelizanJM . Maternal calcium supplementation during pregnancy and dental caries of children at 12 years of age: follow‐up of a randomized controlled trial. Acta Obstetricia et Gynecologica Scandinavica2010;89(11):1396‐402. StephensIF . Effect of calcium supplementation during pregnancy on blood pressure of offspring. Authors cannot be sure of effect's generalisability to all children aged 5‐9 [letter; comment]. BMJ1998;316(7126):234. VillarJ , BelizanJM , RepkeJ . The effect of calcium supplementation on the incidence of hypertensive disorders of pregnancy and prematurity. 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy. 1990:54. VillarJ , BelizanJM , RepkeJT . Does calcium supplementation reduce pregnancy‐induced hypertension and prematurity?. Proceedings of the International Symposium on advances in the prevention of low birthweight; 1988 May 8‐11; Cape Cod, Massachusetts. 1988:187‐95. ">Belizan 1991</a>, only the subset of women recruited in private clinics were contacted; and in <a href="./references#CD001059-bbs2-0094" title="HillerJE , CrowtherCA , MooreVA , WillsonK , RobinsonJS . Calcium supplementation in pregnancy and its impact on blood pressure in children and women: follow up of a randomised controlled trial. Australian and New Zealand Journal of Obstetrics and Gynaecology2007;47(2):115‐21. ">Hiller 2007</a>, the outcomes reported differed from this review (but unpublished data may be made available by the authors at a later date). </p> <p>Other studies have reported outcomes for small subsets of women (<a href="./references#CD001059-bbs2-0007" title="HabliM , LevineRJ , QianC , SibaiB . Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. American Journal of Obstetrics and Gynecology2007;197(4):406.e1‐406.e7. HattonDC , Harrison‐HohnerJ , CosteS , RellerM , McCarronD . Gestational calcium supplementation and blood pressure in the offspring. American Journal of Hypertension2003;16:801‐5. Levine RJ for the CPEP Study Group. Calcium for preeclampsia prevention (CPEP): a double‐blind, placebo‐controlled trial in healthy nulliparas. American Journal of Obstetrics and Gynecology1997;176:S2. Levine RJ for the CPEP Study Group. The trial of calcium for preeclampsia prevention (CPEP). 8th World Congress on Hypertension in Pregnancy ‐ Protagonists and Presentations; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. LevineRJ , EsterlitzJR , RaymondEG , DerSimonianR , HauthJC , Ben CuretL , et al. Trial of calcium for preeclampsia prevention (CPEP): rationale, design, and methods. Controlled Clinical Trials1996;17:442‐69. LevineRJ , HauthJC , CuretLB , SibaiBM , CatalanoPM , MorrisCD , et al. Trial of calcium to prevent preeclampsia. New England Journal of Medicine1997;337(2):69‐76. NCT00000534 . Calcium for pre‐eclampsia prevention (CPEP). clinicaltrials.gov/ct2/show/record/NCT00000534 (first received 27 October 1999). ">CPEP 1997</a>: <a href="./references#CD001059-bbs2-0092" title="HattonDC , Harrison‐HohnerJ , CosteS , RellerM , McCarronD . Gestational calcium supplementation and blood pressure in the offspring. American Journal of Hypertension2003;16:801‐5. ">Hatton 2003</a>; <a href="./references#CD001059-bbs2-0027" title="AbalosE , MerialdiM , WojdylaD , CarroliG , CampodónicoL , YaoSE , et al. Effects of calcium supplementation on fetal growth in mothers with deficient calcium intake: a randomised controlled trial. Paediatric and Perinatal Epidemiology2010;24(1):53‐62. Abdel‐AleemH , MerialdiM , ElsnosyED , ElsedfyGO , Abdel‐AleemMA , VillarJ . The effect of calcium supplementation during pregnancy on fetal and infant growth: a nested randomized controlled trial within WHO calcium supplementation trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2009;22(2):94‐100. CarroliG , MerialdiM , WojdylaD , AbalosE , CampodonicoL , YaoSE , et al. Effects of calcium supplementation on uteroplacental and fetoplacental blood flow in low‐calcium‐intake mothers: a randomized controlled trial. American Journal of Obstetrics and Gynecology2010;202(1):45.e1‐45.e9. HofmeyrGJ , MlokotiZ , NikodemVC , MangesiL , FerreiraS , SingataM , et al. Calcium supplementation during pregnancy for preventing hypertensive disorders is not associated with changes in platelet count, urate, and urinary protein: a randomized control trial. Hypertension in Pregnancy2008;27(3):299‐304. VillarJ , Abdel‐AleemH , MerialdiM , MathaiM , AliM , ZavaletaN , et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. American Journal of Obstetrics and Gynecology2006;194:639‐49. VillarJ , AleemHA , MerialdiM , MathaiM , AliM , ZavaletaN , et al. WHO randomized trial of calcium supplementation among low calcium intake pregnant women [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S2. VillarJ , ISRCTN37214165 . Calcium supplementation during pregnancy in low‐intake populations. isrctn.com/ISRCTN37214165 (first received 19 March 2014). ZhangJ , VillarJ , SunW , MerialdiM , Abdel‐AleemH , MathaiM , et al. Blood pressure dynamics during pregnancy and spontaneous preterm birth. American Journal of Obstetrics and Gynecology2007;197(2):162.e1‐6. ">WHO 2006</a>: <a href="./references#CD001059-bbs2-0125" title="ZhangJ , VillarJ , SunW , MerialdiM , Abdel‐AleemH , MathaiM , et al. Blood pressure dynamics during pregnancy and spontaneous preterm birth. American Journal of Obstetrics and Gynecology2007;197(2):162.e1‐6. ">Zhang 2007</a>), but these data did not meet the inclusion criteria for this review. </p> </section> <section id="CD001059-sec-0085"> <h5 class="title">Low‐dose calcium supplementation (less than 1 g/day)</h5> <p>We included 12 studies: four investigated calcium supplementation alone (<a href="./references#CD001059-bbs2-0001" title="AlmiranteCY . Calcium supplementation during pregnancy in the prevention of EPH gestosis. Prenatal and Neonatal Medicine1998;3 Suppl 1:24. ">Almirante 1998</a>; <a href="./references#CD001059-bbs2-0004" title="BassawB , RoopnarinesinghS , RoopnarinesinghA , HomerH . Prevention of hypertensive disorders of pregnancy. Journal of Obstetrics and Gynaecology1998;18(2):123‐6. ">Bassaw 1998</a>; <a href="./references#CD001059-bbs2-0006" title="CongKJ , ChiSL , LiuGR . Calcium and pregnancy induced hypertension. Chinese Journal of Obstetrics and Gynecology1993;28:657‐9. CongKJ , ChiSL , LiuGR . Calcium supplementation during pregnancy for reducing pregnancy induced hypertension. Chinese Medical Journal1995;108:57‐9. CongKJ , ChiSL , LiuGR . Calcium supplementation during pregnancy to reduce pregnancy induced hypertension. Beijing Medical Journal1992;5:268. ">Cong 1995</a>; <a href="./references#CD001059-bbs2-0021" title="RogersMS , FungHYM , HungCY . Calcium and low‐dose aspirin prophylaxis in women at high risk of pregnancy‐induced hypertension. Hypertension in Pregnancy1999;18(2):165‐72. ">Rogers 1999</a>); five investigated calcium plus vitamin D (<a href="./references#CD001059-bbs2-0002" title="AsemiZ , IRCT201212105623N3 . Comparison of effectiveness of multivitamin, multivitamin‐mineral supplements, probiotic and normal Gaz on pregnancy outcomes in pregnant women. en.search.irct.ir/view/11730 (first received 26 December 2012). AsemiZ , TabassiZ , HeidarzadehZ , KhorammianH , SabihiSS , SamimiM . Effect of calcium‐vitamin D supplementation on metabolic profiles in pregnant women at risk for pre‐eclampsia: a randomized placebo‐controlled trial. Pakistan Journal of Biological Sciences2012;15(7):316‐24. ">Asemi 2012</a>; <a href="./references#CD001059-bbs2-0003" title="AsemiZ , SamimiM , SiavashaniMA , MazloomiM , TabassiZ , KaramaliM , et al. Calcium‐vitamin D co‐supplementation affects metabolic profiles, but not pregnancy outcomes, in healthy pregnant women. International Journal of Preventive Medicine2016;7:49. ">Asemi 2016</a>; <a href="./references#CD001059-bbs2-0014" title="LiX , GouW . Study on prevention of pregnancy induced hypertension and effect of platelet intracellular free ca˜(2+) by calcium supplementation. Journal of Xi'an Medical University2000;21(1):46‐8. ">Li 2000</a>; <a href="./references#CD001059-bbs2-0018" title="MaryaRK , RatheeS , ManrowM . Effect of calcium and vitamin D supplementation on toxaemia of pregnancy. Gynecologic and Obstetric Investigation1987;24:38‐42. ">Marya 1987</a>; <a href="./references#CD001059-bbs2-0024" title="TaherianAA , TaherianA , ShirvaniA . Prevention of pre‐eclampsia with low‐dose aspirin or calcium supplementation. Archives of Iranian Medicine2002;5(3):151‐6. ">Taherian 2002</a>); two studies from the same group investigated calcium plus linoleic acid (<a href="./references#CD001059-bbs2-0009" title="HerreraJA , Arevalo‐HerreraM , HerreraS . Prevention of preeclampsia by linoleic acid and calcium supplementation: a randomized controlled trial. Obstetrics &amp; Gynecology1998;91(4):585‐90. ">Herrera 1998</a>; <a href="./references#CD001059-bbs2-0010" title="HerreraJA , Arevalo‐HerreraM , ShahabuddinAK , ErshengG , HerreraS , GarciaRG , et al. Calcium and conjugated linoleic acid reduces pregnancy‐induced hypertension and decreases intracellular calcium in lymphocytes. American Journal of Hypertension2006;19(4):381‐7. HerreraJA , ShahabuddinAK , ErshengG , WeiY , GarciaRG , Lopez‐JaramilloP . Calcium plus linoleic acid therapy for pregnancy‐induced hypertension. International Journal of Gynecology &amp; Obstetrics2005;91(3):221‐7. HerreraJA , ShahabuddinAKM , FaisalM , ErshengG , WeiY , LixiaD , et al. Effects of supplementation with oral calcium and linoleic acid in primigravidas at high risk [Efectos de la supplementacion oral con calcio y acido linoleico conjugado en primigravidas de alto riesgo]. Colombia Medica2004;35(1):31‐7. ">Herrera 2006</a>); and one investigated calcium plus antioxidants (<a href="./references#CD001059-bbs2-0022" title="RumirisD , PurwosunuY , WibowoN , FarinaA , SekizawaA . Lower rate of preeclampsia after antioxidant supplementation in pregnant women with low antioxidant status. Hypertension in Pregnancy2006;25:241–53. ">Rumiris 2006</a>). </p> <p>Comparisons varied in the studies: five used placebo (<a href="./references#CD001059-bbs2-0002" title="AsemiZ , IRCT201212105623N3 . Comparison of effectiveness of multivitamin, multivitamin‐mineral supplements, probiotic and normal Gaz on pregnancy outcomes in pregnant women. en.search.irct.ir/view/11730 (first received 26 December 2012). AsemiZ , TabassiZ , HeidarzadehZ , KhorammianH , SabihiSS , SamimiM . Effect of calcium‐vitamin D supplementation on metabolic profiles in pregnant women at risk for pre‐eclampsia: a randomized placebo‐controlled trial. Pakistan Journal of Biological Sciences2012;15(7):316‐24. ">Asemi 2012</a>; <a href="./references#CD001059-bbs2-0003" title="AsemiZ , SamimiM , SiavashaniMA , MazloomiM , TabassiZ , KaramaliM , et al. Calcium‐vitamin D co‐supplementation affects metabolic profiles, but not pregnancy outcomes, in healthy pregnant women. International Journal of Preventive Medicine2016;7:49. ">Asemi 2016</a>; <a href="./references#CD001059-bbs2-0009" title="HerreraJA , Arevalo‐HerreraM , HerreraS . Prevention of preeclampsia by linoleic acid and calcium supplementation: a randomized controlled trial. Obstetrics &amp; Gynecology1998;91(4):585‐90. ">Herrera 1998</a>; <a href="./references#CD001059-bbs2-0010" title="HerreraJA , Arevalo‐HerreraM , ShahabuddinAK , ErshengG , HerreraS , GarciaRG , et al. Calcium and conjugated linoleic acid reduces pregnancy‐induced hypertension and decreases intracellular calcium in lymphocytes. American Journal of Hypertension2006;19(4):381‐7. HerreraJA , ShahabuddinAK , ErshengG , WeiY , GarciaRG , Lopez‐JaramilloP . Calcium plus linoleic acid therapy for pregnancy‐induced hypertension. International Journal of Gynecology &amp; Obstetrics2005;91(3):221‐7. HerreraJA , ShahabuddinAKM , FaisalM , ErshengG , WeiY , LixiaD , et al. Effects of supplementation with oral calcium and linoleic acid in primigravidas at high risk [Efectos de la supplementacion oral con calcio y acido linoleico conjugado en primigravidas de alto riesgo]. Colombia Medica2004;35(1):31‐7. ">Herrera 2006</a>; <a href="./references#CD001059-bbs2-0022" title="RumirisD , PurwosunuY , WibowoN , FarinaA , SekizawaA . Lower rate of preeclampsia after antioxidant supplementation in pregnant women with low antioxidant status. Hypertension in Pregnancy2006;25:241–53. ">Rumiris 2006</a>); one used aspirin tablets (<a href="./references#CD001059-bbs2-0004" title="BassawB , RoopnarinesinghS , RoopnarinesinghA , HomerH . Prevention of hypertensive disorders of pregnancy. Journal of Obstetrics and Gynaecology1998;18(2):123‐6. ">Bassaw 1998</a>); four compared with no treatment (<a href="./references#CD001059-bbs2-0006" title="CongKJ , ChiSL , LiuGR . Calcium and pregnancy induced hypertension. Chinese Journal of Obstetrics and Gynecology1993;28:657‐9. CongKJ , ChiSL , LiuGR . Calcium supplementation during pregnancy for reducing pregnancy induced hypertension. Chinese Medical Journal1995;108:57‐9. CongKJ , ChiSL , LiuGR . Calcium supplementation during pregnancy to reduce pregnancy induced hypertension. Beijing Medical Journal1992;5:268. ">Cong 1995</a>; <a href="./references#CD001059-bbs2-0014" title="LiX , GouW . Study on prevention of pregnancy induced hypertension and effect of platelet intracellular free ca˜(2+) by calcium supplementation. Journal of Xi'an Medical University2000;21(1):46‐8. ">Li 2000</a>; <a href="./references#CD001059-bbs2-0018" title="MaryaRK , RatheeS , ManrowM . Effect of calcium and vitamin D supplementation on toxaemia of pregnancy. Gynecologic and Obstetric Investigation1987;24:38‐42. ">Marya 1987</a>; <a href="./references#CD001059-bbs2-0024" title="TaherianAA , TaherianA , ShirvaniA . Prevention of pre‐eclampsia with low‐dose aspirin or calcium supplementation. Archives of Iranian Medicine2002;5(3):151‐6. ">Taherian 2002</a>); and two did not clearly describe their control group (<a href="./references#CD001059-bbs2-0001" title="AlmiranteCY . Calcium supplementation during pregnancy in the prevention of EPH gestosis. Prenatal and Neonatal Medicine1998;3 Suppl 1:24. ">Almirante 1998</a>; <a href="./references#CD001059-bbs2-0021" title="RogersMS , FungHYM , HungCY . Calcium and low‐dose aspirin prophylaxis in women at high risk of pregnancy‐induced hypertension. Hypertension in Pregnancy1999;18(2):165‐72. ">Rogers 1999</a>). </p> </section> <section id="CD001059-sec-0086"> <h5 class="title">High‐dose versus low‐dose calcium supplementation (1 g/day or more versus less than 1 g/day) </h5> <p>One study compared high‐dose (2 g) with low‐dose (500 mg) calcium supplementation in unselected, normotensive pregnant women from a low socio‐economic status population in West Begal, India, from 34 weeks of pregnancy at the latest (<a href="./references#CD001059-bbs2-0012" title="KhanA , MandalSK , PalA . Role of high dose calcium in the prevention of preeclampsia. Bangladesh Journal of Obstetrics and Gynecology2013;28(2):66‐70. ">Khan 2013</a>) . A discrepancy between the numbers in each group was not accounted for, and we assessed the risk of bias as unclear. </p> <p>Please see <a href="./references#CD001059-sec-0178" title="">Characteristics of included studies</a> for further details. </p> </section> </section> <section id="CD001059-sec-0087"> <h4 class="title">Excluded studies</h4> <p>We excluded 44 studies from the review (<a href="./references#CD001059-sec-0179" title="">Characteristics of excluded studies</a>). </p> <p>There were a number of reasons for exclusion, and we excluded some studies for more than one reason. In five studies it was not clear how participants were allocated to groups and in some cases the method of allocation was non‐random (<a href="./references#CD001059-bbs2-0043" title="FelixC , JacomeP , LopezA , MoyaW , NarvaezM , Lopez‐JaramilloP . The hypotensive effect of calcium supplementation during normal pregnancy in Andean women is not related to vascular production of prostacyclin by umbilical arteries. Journal of Obstetrics and Gynaecology1991;11(2):93‐6. ">Felix 1991</a>; <a href="./references#CD001059-bbs2-0048" title="KarandishM , DjazayeryA , MahmoudiM , BehroozA . The effect of calcium supplementation during pregnancy on birth weight. Medical Journal of Reproduction and Infertility2003;4(3):184. ">Karandish 2003</a>; <a href="./references#CD001059-bbs2-0049" title="KawasakiN , MatsuiK , ItoM , NakamuraT , YoshimuraT , UshijimaH , et al. Effect of calcium supplementation on the vascular sensitivity to angiotensin II in pregnant women. American Journal of Obstetrics and Gynecology1985;153:576‐82. ">Kawasaki 1985</a>; <a href="./references#CD001059-bbs2-0060" title="RamanL , RajalakshmiK , KrishnamachariK , Gowrinath SastryJ . Effect of calcium supplementation to undernourished mothers during pregnancy on the bone density of neonates. American Journal of Clinical Nutrition1978;31:466‐9. ">Raman 1978</a>; <a href="./references#CD001059-bbs2-0063" title="SalzanoP , FelicettiM , LaboccettaA , BorrelliP , DiDomenicoA , BorrelliA . Prevention of gestational hypertension with calcium, linoleic acid, mono and polyunsaturated fatty acid supplements. Minerva Ginecologica2001;53(4):235‐8. ">Salzano 2001</a>). We excluded two other studies because of methodological problems; either the specified outcomes were not reported (<a href="./references#CD001059-bbs2-0036" title="BoggessKA , SamuelL , SchmucklerBC , WatersJ , EasterlingTR . A randomised controlled trial of the effect of third trimester calcium supplementation on maternal hemodynamic function. Obstetrics &amp; Gynecology1997;90:157‐61. ">Boggess 1997</a>), or there were unexplained group discrepancies (<a href="./references#CD001059-bbs2-0041" title="DizavandyEB , AlaviGS , CordiM . The effect of calcium supplementation in the prevention of hypertensive disorders of pregnancy in nulliparous women. Medical Journal of the Islamic Republic of Iran1998;12(1):11‐4. ">Dizavandy 1998</a>). In seven studies, reported in abstracts, there was too little information on methods and results for us to judge risk of bias and include data (<a href="./references#CD001059-bbs2-0028" title="AghamohammadiA , RajabiA . The effect of calcium supplementation during pregnancy on preterm delivery and preeclampsia in nulliparous beyond age 35. Acta Obstetricia et Gynecologica Scandinavica2012;91 (Suppl 159):60. AghamohammadyA . The effect of calcium supplementation during pregnancy on preterm delivery in primiparous beyond age 35. Journal of Maternal‐Fetal and Neonatal Medicine2010;23(S1):100. ">Aghamohammady 2010</a>; <a href="./references#CD001059-bbs2-0032" title="AugustP , SisonM , HelsethG . Identification of prognostic indices and impact of calcium supplementation in women at high risk for pre‐eclampsia: data from a randomized clinical trial [abstract]. Hypertension in Pregnancy2002;21(Suppl 1):44. AugustP , SisonMC , HelsethG . Clinical outcomes of African Americans with chronic hypertension during pregnancy. Hypertension in Pregnancy2002; Vol. 21, issue Suppl 1:55. ">August 2002</a>; <a href="./references#CD001059-bbs2-0034" title="BelizanJM , VillarJ , ZalazarA , RojasL , ChanD , BryceGF . Preliminary evidence of the effect of calcium supplementation on blood pressure in normal pregnant women. American Journal of Obstetrics and Gynecology1983;146:175‐80. ">Belizan 1983</a>; <a href="./references#CD001059-bbs2-0037" title="ChamesM , BendichA , BogdenJ , SibaiB , PradaJ . A randomized trial of calcium supplementation effects on blood lead levels in pregnancy [abstract]. American Journal of Obstetrics and Gynecology2002;187(6 Pt 2):S137. ">Chames 2002</a>; <a href="./references#CD001059-bbs2-0058" title="PradaJ , TsangR , GuoS . Reduction of blood pressure from calcium supplementation in adolescent pregnancy: a randomized trial [abstract]. American Journal of Hypertension2001;14(4 Pt 2):179A. ">Prada 2001</a>; <a href="./references#CD001059-bbs2-0059" title="PradaJA , SibaiBM , GuoS . Effect of calcium supplementation on the maternal blood pressure of adolescents and twins [abstract]. American Journal of Obstetrics and Gynecology2002;187(6 Pt 2):S217. ">Prada 2002</a>; <a href="./references#CD001059-bbs2-0061" title="RepkeJ , VillarJ , BergelE , BelizanJM . The effect of iron absorption in patients receiving calcium supplementation. 9th Annual Meeting of the Society of Perinatal Obstetricians; 1989 February 1‐4; New Orleans, Louisiana, USA. 1989:512. ">Repke 1989</a>). There were four studies reported in trial registrations where it was not clear that studies had started or been completed (<a href="./references#CD001059-bbs2-0030" title="AnumbaD , ISRCTN25268811 . Randomised double blind placebo controlled trial of calcium supplements in teenage pregnancy. isrctn.com/ISRCTN25268811 (first received 29 September 2006). ">Anumba 2006</a>; <a href="./references#CD001059-bbs2-0035" title="BhatiaV , CTRI/2010/091/000499 . Vitamin D and calcium nutrition: deficiency and evaluation of supplementation. http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=1674 (first received 19 May 2010). ">Bhatia 2010</a>; <a href="./references#CD001059-bbs2-0044" title="FungE , NCT01145573 . Testing the calcium DRI during pregnancy: a study of bone health in black and white women. clinicaltrials.gov/show/NCT01145573 (first received 11 June 2010). [NCT01145573] ">Fung 2010</a>; <a href="./references#CD001059-bbs2-0051" title="LavinJP . The effect of calcium supplementation on pregnancy induced hypertension. Personal communication1986. ">Lavin 1986</a>). In one study the intervention was not calcium but rather dairy foods (<a href="./references#CD001059-bbs2-0038" title="ChanG , NCT00320125 . Effects of dairy foods on adolescent pregnant mothers and their newborns. https://clinicaltrials.gov/ct2/show/record/NCT00320125 (first received 28 April 2006). [NCT00320125] ">Chan 2006</a>), and in eight studies the intervention was not calcium alone but rather calcium plus other vitamins and minerals which could not be meaningfully included (<a href="./references#CD001059-bbs2-0031" title="AsemiZ , IRCT201704225623N109 . Clinical trial of the effect of multi mineral‐vitamin D supplementation compared with the placebo on pregnancy outcomes in women with gestational diabetes. en.search.irct.ir/view/37291 (first received 25 April 2017). ">Asemi 2017</a>; <a href="./references#CD001059-bbs2-0033" title="AzamiM , AzadiT , FarhangS , RahmatiS , PourtaghiK . The effects of multi mineral‐vitamin D and vitamins (C+E) supplementation in the prevention of preeclampsia: an RCT. International Journal of Reproductive Biomedicine2017; Vol. 15, issue 5:273‐8. AzamiM , IRCT2016062528617N1 . The effects of multi minerals (Zn, Mg and Ca) and vitamins (C and E) supplementation in the prevention of preeclampsia. en.search.irct.ir/view/31125 (first received 24 September 2016). ">Azami 2017</a> (unclear trial procedures); <a href="./references#CD001059-bbs2-0039" title="deSouzaEV . Aspirin and calcium to prevent preeclampsia in chronic hypertensive women with abnormal uterine artery Doppler ultrasound [abstract] [Acido acetilalicilico associado ao calcio na prevencao da pre‐eclampsia em gestantes hipertensas cronicas selecionadas pela dopplervelocimetria das arterias uterinas]. Revista Brasileira de Ginecologia y Obstetricia2006;28(2):136. deSouzaEV , SassN , AtallahAN , KularLJr . Aspirin and calcium to prevent pre eclampsia in chronic hypertension women with abnormal uterine artery doppler ultrasound [abstract]. Hypertension in Pregnancy2006;25(Suppl 1):152. ">de Souza 2006</a> (high‐dose calcium plus aspirin); <a href="./references#CD001059-bbs2-0040" title="BezerraFF , NCT01732328 . Calcium plus vitamin D supplementation during pregnancy of adolescent mothers: effects on maternal and infant bone mass, calcium and bone metabolism and breast milk composition. clinicaltrials.gov/show/NCT01732328 (first received 19 November 2012). DiogenesME , BezerraFF , RezendeEP , DonangeloCM . Calcium plus vitamin D supplementation during third trimester of pregnancy in adolescents accustomed to low calcium diets did not affect infant bone mass at early lactation in a randomized controlled trial. Journal of Nutrition2015;145:1515‐23. DiogenesME , BezerraFF , RezendeEP , TaveiraMF , PinhalI , DonangeloCM . Effect of calcium plus vitamin D supplementation during pregnancy in Brazilian adolescent mothers: a randomized, placebo‐controlled trial. American Journal of Clinical Nutrition2013;98(1):82‐91. DiogenesMEL , BezerraFF , RezendeEP , TaveiraMF , PinhalI , DonangeloCM . Maternal vitamin D status of adolescent mothers at mid‐pregnancy influence bone mineral content of their newborns. FASEB Journal2011;25:603.19. NormandoP , DiogenesME , CabelloPH , CabelloGM , DonangeloCM , BezerraFF . Calcium plus vitamin D supplementation during pregnancy interacts with polymorphisms in the promoter region of the VDR gene to affect postpartum bone mass of Brazilian adolescent mothers: a randomized controlled trial. Nutrition2016;32(10):1068‐74. ">Diogenes 2011</a> (no hypertension data); <a href="./references#CD001059-bbs2-0052" title="MacDonaldHN . Fetal and maternal benefits from calcium and vitamin D supplementation of pregnant Asians. Personal communication1986. ">MacDonald 1986</a> (no methods or results); <a href="./references#CD001059-bbs2-0055" title="MosalanejadN , IRCT2016121430612N2 . Compare the effect of vitamin D and calcium plus vitamin D on pregnancy outcomes in pregnant women. en.search.irct.ir/view/34642 (first received 26 December 2016). ">Mosalanejad 2016</a> (calcium in both groups, vitamin D dose varied); <a href="./references#CD001059-bbs2-0057" title="NooripourS , IRCT2015041321736N1 . Clinical trial on the evaluation of calcium and vitamin d in the cord serum of neonates, whose mothers were under vitamin d treatment during their pregnancy. en.search.irct.ir/view/22976 (first received 1 February 2016). ">Nooripour 2016</a> (calcium in both groups, vitamin D varied); <a href="./references#CD001059-bbs2-0065" title="SouzaEV , TorloniMR , AtallahAN , Dos SantosGM , Kulay JrL , SassN . Aspirin plus calcium supplementation to prevent superimposed preeclampsia: a randomized trial. Brazilian Journal of Medical and Biological Research2014;47(5):419‐25. ">Souza 2014</a> (high‐dose calcium plus aspirin)). In seven studies there was no placebo and calcium may have been compared with other active interventions (<a href="./references#CD001059-bbs2-0029" title="AnuMS , CTRI/2017/03/008259 . Ayurvedic management in preventing intra uterine growth retardation. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=18028 (first received 30 March 2017). ">Anu 2017</a>; <a href="./references#CD001059-bbs2-0050" title="KnightKB , KeithRE . Calcium supplementation on normotensive and hypertensive pregnant women. American Journal of Clinical Nutrition1992;55:891‐5. ">Knight 1992</a>; <a href="./references#CD001059-bbs2-0054" title="MontanaroD , BoscuttiG , AntonucciF , MessaP , MioniG , DriulP , et al. Prevention of pregnancy‐induced hypertension (PIH) and pre‐eclampsia (PE) by oral calcium supplementation. Proceedings of the 10th International Congress of Nephrology; 1987 July 26‐31; London, UK. 1987:281. MontanaroD , BoscuttiG , MioniG , DriulP , TosoliniG . Calcium supplementation decreases the incidence of pregnancy‐induced hypertension (PIH) and pre‐eclampsia (PE). 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy. 1990:267. ">Montanaro 1990</a>; <a href="./references#CD001059-bbs2-0067" title="SubprabhaK , CTRI/2016/10/007373 . Role of madhuraushadha siddha avaleha as garbhini rasayana in the 6th and 7th month of pregnancy. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=15659 (first received 22 May 2017). ">Subprabha 2017</a>; <a href="./references#CD001059-bbs2-0068" title="SuzukiY , ItohY , HayashiY , MurakamiI , YamaguchiK , OhshimaT , et al. Calcium supplementation to prevent gestational hypertension. 10th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1996 August 4‐8; Seattle, Washington. 1996:113. ">Suzuki 1996</a>; <a href="./references#CD001059-bbs2-0070" title="WanchuM , MalhotraS , KhullarM . Calcium supplementation in pre‐eclampsia. Journal of the Association of Physicians of India2001;49:795‐8. ">Wanchu 2001</a>; <a href="./references#CD001059-bbs2-0071" title="ZhengQS , ZhangYP . Clinical experience with calcium supplementation in pregnancy. Journal of Practical Obstetrics and Gynecology2000;16(2):102‐3. ">Zheng 2000</a>). In three studies the aim of the intervention did not relate to maternal hypertension (<a href="./references#CD001059-bbs2-0042" title="EttingerAS , LamadridH , MercadoA , KordasK , PetersonK , HuH , et al. Effect of calcium on bone resorption and bone mineral density in pregnancy: A randomized control trial. American Journal of Epidemiology2011;173(Suppl):S236. HuH , Hernandez‐AvilaM , NCT00558623 . Controlled trial in pregnancy of dietary supplements for suppression of bone resorption and mobilization of lead into plasma. clinicaltrials.gov/show/NCT00558623 (first received 14 November 2007). ">Ettinger 2011</a>; <a href="./references#CD001059-bbs2-0045" title="HerreraJA , Arevalo‐HerreraM , VillegasA , HerreraS , VillalbaM , BrometA . Calcium oral supplementation in adolescent pregnant women. Colombia Medica2006;37(2 Suppl 1):15‐20. ">Herrera 2006a</a>; <a href="./references#CD001059-bbs2-0047" title="KaramaliM , AsemiZ , Ahmadi‐DastjerdiM , EsmaillzadehA . Calcium plus vitamin D supplementation affects pregnancy outcomes in gestational diabetes: randomized, double‐blind, placebo‐controlled trial. Public Health Nutrition2016;19(1):156‐63. KaramaliM , IRCT201407115623N23 . Effect of vitamin D plus calcium co‐supplementation on pregnancy outcomes in gestational diabetes. en.search.irct.ir/view/19118 (first received 21 July 2014). ">Karamali 2016</a>), and in a further three the participants were not eligible (e.g. they already had hypertension at recruitment) (<a href="./references#CD001059-bbs2-0056" title="NCT00000543 . Oral calcium in pregnant women with hypertension. clinicaltrials.gov/ct2/show/record/NCT00000543 (first received 27 October 1999). ">NCT00000543</a>; <a href="./references#CD001059-bbs2-0066" title="Sanchez‐RamosL , AdairCD , DelvalleGO , GaudierF , DelkeI . Calcium supplementation in mild preeclampsia remote from term: a prospective randomized double‐blind clinical trial. American Journal of Obstetrics and Gynecology1993;168:385. Sanchez‐RamosL , AdairD , KaunitzAM , BrionesDK , DelvalleGO , DelkeI . Calcium supplementation in mild pre‐eclampsia remote from term: a randomized double‐blind clinical trial. Obstetrics &amp; Gynecology1995;85:915‐8. ">S‐Ramos 1995</a>; <a href="./references#CD001059-bbs2-0069" title="TamasP , SzaboI , SzekelyJ , CsermelyT , PrievaraFT , NemethL , et al. Effects of Doxium 500 (R) in gestational hypertension [A doxium 500 (R) Hatasanak vizsgalata terhessegi Hypertoniaban (kettos vak, placebo‐kontrollalt tanulmany)]. Magyar Noorvosok Lapja1997;60(3):181‐7. ">Tamas 1997</a>). In <a href="./references#CD001059-bbs2-0046" title="HofmeyrGJ , PACTR201105000267371 . WHO randomized trial of calcium supplementation before pregnancy to reduce recurrent pre‐eclampsia. pactr.org/ATMWeb/appmanager/atm/atmregistry?dar=true&amp;tNo=PACTR201105000267371 (first received 6 December 2010). HofmeyrGJ , SeucAH , BetranAP , PurnatTD , CigandaA , MunjanjaSP , et al. The effect of calcium supplementation on blood pressure in non‐pregnant women with previous pre‐eclampsia: an exploratory, randomized placebo controlled study. Pregnancy Hypertension2015;5(4):273‐9. ">Hofmeyr 2015</a>, women were not pregnant at the time of recruitment. One study was a dose comparison (<a href="./references#CD001059-bbs2-0053" title="DickinK . A cluster‐randomized, non‐inferiority open‐label trial of the impact of supplementation regimen on consumption of prenatal calcium and iron/folic acid supplements and adherence to related recommendations. clinicaltrials.gov/ct2/show/record/NCT02238704 (first received 5 September 2014). [NCT02238704] MartinSL , OmotayoMO , PeltoGH , ChapleauGM , StoltzfusRJ , DickinKL . Adherence‐specific social support enhances adherence to calcium supplementation regimens among pregnant women. Journal of Nutrition2017;147(4):688‐96. OmotayoM , StoltzfusR , MartinS , Kung'uJ , DickinK . WHO guidelines on calcium supplementation for prevention of preeclampsia: adoption, feasibility and acceptability in rural Kenya. FASEB Journal2016;30:[abstract no: 1149.29]. OmotayoMO , DickinKL , ChapleauGM , MartinSL , ChangC , MwangaEO , et al. Cluster‐randomized non‐inferiority trial to compare supplement consumption and adherence to different dosing regimens for antenatal calcium and iron‐folic acid supplementation to prevent preeclampsia and anaemia: rationale and design of the micronutrient initiative study. Journal of Public Health Research2015;4(3):582. OmotayoMO , DickinKL , PelletierDL , MwangaEO , Kung'uJK , StoltzfusRJ . A simplified regimen compared with who guidelines decreases antenatal calcium supplement intake for prevention of preeclampsia in a cluster‐randomized noninferiority trial in rural kenya. Journal of Nutrition2017 [epub ahead print]. ">Martin 2017</a>), one examined high‐dose calcium (1 g) with vitamin D (<a href="./references#CD001059-bbs2-0064" title="SamimiM , IRCT201102135444N3 . Effects of calcium and vitamin D co‐supplementation on pre‐eclampsia parameters, metabolic status and biomarkers of oxidative stress in pregnant women at risk for pre‐eclampsia. en.search.irct.ir/view/5288 (first received 31 January 2015). SamimiM , KashiM , ForoozanfardF , KaramaliM , BahmaniF , AsemiZ , et al. The effects of vitamin D plus calcium supplementation on metabolic profiles, biomarkers of inflammation, oxidative stress and pregnancy outcomes in pregnant women at risk for pre‐eclampsia. Journal of Human Nutrition and Dietetics2016;29(4):505‐16. ">Samimi 2016</a>), and another examined the effects of enteric coating of calcium supplements on absorption (<a href="./references#CD001059-bbs2-0062" title="RothD , ZlotkinS , NCT01678079 . Bioavailability and acceptability of enteric‐coated microencapsulated calcium during pregnancy: a randomized crossover trial in Bangladesh (Encapsulated Calcium Absorption in Pregnancy). clinicaltrials.gov/show/NCT01678079 (first received 30 August 2012). RothDE , PezzackB , Al MahmudA , AbramsSA , IslamM , Aimone PhillipsA , et al. Bioavailability of enteric‐coated microencapsulated calcium during pregnancy: a randomized crossover trial in Bangladesh. American Journal of Clinical Nutrition2014;100(6):1587‐95. ">Roth 2014</a>). </p> </section> </section> <section id="CD001059-sec-0088"> <h3 class="title">Risk of bias in included studies</h3> <p>See <a href="./references#CD001059-sec-0178" title="">Characteristics of included studies</a>, <a href="#CD001059-fig-0002">Figure 2</a> and <a href="#CD001059-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD001059-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD001059-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD001059-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD001059-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD001059-sec-0089"> <h4 class="title">Allocation</h4> <p>The majority of studies included in the review used methods of sequence generation and allocation that we assessed as having low risk of bias. Sixteen trials used random number tables, computer generation or central randomisation methods to generate the randomisation sequence. Nine trials did not provide clear information about how the sequence was generated and two studies used methods that we assessed as being at high risk of bias (<a href="./references#CD001059-bbs2-0018" title="MaryaRK , RatheeS , ManrowM . Effect of calcium and vitamin D supplementation on toxaemia of pregnancy. Gynecologic and Obstetric Investigation1987;24:38‐42. ">Marya 1987</a>; <a href="./references#CD001059-bbs2-0021" title="RogersMS , FungHYM , HungCY . Calcium and low‐dose aspirin prophylaxis in women at high risk of pregnancy‐induced hypertension. Hypertension in Pregnancy1999;18(2):165‐72. ">Rogers 1999</a>). The methods to conceal allocation at the point of randomisation were assessed as having low risk of bias in 16 trials, unclear risk of bias in nine trials, and high risk of bias in two trials. </p> </section> <section id="CD001059-sec-0090"> <h4 class="title">Blinding</h4> <p>Where trials were placebo controlled, and it was clear that women and staff providing care were blind to treatment allocation, we assessed the studies as having low risk of performance bias; this applied to 14 trials. In six trials the methods to achieve blinding were not clearly described, and we assessed seven trials to have high risk of performance bias as women or staff were aware of the treatment group. For detection bias, we assessed 15 studies to have low risk of bias, six to have unclear risk of bias, and six to be at high risk of bias. </p> </section> <section id="CD001059-sec-0091"> <h4 class="title">Incomplete outcome data</h4> <p>In six studies there were post‐randomisation exclusions or loss to follow‐up that meant we considered the studies to be at high risk of attrition bias. In seven studies, sample loss was either not described or we were uncertain about the impact of loss to follow‐up on results. In the remaining 14 trials, loss to follow‐up was low and balanced across groups and so we assessed these studies as being at low risk of bias. </p> </section> <section id="CD001059-sec-0092"> <h4 class="title">Selective reporting</h4> <p>For 16 trials we had insufficient information to assess risk of outcome reporting bias; many trials did not have published protocols or did not report expected outcomes fully. We assessed 11 trials as being at low risk of outcome reporting bias. </p> </section> <section id="CD001059-sec-0093"> <h4 class="title">Other potential sources of bias</h4> <p>We assessed eight trials as being at high risk of other bias, mainly because the methods were very poorly described. We assessed another eight trials as being unlikely to be at high risk of other bias; and for 11 studies we were uncertain, again often because of limited reporting. </p> <section id="CD001059-sec-0094"> <h5 class="title">Overall risk of bias in our main comparisons</h5> <section id="CD001059-sec-0095"> <h6 class="title">High‐dose calcium supplementation</h6> <p>For overall risk of bias, all were double‐blind, placebo‐controlled trials. Pre‐specified outcome data were not available from all trials. Not all outcomes were consistently reported, therefore there is a possibility of reporting bias in some trials. </p> <p>In <a href="./references#CD001059-bbs2-0016" title="Lopez‐JaramilloP , NarvaezM , FelixC , LopezA . Dietary calcium supplementation and prevention of pregnancy hypertension. Lancet1990;335:293. NarvaezM , Lopez‐JaramilloP , WeigelM . Calcium (Ca++) supplementation reduces the risk for pregnancy induced hypertension (PIH). World Congress of Gynecology and Obstetrics; 1988 October 23‐28; Brazil. 1988:180‐1. ">L‐Jaramillo 1990</a>, a large discrepancy in numbers allocated to each group was not explained. For <a href="./references#CD001059-bbs2-0013" title="KumarA , DeviSG , BatraS , SinghC , ShuklaDK . Calcium supplementation for the prevention of pre‐eclampsia. International Journal of Gynecology &amp; Obstetrics2009;104(1):32‐6. ">Kumar 2009</a>, we contacted the authors to clarify the imbalance in group size that occurred in their study. They have provided the explanation (see notes in <a href="./references#CD001059-sec-0178" title="">Characteristics of included studies</a>), but the imbalance does increase the potential for bias. </p> <p>In some trials, individual denominators were not given for specific outcomes. Where it was clear that the outcomes were not measured in the entire group, we have adjusted the denominators accordingly. In other respects, the methodology of the studies included appears sound. </p> </section> <section id="CD001059-sec-0096"> <h6 class="title">Low‐dose calcium supplementation</h6> <p>We considered four of these studies to be at low risk of bias (<a href="./references#CD001059-bbs2-0004" title="BassawB , RoopnarinesinghS , RoopnarinesinghA , HomerH . Prevention of hypertensive disorders of pregnancy. Journal of Obstetrics and Gynaecology1998;18(2):123‐6. ">Bassaw 1998</a>; <a href="./references#CD001059-bbs2-0009" title="HerreraJA , Arevalo‐HerreraM , HerreraS . Prevention of preeclampsia by linoleic acid and calcium supplementation: a randomized controlled trial. Obstetrics &amp; Gynecology1998;91(4):585‐90. ">Herrera 1998</a>; <a href="./references#CD001059-bbs2-0010" title="HerreraJA , Arevalo‐HerreraM , ShahabuddinAK , ErshengG , HerreraS , GarciaRG , et al. Calcium and conjugated linoleic acid reduces pregnancy‐induced hypertension and decreases intracellular calcium in lymphocytes. American Journal of Hypertension2006;19(4):381‐7. HerreraJA , ShahabuddinAK , ErshengG , WeiY , GarciaRG , Lopez‐JaramilloP . Calcium plus linoleic acid therapy for pregnancy‐induced hypertension. International Journal of Gynecology &amp; Obstetrics2005;91(3):221‐7. HerreraJA , ShahabuddinAKM , FaisalM , ErshengG , WeiY , LixiaD , et al. Effects of supplementation with oral calcium and linoleic acid in primigravidas at high risk [Efectos de la supplementacion oral con calcio y acido linoleico conjugado en primigravidas de alto riesgo]. Colombia Medica2004;35(1):31‐7. ">Herrera 2006</a>; <a href="./references#CD001059-bbs2-0022" title="RumirisD , PurwosunuY , WibowoN , FarinaA , SekizawaA . Lower rate of preeclampsia after antioxidant supplementation in pregnant women with low antioxidant status. Hypertension in Pregnancy2006;25:241–53. ">Rumiris 2006</a>), and six to be at high risk of bias because no placebo was used and either because random sequence generation and allocation concealment were not reported (<a href="./references#CD001059-bbs2-0001" title="AlmiranteCY . Calcium supplementation during pregnancy in the prevention of EPH gestosis. Prenatal and Neonatal Medicine1998;3 Suppl 1:24. ">Almirante 1998</a>; <a href="./references#CD001059-bbs2-0006" title="CongKJ , ChiSL , LiuGR . Calcium and pregnancy induced hypertension. Chinese Journal of Obstetrics and Gynecology1993;28:657‐9. CongKJ , ChiSL , LiuGR . Calcium supplementation during pregnancy for reducing pregnancy induced hypertension. Chinese Medical Journal1995;108:57‐9. CongKJ , ChiSL , LiuGR . Calcium supplementation during pregnancy to reduce pregnancy induced hypertension. Beijing Medical Journal1992;5:268. ">Cong 1995</a>; <a href="./references#CD001059-bbs2-0014" title="LiX , GouW . Study on prevention of pregnancy induced hypertension and effect of platelet intracellular free ca˜(2+) by calcium supplementation. Journal of Xi'an Medical University2000;21(1):46‐8. ">Li 2000</a>); a consecutive series was used (<a href="./references#CD001059-bbs2-0018" title="MaryaRK , RatheeS , ManrowM . Effect of calcium and vitamin D supplementation on toxaemia of pregnancy. Gynecologic and Obstetric Investigation1987;24:38‐42. ">Marya 1987</a>); an open envelope method was used (<a href="./references#CD001059-bbs2-0021" title="RogersMS , FungHYM , HungCY . Calcium and low‐dose aspirin prophylaxis in women at high risk of pregnancy‐induced hypertension. Hypertension in Pregnancy1999;18(2):165‐72. ">Rogers 1999</a>); or a 'table of random numbers' was reported to be used but there was no report of allocation concealment (<a href="./references#CD001059-bbs2-0024" title="TaherianAA , TaherianA , ShirvaniA . Prevention of pre‐eclampsia with low‐dose aspirin or calcium supplementation. Archives of Iranian Medicine2002;5(3):151‐6. ">Taherian 2002</a>). </p> </section> </section> </section> </section> <section id="CD001059-sec-0097"> <h3 class="title" id="CD001059-sec-0097">Effects of interventions</h3> <p>See: <a href="./full#CD001059-tbl-0001"><b>Summary of findings for the main comparison</b> </a> </p> <section id="CD001059-sec-0098"> <h4 class="title">High‐dose calcium supplementation versus placebo</h4> <p>In the 13 studies included in the meta‐analysis, significant heterogeneity of results occurred for four outcomes: pre‐eclampsia; high blood pressure; preterm birth and birthweight less than 2500 g. Factors accounting for the heterogeneity appeared to be maternal risk at trial entry, dietary calcium and trial size. The small trials have bigger effect sizes than the large trials; but as all the small trials recruited high‐risk women, this could also be related to risk status. In view of the heterogeneity, we used a random‐effects model for these four outcomes. As part of our sensitivity analysis, we removed the data from a study assessed to be at high risk of attrition bias (<a href="./references#CD001059-bbs2-0015" title="Lopez‐JaramilloP , NarvaezM , WeigelRM , YepezR . Calcium supplementation reduces the risk of pregnancy‐induced hypertension in an Andes population. British Journal of Obstetrics and Gynaecology1989;96:648‐55. Lopez‐JaramilloP , NarvaezM , YepezR . Effect of calcium supplementation on the vascular sensitivity to angiotensin II in pregnant women. American Journal of Obstetrics and Gynecology1987;156:261‐2. NarvaezM , Lopez‐JaramilloP , WeigelM . Calcium (Ca++) supplementation reduces the risk for pregnancy induced hypertension (PIH). World Congress of Gynecology and Obstetrics; 1988 October 23‐28; Brazil. 1988:180‐1. ">L‐Jaramillo 1989</a>). </p> <p>Data were not available for the following secondary outcomes: mother's hospital stay seven days or more; miscarriage; neonate in intensive care unit seven days or more; death or severe neonatal morbidity; and childhood disability. </p> </section> <section id="CD001059-sec-0099"> <h4 class="title">Primary outcomes</h4> <section id="CD001059-sec-0100"> <h5 class="title">(1) High blood pressure with or without proteinuria</h5> <p>The results follow a similar pattern to those for pre‐eclampsia (see below). Overall, there were fewer women with high blood pressure with calcium supplementation compared with placebo (12 trials, 15,470 women: average risk ratio (RR) 0.65, 95% confidence interval (CI) 0.53 to 0.81; heterogeneity: Tau² = 0.06; Chi² = 42.40, df = 11, P &lt; 0.0001; I² = 74%; <a href="./references#CD001059-fig-0013" title="">Analysis 1.1</a>). The reduction in RR was greatest for the small trials, i.e. trials with fewer than 400 women (seven trials, 675 women: average RR 0.38, 95% CI 0.21 to 0.68; heterogeneity: Tau² = 0.38; Chi² = 18.26, df = 6, P = 0.006; I² = 67%; test for subgroup differences: Chi² = 6.20, df = 1 (P = 0.01), I² = 83.9%; <a href="./references#CD001059-fig-0037" title="">Analysis 3.1</a>.1), and for those with low baseline dietary calcium (seven trials, 10,418 women: average RR 0.44, 95% CI 0.28 to 0.70; heterogeneity: Tau² = 0.26; Chi² = 39.35, df = 6; test for subgroup differences: Chi² = 8.78, df = 2 (P = 0.01), I² = 77.2%; <a href="./references#CD001059-fig-0013" title="">Analysis 1.1</a>.2). Asymmetric funnel plots for these analyses suggest that the treatment effect may be overestimated due to small‐study effects or publication bias (<a href="#CD001059-fig-0004">Figure 4</a>, <a href="#CD001059-fig-0005">Figure 5</a>, <a href="#CD001059-fig-0006">Figure 6</a>). </p> <div class="figure" id="CD001059-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 2 Routine high‐dose calcium supplementation in pregnancy by hypertension risk, outcome: 2.1 High blood pressure (with or without proteinuria)." data-id="CD001059-fig-0004" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 2 Routine high‐dose calcium supplementation in pregnancy by hypertension risk, outcome: 2.1 High blood pressure (with or without proteinuria). </p> </div> </div> </div> <div class="figure" id="CD001059-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, outcome: 1.1 High blood pressure (with or without proteinuria)." data-id="CD001059-fig-0005" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, outcome: 1.1 High blood pressure (with or without proteinuria). </p> </div> </div> </div> <div class="figure" id="CD001059-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 3 Routine high‐dose calcium supplementation in pregnancy by study sample size, outcome: 3.1 High blood pressure (with or without proteinuria)." data-id="CD001059-fig-0006" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 3 Routine high‐dose calcium supplementation in pregnancy by study sample size, outcome: 3.1 High blood pressure (with or without proteinuria). </p> </div> </div> </div> </section> <section id="CD001059-sec-0101"> <h5 class="title">(2) Pre‐eclampsia</h5> <p>Overall, there was a reduction in the average risk of pre‐eclampsia (13 trials, 15,730 women: RR 0.45, 95% CI 0.31 to 0.65, low‐quality evidence; heterogeneity: Tau² = 0.20; Chi² = 40.31, df = 12 (P &lt; 0.0001; I² = 70%); <a href="./references#CD001059-fig-0014" title="">Analysis 1.2</a>. This reduction in RR was greatest for women at high risk of pre‐eclampsia (five trials, 587 women: average RR 0.22, 95% CI 0.12 to 0.42; test for subgroup differences: Chi² = 6.81, df = 1, P = 0.009, I² = 85.3%; <a href="./references#CD001059-fig-0033" title="">Analysis 2.2</a>). Pre‐eclampsia was not reduced in the subgroup with adequate dietary calcium, but was for those with low baseline calcium intake (eight trials, 10,678 women: average RR 0.36, 95% CI 0.20 to 0.65; heterogeneity: Tau² = 0.44; Chi² = 29.35, df = 7, P = 0.0001; I² = 76%; <a href="./references#CD001059-fig-0014" title="">Analysis 1.2</a>). Assymetric funnel plots for these analyses suggest that the treatment effect may be overestimated due to small‐study effects or publication bias (<a href="#CD001059-fig-0007">Figure 7</a>, <a href="#CD001059-fig-0008">Figure 8</a>). There was also evidence of a subgroup difference between studies with small and larger samples sizes (test for subgroup differences: Chi² = 15.20, df = 1 (P &lt; 0.0001), I² = 93.4%), <a href="./references#CD001059-fig-0038" title="">Analysis 3.2</a>. </p> <div class="figure" id="CD001059-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, outcome: 1.2 Pre‐eclampsia." data-id="CD001059-fig-0007" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, outcome: 1.2 Pre‐eclampsia. </p> </div> </div> </div> <div class="figure" id="CD001059-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 2 Routine high‐dose calcium supplementation in pregnancy by hypertension risk, outcome: 2.2 Pre‐eclampsia." data-id="CD001059-fig-0008" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG08.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 2 Routine high‐dose calcium supplementation in pregnancy by hypertension risk, outcome: 2.2 Pre‐eclampsia. </p> </div> </div> </div> <p>When subgrouped by both dietary calcium intake and study size, the effect size appeared to be associated most strongly with study size (in the small studies, RR 0.21 for the low‐calcium trials and RR 0.26 for the adequate‐calcium trials; and in the large studies RR 0.63 and RR 0.70 respectively; <a href="./references#CD001059-fig-0042" title="">Analysis 4.1</a>; test for subgroup differences: Chi² = 10.28, df = 4 (P = 0.04), I² = 61.1%); <a href="#CD001059-fig-0009">Figure 9</a>. </p> <div class="figure" id="CD001059-fig-0009"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 9</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 4 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium and study sample size (not pre‐specified), outcome: 4.1 Pre‐eclampsia." data-id="CD001059-fig-0009" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG09.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 4 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium and study sample size (not pre‐specified), outcome: 4.1 Pre‐eclampsia. </p> </div> </div> </div> <p>Only one study included women with high risk of pre‐eclampsia and adequate dietary calcium (<a href="./references#CD001059-bbs2-0026" title="VillarJ , BelizanJM , RepkeJ . The effect of calcium supplementation on the incidence of hypertensive disorders of pregnancy and prematurity. 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy. 1990:54. VillarJ , BelizanJM , RepkeJT . Does calcium supplementation reduce pregnancy‐induced hypertension and prematurity?. Advances in the prevention of low birthweight; 1988 May 8‐11; Cape Cod, Massachusetts. 1998:187‐95. VillarJ , RepkeJT . Calcium supplementation during pregnancy may reduce preterm delivery in high‐risk populations. American Journal of Obstetrics and Gynecology1990;163:1124‐31. ">Villar 1990</a>). The numbers were too small for meaningful statistical analysis (pre‐eclampsia in 0/90 participants with calcium, versus 3/88 participants with placebo). </p> </section> <section id="CD001059-sec-0102"> <h5 class="title">(3) Preterm birth</h5> <p>Calcium supplementation reduced the average risk of preterm birth overall (11 trials 15,275 women: RR 0.76, 95% CI 0.60 to 0.97; low‐quality evidence; heterogeneity: Tau² = 0.05; Chi² = 20.04, df = 8 (P = 0.01); I² = 60%; <a href="./references#CD001059-fig-0015" title="">Analysis 1.3</a>), and amongst women at high risk of developing pre‐eclampsia recruited to four small trials (568 women: average RR 0.45, 95% CI 0.24 to 0.83; heterogeneity: Tau² = 0.00; Chi² = 1.73, df = 2, P = 0.42; I² = 0%; test for subgroup differences: Chi² = 3.48, df = 1 (P = 0.06), I² = 71.3%; <a href="./references#CD001059-fig-0034" title="">Analysis 2.3</a>). However, this reduction did not translate to a reduction in neonatal high care admissions of babies born &lt; 2500 g. Asymmetric funnel plots for these analyses suggest that the treatment effect may be overestimated due to small‐study effects or publication bias (<a href="#CD001059-fig-0010">Figure 10</a>, <a href="#CD001059-fig-0011">Figure 11</a>, <a href="#CD001059-fig-0012">Figure 12</a>). There was also evidence of a subgroup difference between studies with small and larger samples sizes (test for subgroup differences: Chi² = 4.90, df = 1 (P = 0.03), I² = 79.6%, <a href="./references#CD001059-fig-0039" title="">Analysis 3.3</a>). </p> <div class="figure" id="CD001059-fig-0010"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 10</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, outcome: 1.3 Preterm birth." data-id="CD001059-fig-0010" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG10.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, outcome: 1.3 Preterm birth. </p> </div> </div> </div> <div class="figure" id="CD001059-fig-0011"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 11</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 2 Routine high‐dose calcium supplementation in pregnancy by hypertension risk, outcome: 2.3 Preterm birth." data-id="CD001059-fig-0011" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG11.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 2 Routine high‐dose calcium supplementation in pregnancy by hypertension risk, outcome: 2.3 Preterm birth. </p> </div> </div> </div> <div class="figure" id="CD001059-fig-0012"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 12</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 3 Routine high‐dose calcium supplementation in pregnancy by study sample size, outcome: 3.3 Preterm birth." data-id="CD001059-fig-0012" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG12.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 3 Routine high‐dose calcium supplementation in pregnancy by study sample size, outcome: 3.3 Preterm birth. </p> </div> </div> </div> </section> <section id="CD001059-sec-0103"> <h5 class="title">(4) Admission to neonatal intensive care unit</h5> <p>There was no overall effect on the RR of admission to a neonatal intensive care unit (four trials, 13,406 women: RR 1.05, 95% CI 0.94 to 1.18; heterogeneity: Chi² = 2.83, df = 3 (P = 0.42); I² = 0%; <a href="./references#CD001059-fig-0016" title="">Analysis 1.4</a>). </p> </section> <section id="CD001059-sec-0104"> <h5 class="title">(5) Stillbirth or death before discharge from hospital</h5> <p>There was no overall effect on the RR of a stillbirth or the baby dying before discharge from hospital (11 trials, 15,665 women: RR 0.90, 95% CI 0.74 to 1.09; heterogeneity: Chi² = 1.46, df = 5 (P = 0.92); I² = 0%; <a href="./references#CD001059-fig-0017" title="">Analysis 1.5</a>). </p> </section> </section> <section id="CD001059-sec-0105"> <h4 class="title">Secondary outcomes</h4> <section id="CD001059-sec-0106"> <h5 class="title">(6) Maternal death or serious morbidity</h5> <p>The risk of maternal death or serious morbidity was reduced for women allocated to calcium supplementation compared with placebo (four trials, 9732 women: RR 0.80, 95% CI 0.66 to 0.98; <a href="./references#CD001059-fig-0018" title="">Analysis 1.6</a>). It should be noted that all events were restricted to one trial (<a href="./references#CD001059-bbs2-0027" title="AbalosE , MerialdiM , WojdylaD , CarroliG , CampodónicoL , YaoSE , et al. Effects of calcium supplementation on fetal growth in mothers with deficient calcium intake: a randomised controlled trial. Paediatric and Perinatal Epidemiology2010;24(1):53‐62. Abdel‐AleemH , MerialdiM , ElsnosyED , ElsedfyGO , Abdel‐AleemMA , VillarJ . The effect of calcium supplementation during pregnancy on fetal and infant growth: a nested randomized controlled trial within WHO calcium supplementation trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2009;22(2):94‐100. CarroliG , MerialdiM , WojdylaD , AbalosE , CampodonicoL , YaoSE , et al. Effects of calcium supplementation on uteroplacental and fetoplacental blood flow in low‐calcium‐intake mothers: a randomized controlled trial. American Journal of Obstetrics and Gynecology2010;202(1):45.e1‐45.e9. HofmeyrGJ , MlokotiZ , NikodemVC , MangesiL , FerreiraS , SingataM , et al. Calcium supplementation during pregnancy for preventing hypertensive disorders is not associated with changes in platelet count, urate, and urinary protein: a randomized control trial. Hypertension in Pregnancy2008;27(3):299‐304. VillarJ , Abdel‐AleemH , MerialdiM , MathaiM , AliM , ZavaletaN , et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. American Journal of Obstetrics and Gynecology2006;194:639‐49. VillarJ , AleemHA , MerialdiM , MathaiM , AliM , ZavaletaN , et al. WHO randomized trial of calcium supplementation among low calcium intake pregnant women [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S2. VillarJ , ISRCTN37214165 . Calcium supplementation during pregnancy in low‐intake populations. isrctn.com/ISRCTN37214165 (first received 19 March 2014). ZhangJ , VillarJ , SunW , MerialdiM , Abdel‐AleemH , MathaiM , et al. Blood pressure dynamics during pregnancy and spontaneous preterm birth. American Journal of Obstetrics and Gynecology2007;197(2):162.e1‐6. ">WHO 2006</a>) as the other three trials did not have any events. </p> </section> <section id="CD001059-sec-0107"> <h5 class="title">(7) Placental abruption</h5> <p>In the five trials reporting this outcome, there was no clear difference between the groups (14,336 women: RR 0.86, 95% CI 0.55 to 1.34; heterogeneity: Chi² = 0.91, df = 2 (P = 0.63); I² = 0%; <a href="./references#CD001059-fig-0019" title="">Analysis 1.7</a>). </p> </section> <section id="CD001059-sec-0108"> <h5 class="title">(8) Caesarean section</h5> <p>There was a reduction in caesarean section for women in the calcium group (eight trials, 15,234 women: RR 0.95, 95% CI 0.89 to 1.02; heterogeneity: Chi² = 5.21, df = 7 (P = 0.63); I² = 0%; <a href="./references#CD001059-fig-0020" title="">Analysis 1.8</a>), although the upper confidence limit just crossed the line of no effect. </p> </section> <section id="CD001059-sec-0109"> <h5 class="title">(9) *Proteinuria</h5> <p>Only one trial reported proteinuria (<a href="./references#CD001059-bbs2-0027" title="AbalosE , MerialdiM , WojdylaD , CarroliG , CampodónicoL , YaoSE , et al. Effects of calcium supplementation on fetal growth in mothers with deficient calcium intake: a randomised controlled trial. Paediatric and Perinatal Epidemiology2010;24(1):53‐62. Abdel‐AleemH , MerialdiM , ElsnosyED , ElsedfyGO , Abdel‐AleemMA , VillarJ . The effect of calcium supplementation during pregnancy on fetal and infant growth: a nested randomized controlled trial within WHO calcium supplementation trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2009;22(2):94‐100. CarroliG , MerialdiM , WojdylaD , AbalosE , CampodonicoL , YaoSE , et al. Effects of calcium supplementation on uteroplacental and fetoplacental blood flow in low‐calcium‐intake mothers: a randomized controlled trial. American Journal of Obstetrics and Gynecology2010;202(1):45.e1‐45.e9. HofmeyrGJ , MlokotiZ , NikodemVC , MangesiL , FerreiraS , SingataM , et al. Calcium supplementation during pregnancy for preventing hypertensive disorders is not associated with changes in platelet count, urate, and urinary protein: a randomized control trial. Hypertension in Pregnancy2008;27(3):299‐304. VillarJ , Abdel‐AleemH , MerialdiM , MathaiM , AliM , ZavaletaN , et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. American Journal of Obstetrics and Gynecology2006;194:639‐49. VillarJ , AleemHA , MerialdiM , MathaiM , AliM , ZavaletaN , et al. WHO randomized trial of calcium supplementation among low calcium intake pregnant women [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S2. VillarJ , ISRCTN37214165 . Calcium supplementation during pregnancy in low‐intake populations. isrctn.com/ISRCTN37214165 (first received 19 March 2014). ZhangJ , VillarJ , SunW , MerialdiM , Abdel‐AleemH , MathaiM , et al. Blood pressure dynamics during pregnancy and spontaneous preterm birth. American Journal of Obstetrics and Gynecology2007;197(2):162.e1‐6. ">WHO 2006</a>), and there was no overall difference between the groups (8312 women: RR 1.04, 95% CI 0.86 to 1.26; <a href="./references#CD001059-fig-0021" title="">Analysis 1.9</a>). </p> </section> <section id="CD001059-sec-0110"> <h5 class="title">(10) *Severe pre‐eclampsia as defined by trial authors</h5> <p>Only one trial reported severe pre‐eclampsia (<a href="./references#CD001059-bbs2-0027" title="AbalosE , MerialdiM , WojdylaD , CarroliG , CampodónicoL , YaoSE , et al. Effects of calcium supplementation on fetal growth in mothers with deficient calcium intake: a randomised controlled trial. Paediatric and Perinatal Epidemiology2010;24(1):53‐62. Abdel‐AleemH , MerialdiM , ElsnosyED , ElsedfyGO , Abdel‐AleemMA , VillarJ . The effect of calcium supplementation during pregnancy on fetal and infant growth: a nested randomized controlled trial within WHO calcium supplementation trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2009;22(2):94‐100. CarroliG , MerialdiM , WojdylaD , AbalosE , CampodonicoL , YaoSE , et al. Effects of calcium supplementation on uteroplacental and fetoplacental blood flow in low‐calcium‐intake mothers: a randomized controlled trial. American Journal of Obstetrics and Gynecology2010;202(1):45.e1‐45.e9. HofmeyrGJ , MlokotiZ , NikodemVC , MangesiL , FerreiraS , SingataM , et al. Calcium supplementation during pregnancy for preventing hypertensive disorders is not associated with changes in platelet count, urate, and urinary protein: a randomized control trial. Hypertension in Pregnancy2008;27(3):299‐304. VillarJ , Abdel‐AleemH , MerialdiM , MathaiM , AliM , ZavaletaN , et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. American Journal of Obstetrics and Gynecology2006;194:639‐49. VillarJ , AleemHA , MerialdiM , MathaiM , AliM , ZavaletaN , et al. WHO randomized trial of calcium supplementation among low calcium intake pregnant women [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S2. VillarJ , ISRCTN37214165 . Calcium supplementation during pregnancy in low‐intake populations. isrctn.com/ISRCTN37214165 (first received 19 March 2014). ZhangJ , VillarJ , SunW , MerialdiM , Abdel‐AleemH , MathaiM , et al. Blood pressure dynamics during pregnancy and spontaneous preterm birth. American Journal of Obstetrics and Gynecology2007;197(2):162.e1‐6. ">WHO 2006</a>). Again, there was no clear difference between the groups (one trial, 8302 women: RR 0.74, 95% CI 0.48 to 1.15; <a href="./references#CD001059-fig-0022" title="">Analysis 1.10</a>). </p> </section> <section id="CD001059-sec-0111"> <h5 class="title">(11) *Eclampsia</h5> <p>The two largest trials reported eclampsia (<a href="./references#CD001059-bbs2-0007" title="HabliM , LevineRJ , QianC , SibaiB . Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. American Journal of Obstetrics and Gynecology2007;197(4):406.e1‐406.e7. HattonDC , Harrison‐HohnerJ , CosteS , RellerM , McCarronD . Gestational calcium supplementation and blood pressure in the offspring. American Journal of Hypertension2003;16:801‐5. Levine RJ for the CPEP Study Group. Calcium for preeclampsia prevention (CPEP): a double‐blind, placebo‐controlled trial in healthy nulliparas. American Journal of Obstetrics and Gynecology1997;176:S2. Levine RJ for the CPEP Study Group. The trial of calcium for preeclampsia prevention (CPEP). 8th World Congress on Hypertension in Pregnancy ‐ Protagonists and Presentations; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. LevineRJ , EsterlitzJR , RaymondEG , DerSimonianR , HauthJC , Ben CuretL , et al. Trial of calcium for preeclampsia prevention (CPEP): rationale, design, and methods. Controlled Clinical Trials1996;17:442‐69. LevineRJ , HauthJC , CuretLB , SibaiBM , CatalanoPM , MorrisCD , et al. Trial of calcium to prevent preeclampsia. New England Journal of Medicine1997;337(2):69‐76. NCT00000534 . Calcium for pre‐eclampsia prevention (CPEP). clinicaltrials.gov/ct2/show/record/NCT00000534 (first received 27 October 1999). ">CPEP 1997</a>; <a href="./references#CD001059-bbs2-0027" title="AbalosE , MerialdiM , WojdylaD , CarroliG , CampodónicoL , YaoSE , et al. Effects of calcium supplementation on fetal growth in mothers with deficient calcium intake: a randomised controlled trial. Paediatric and Perinatal Epidemiology2010;24(1):53‐62. Abdel‐AleemH , MerialdiM , ElsnosyED , ElsedfyGO , Abdel‐AleemMA , VillarJ . The effect of calcium supplementation during pregnancy on fetal and infant growth: a nested randomized controlled trial within WHO calcium supplementation trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2009;22(2):94‐100. CarroliG , MerialdiM , WojdylaD , AbalosE , CampodonicoL , YaoSE , et al. Effects of calcium supplementation on uteroplacental and fetoplacental blood flow in low‐calcium‐intake mothers: a randomized controlled trial. American Journal of Obstetrics and Gynecology2010;202(1):45.e1‐45.e9. HofmeyrGJ , MlokotiZ , NikodemVC , MangesiL , FerreiraS , SingataM , et al. Calcium supplementation during pregnancy for preventing hypertensive disorders is not associated with changes in platelet count, urate, and urinary protein: a randomized control trial. Hypertension in Pregnancy2008;27(3):299‐304. VillarJ , Abdel‐AleemH , MerialdiM , MathaiM , AliM , ZavaletaN , et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. American Journal of Obstetrics and Gynecology2006;194:639‐49. VillarJ , AleemHA , MerialdiM , MathaiM , AliM , ZavaletaN , et al. WHO randomized trial of calcium supplementation among low calcium intake pregnant women [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S2. VillarJ , ISRCTN37214165 . Calcium supplementation during pregnancy in low‐intake populations. isrctn.com/ISRCTN37214165 (first received 19 March 2014). ZhangJ , VillarJ , SunW , MerialdiM , Abdel‐AleemH , MathaiM , et al. Blood pressure dynamics during pregnancy and spontaneous preterm birth. American Journal of Obstetrics and Gynecology2007;197(2):162.e1‐6. ">WHO 2006</a>), as well as <a href="./references#CD001059-bbs2-0013" title="KumarA , DeviSG , BatraS , SinghC , ShuklaDK . Calcium supplementation for the prevention of pre‐eclampsia. International Journal of Gynecology &amp; Obstetrics2009;104(1):32‐6. ">Kumar 2009</a>. There was no clear difference between the groups (three trials, 13,425 women: RR 0.73, 95% CI 0.41 to 1.27; <a href="./references#CD001059-fig-0023" title="">Analysis 1.11</a>). </p> </section> <section id="CD001059-sec-0112"> <h5 class="title">(12) *HELLP syndrome</h5> <p>Only the two largest studies reported HELLP syndrome (<a href="./references#CD001059-bbs2-0007" title="HabliM , LevineRJ , QianC , SibaiB . Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. American Journal of Obstetrics and Gynecology2007;197(4):406.e1‐406.e7. HattonDC , Harrison‐HohnerJ , CosteS , RellerM , McCarronD . Gestational calcium supplementation and blood pressure in the offspring. American Journal of Hypertension2003;16:801‐5. Levine RJ for the CPEP Study Group. Calcium for preeclampsia prevention (CPEP): a double‐blind, placebo‐controlled trial in healthy nulliparas. American Journal of Obstetrics and Gynecology1997;176:S2. Levine RJ for the CPEP Study Group. The trial of calcium for preeclampsia prevention (CPEP). 8th World Congress on Hypertension in Pregnancy ‐ Protagonists and Presentations; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. LevineRJ , EsterlitzJR , RaymondEG , DerSimonianR , HauthJC , Ben CuretL , et al. Trial of calcium for preeclampsia prevention (CPEP): rationale, design, and methods. Controlled Clinical Trials1996;17:442‐69. LevineRJ , HauthJC , CuretLB , SibaiBM , CatalanoPM , MorrisCD , et al. Trial of calcium to prevent preeclampsia. New England Journal of Medicine1997;337(2):69‐76. NCT00000534 . Calcium for pre‐eclampsia prevention (CPEP). clinicaltrials.gov/ct2/show/record/NCT00000534 (first received 27 October 1999). ">CPEP 1997</a>; <a href="./references#CD001059-bbs2-0027" title="AbalosE , MerialdiM , WojdylaD , CarroliG , CampodónicoL , YaoSE , et al. Effects of calcium supplementation on fetal growth in mothers with deficient calcium intake: a randomised controlled trial. Paediatric and Perinatal Epidemiology2010;24(1):53‐62. Abdel‐AleemH , MerialdiM , ElsnosyED , ElsedfyGO , Abdel‐AleemMA , VillarJ . The effect of calcium supplementation during pregnancy on fetal and infant growth: a nested randomized controlled trial within WHO calcium supplementation trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2009;22(2):94‐100. CarroliG , MerialdiM , WojdylaD , AbalosE , CampodonicoL , YaoSE , et al. Effects of calcium supplementation on uteroplacental and fetoplacental blood flow in low‐calcium‐intake mothers: a randomized controlled trial. American Journal of Obstetrics and Gynecology2010;202(1):45.e1‐45.e9. HofmeyrGJ , MlokotiZ , NikodemVC , MangesiL , FerreiraS , SingataM , et al. Calcium supplementation during pregnancy for preventing hypertensive disorders is not associated with changes in platelet count, urate, and urinary protein: a randomized control trial. Hypertension in Pregnancy2008;27(3):299‐304. VillarJ , Abdel‐AleemH , MerialdiM , MathaiM , AliM , ZavaletaN , et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. American Journal of Obstetrics and Gynecology2006;194:639‐49. VillarJ , AleemHA , MerialdiM , MathaiM , AliM , ZavaletaN , et al. WHO randomized trial of calcium supplementation among low calcium intake pregnant women [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S2. VillarJ , ISRCTN37214165 . Calcium supplementation during pregnancy in low‐intake populations. isrctn.com/ISRCTN37214165 (first received 19 March 2014). ZhangJ , VillarJ , SunW , MerialdiM , Abdel‐AleemH , MathaiM , et al. Blood pressure dynamics during pregnancy and spontaneous preterm birth. American Journal of Obstetrics and Gynecology2007;197(2):162.e1‐6. ">WHO 2006</a>). The RR was higher for women allocated calcium supplementation, compared with placebo (two trials, 12,901 women: RR 2.67, 95% CI 1.05 to 6.82; high‐quality evidence; heterogeneity: Chi² = 0.19, df = 1 (P = 0.66); I² = 0%; <a href="./references#CD001059-fig-0024" title="">Analysis 1.12</a>). </p> </section> <section id="CD001059-sec-0113"> <h5 class="title">(13) *Maternal intensive care unit admission</h5> <p>Only one trial reported admission to intensive care (<a href="./references#CD001059-bbs2-0027" title="AbalosE , MerialdiM , WojdylaD , CarroliG , CampodónicoL , YaoSE , et al. Effects of calcium supplementation on fetal growth in mothers with deficient calcium intake: a randomised controlled trial. Paediatric and Perinatal Epidemiology2010;24(1):53‐62. Abdel‐AleemH , MerialdiM , ElsnosyED , ElsedfyGO , Abdel‐AleemMA , VillarJ . The effect of calcium supplementation during pregnancy on fetal and infant growth: a nested randomized controlled trial within WHO calcium supplementation trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2009;22(2):94‐100. CarroliG , MerialdiM , WojdylaD , AbalosE , CampodonicoL , YaoSE , et al. Effects of calcium supplementation on uteroplacental and fetoplacental blood flow in low‐calcium‐intake mothers: a randomized controlled trial. American Journal of Obstetrics and Gynecology2010;202(1):45.e1‐45.e9. HofmeyrGJ , MlokotiZ , NikodemVC , MangesiL , FerreiraS , SingataM , et al. Calcium supplementation during pregnancy for preventing hypertensive disorders is not associated with changes in platelet count, urate, and urinary protein: a randomized control trial. Hypertension in Pregnancy2008;27(3):299‐304. VillarJ , Abdel‐AleemH , MerialdiM , MathaiM , AliM , ZavaletaN , et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. American Journal of Obstetrics and Gynecology2006;194:639‐49. VillarJ , AleemHA , MerialdiM , MathaiM , AliM , ZavaletaN , et al. WHO randomized trial of calcium supplementation among low calcium intake pregnant women [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S2. VillarJ , ISRCTN37214165 . Calcium supplementation during pregnancy in low‐intake populations. isrctn.com/ISRCTN37214165 (first received 19 March 2014). ZhangJ , VillarJ , SunW , MerialdiM , Abdel‐AleemH , MathaiM , et al. Blood pressure dynamics during pregnancy and spontaneous preterm birth. American Journal of Obstetrics and Gynecology2007;197(2):162.e1‐6. ">WHO 2006</a>). There was no clear difference between the groups (one trial, 8312 women: RR 0.84, 95% CI 0.66 to 1.07; <a href="./references#CD001059-fig-0025" title="">Analysis 1.13</a>). </p> </section> <section id="CD001059-sec-0114"> <h5 class="title">(14) *Maternal death</h5> <p>Only one trial reported maternal deaths (<a href="./references#CD001059-bbs2-0027" title="AbalosE , MerialdiM , WojdylaD , CarroliG , CampodónicoL , YaoSE , et al. Effects of calcium supplementation on fetal growth in mothers with deficient calcium intake: a randomised controlled trial. Paediatric and Perinatal Epidemiology2010;24(1):53‐62. Abdel‐AleemH , MerialdiM , ElsnosyED , ElsedfyGO , Abdel‐AleemMA , VillarJ . The effect of calcium supplementation during pregnancy on fetal and infant growth: a nested randomized controlled trial within WHO calcium supplementation trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2009;22(2):94‐100. CarroliG , MerialdiM , WojdylaD , AbalosE , CampodonicoL , YaoSE , et al. Effects of calcium supplementation on uteroplacental and fetoplacental blood flow in low‐calcium‐intake mothers: a randomized controlled trial. American Journal of Obstetrics and Gynecology2010;202(1):45.e1‐45.e9. HofmeyrGJ , MlokotiZ , NikodemVC , MangesiL , FerreiraS , SingataM , et al. Calcium supplementation during pregnancy for preventing hypertensive disorders is not associated with changes in platelet count, urate, and urinary protein: a randomized control trial. Hypertension in Pregnancy2008;27(3):299‐304. VillarJ , Abdel‐AleemH , MerialdiM , MathaiM , AliM , ZavaletaN , et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. American Journal of Obstetrics and Gynecology2006;194:639‐49. VillarJ , AleemHA , MerialdiM , MathaiM , AliM , ZavaletaN , et al. WHO randomized trial of calcium supplementation among low calcium intake pregnant women [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S2. VillarJ , ISRCTN37214165 . Calcium supplementation during pregnancy in low‐intake populations. isrctn.com/ISRCTN37214165 (first received 19 March 2014). ZhangJ , VillarJ , SunW , MerialdiM , Abdel‐AleemH , MathaiM , et al. Blood pressure dynamics during pregnancy and spontaneous preterm birth. American Journal of Obstetrics and Gynecology2007;197(2):162.e1‐6. ">WHO 2006</a>). There were few events in any group, with only one death in the calcium group and six in the placebo group (one trial, 8312 women: RR 0.17, 95% CI 0.02 to 1.39; <a href="./references#CD001059-fig-0026" title="">Analysis 1.14</a>). </p> </section> <section id="CD001059-sec-0115"> <h5 class="title">(15) Low birthweight (birthweight less than 2500 g)</h5> <p>Women in the calcium group were at reduced risk of having a baby with birthweight less than 2500 g (nine trials, 14,883 women: average RR 0.85, 95% CI 0.72 to 1.01; heterogeneity: Tau² = 0.02; Chi² = 9.93, df = 5 (P = 0.08); I² = 50%; <a href="./references#CD001059-fig-0027" title="">Analysis 1.15</a>), although the overall effect estimate just crossed the line of no effect. </p> </section> <section id="CD001059-sec-0116"> <h5 class="title">(16) Neonate small‐for‐gestational age</h5> <p>There was no overall effect on the RR of the baby being born small‐for‐gestational age (four trials, 13,615 women: RR 1.05, 95% CI 0.86 to 1.29; heterogeneity: Chi² = 2.74, df = 3 (P = 0.43); I² = 0%; <a href="./references#CD001059-fig-0028" title="">Analysis 1.16</a>). </p> </section> <section id="CD001059-sec-0117"> <h5 class="title">(17) Childhood systolic blood pressure &gt; 95th percentile</h5> <p>One trial assessed during childhood a subset of the children recruited whilst in utero (<a href="./references#CD001059-bbs2-0005" title="BelizanJM . Prevention of hypertensive disorders of pregnancy with calcium supplementation. 8th World Congress on Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires. 1992:93. BelizanJM , VillarJ , BergelE , delPinoA , DiFulvioS , GallianoSV , et al. Long term effect of calcium supplementation during pregnancy on the blood pressure of offspring: follow up of a randomised controlled trial. BMJ1997;315:281‐5. BelizanJM , VillarJ , GonzalezL , CampodonicoL , BergelE . Calcium supplementation to prevent hypertensive disorders of pregnancy. New England Journal of Medicine1991;325:1399‐405. BergelE , GibbonsL , RasinesMG , LuetichA , BelizanJM . Maternal calcium supplementation during pregnancy and dental caries of children at 12 years of age: follow‐up of a randomized controlled trial. Acta Obstetricia et Gynecologica Scandinavica2010;89(11):1396‐402. StephensIF . Effect of calcium supplementation during pregnancy on blood pressure of offspring. Authors cannot be sure of effect's generalisability to all children aged 5‐9 [letter; comment]. BMJ1998;316(7126):234. VillarJ , BelizanJM , RepkeJ . The effect of calcium supplementation on the incidence of hypertensive disorders of pregnancy and prematurity. 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy. 1990:54. VillarJ , BelizanJM , RepkeJT . Does calcium supplementation reduce pregnancy‐induced hypertension and prematurity?. Proceedings of the International Symposium on advances in the prevention of low birthweight; 1988 May 8‐11; Cape Cod, Massachusetts. 1988:187‐95. ">Belizan 1991</a>). At about seven years of age, diastolic blood pressure greater than 95th percentile was reduced (514 women: RR 0.59, 95% CI 0.39 to 0.91; <a href="./references#CD001059-fig-0029" title="">Analysis 1.17</a>). While the baseline calcium intake in the original study was low (mean 646 mg, standard deviation (SD) 396 in the calcium group; and mean 642 mg, SD 448 in the placebo group, in a sample assessed during the first four months of the study), the group followed up were only from among the 614 women from the private hospital, not the 580 from the public hospitals. Their dietary calcium intake may have differed from the mean (i.e. it is more likely to be higher in more affluent women). The baseline calcium status of the women in this part of the study therefore cannot be classified. </p> <p>In <a href="./references#CD001059-bbs2-0008" title="CrowtherC , HillerJ , PridmoreB , BryceR , DugganP , HagueW , et al. Calcium supplementation in nulliparous women for the prevention of pregnancy included hypertension, pre‐eclampsia and preterm birth: an Australian randomised trial. 2nd Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. 1998:101. CrowtherCA , HillerJE , PridmoreB , BryceR , DugganP , HagueWM , et al. Calcium supplementation in nulliparous women for the prevention of pregnancy‐induced hypertension, preeclampsia and preterm birth: an Australian randomized trial. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(1):12‐8. HillerJE , CrowtherCA , MooreVA , WillsonK , RobinsonJS . Calcium supplementation in pregnancy and its impact on blood pressure in children and women: follow up of a randomised controlled trial. Australian and New Zealand Journal of Obstetrics and Gynaecology2007;47(2):115‐21. ">Crowther 1999</a>, a follow‐up of mothers and offspring was conducted four to seven years later (45% of the original participants) and reported in <a href="./references#CD001059-bbs2-0094" title="HillerJE , CrowtherCA , MooreVA , WillsonK , RobinsonJS . Calcium supplementation in pregnancy and its impact on blood pressure in children and women: follow up of a randomised controlled trial. Australian and New Zealand Journal of Obstetrics and Gynaecology2007;47(2):115‐21. ">Hiller 2007</a>. Childhood blood pressure was reported as a continuous variable. It was concluded that calcium supplementation during pregnancy may lower the mean blood pressure of the children of women with hypertension in pregnancy. We have sought additional unpublished data from the authors which may be available/suitable for inclusion in the next update. </p> <p>A limited follow‐up of mothers and infants from <a href="./references#CD001059-bbs2-0007" title="HabliM , LevineRJ , QianC , SibaiB . Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. American Journal of Obstetrics and Gynecology2007;197(4):406.e1‐406.e7. HattonDC , Harrison‐HohnerJ , CosteS , RellerM , McCarronD . Gestational calcium supplementation and blood pressure in the offspring. American Journal of Hypertension2003;16:801‐5. Levine RJ for the CPEP Study Group. Calcium for preeclampsia prevention (CPEP): a double‐blind, placebo‐controlled trial in healthy nulliparas. American Journal of Obstetrics and Gynecology1997;176:S2. Levine RJ for the CPEP Study Group. The trial of calcium for preeclampsia prevention (CPEP). 8th World Congress on Hypertension in Pregnancy ‐ Protagonists and Presentations; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. LevineRJ , EsterlitzJR , RaymondEG , DerSimonianR , HauthJC , Ben CuretL , et al. Trial of calcium for preeclampsia prevention (CPEP): rationale, design, and methods. Controlled Clinical Trials1996;17:442‐69. LevineRJ , HauthJC , CuretLB , SibaiBM , CatalanoPM , MorrisCD , et al. Trial of calcium to prevent preeclampsia. New England Journal of Medicine1997;337(2):69‐76. NCT00000534 . Calcium for pre‐eclampsia prevention (CPEP). clinicaltrials.gov/ct2/show/record/NCT00000534 (first received 27 October 1999). ">CPEP 1997</a>, found reduced systolic blood pressure at two years of age in the calcium supplementation group (mean 95.4 mmHg, SD 7.6, n = 35 versus 100.2, 7.9, n = 18). We have not included the data in this review because the low and unequal follow‐up rate (35 and 18 from 497 invited to participate) limits the reliability of the results. In another report of <a href="./references#CD001059-bbs2-0007" title="HabliM , LevineRJ , QianC , SibaiB . Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. American Journal of Obstetrics and Gynecology2007;197(4):406.e1‐406.e7. HattonDC , Harrison‐HohnerJ , CosteS , RellerM , McCarronD . Gestational calcium supplementation and blood pressure in the offspring. American Journal of Hypertension2003;16:801‐5. Levine RJ for the CPEP Study Group. Calcium for preeclampsia prevention (CPEP): a double‐blind, placebo‐controlled trial in healthy nulliparas. American Journal of Obstetrics and Gynecology1997;176:S2. Levine RJ for the CPEP Study Group. The trial of calcium for preeclampsia prevention (CPEP). 8th World Congress on Hypertension in Pregnancy ‐ Protagonists and Presentations; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. LevineRJ , EsterlitzJR , RaymondEG , DerSimonianR , HauthJC , Ben CuretL , et al. Trial of calcium for preeclampsia prevention (CPEP): rationale, design, and methods. Controlled Clinical Trials1996;17:442‐69. LevineRJ , HauthJC , CuretLB , SibaiBM , CatalanoPM , MorrisCD , et al. Trial of calcium to prevent preeclampsia. New England Journal of Medicine1997;337(2):69‐76. NCT00000534 . Calcium for pre‐eclampsia prevention (CPEP). clinicaltrials.gov/ct2/show/record/NCT00000534 (first received 27 October 1999). ">CPEP 1997</a> (<a href="./references#CD001059-bbs2-0092" title="HattonDC , Harrison‐HohnerJ , CosteS , RellerM , McCarronD . Gestational calcium supplementation and blood pressure in the offspring. American Journal of Hypertension2003;16:801‐5. ">Hatton 2003</a>), reduced systolic blood pressure was found in the offspring of the calcium supplementation group at two years of age. We have not included these data either because of the high losses to follow‐up. </p> <p>A subsequent report of the Gambian trial (<a href="./references#CD001059-bbs2-0011" title='GoldbergG , YinJ , JarjouL , PrenticeA . Maternal calcium supplementation during pregnancy and blood pressure in rural Gambian children at 3 and 9 years old. Annals of Nutrition &amp; Metabolism2013;63(Suppl 1):728, Abstract no: PO982. GoldbergGR , JarjouLM , ColeTJ , PrenticeA . Randomized, placebo‐controlled, calcium supplementation trial in pregnant Gambian women accustomed to a low calcium intake: effects on maternal blood pressure and infant growth. American Journal of Clinical Nutrition2013;98(4):972‐82. HawkesworthS , SawoY , FulfordAJ , GoldbergGR , JarjouLM , PrenticeA , et al. Effect of maternal calcium supplementation on offspring blood pressure in 5‐ to 10‐y‐old rural Gambian children. American Journal of Clinical Nutrition2010;92(4):741‐7. HawkesworthS , WalkerCG , SawoY , FulfordAJ , JarjouLM , GoldbergGR , et al. Nutritional supplementation during pregnancy and offspring cardiovascular disease risk in The Gambia. American Journal of Clinical Nutrition2011;94(6 Suppl):1853S‐1860S. JarjouLM , LaskeyMA , SawoY , GoldbergGR , ColeTJ , PrenticeA . Effect of calcium supplementation in pregnancy on maternal bone outcomes in women with a low calcium intake. American Journal of Clinical Nutrition2010;92(2):450‐7. JarjouLM , PrenticeA , BennettJ . Impact of calcium supplementation in the preceding pregnancy on the human milk calcium concentration of Gambian women. Advances in Experimental Medicine and Biology2004;54:347‐9. JarjouLM , PrenticeA , SawoY , LaskeyMA , BennettJ , GoldbergGR , et al. Randomized, placebo‐controlled, calcium supplementation study in pregnant Gambian women: effects on breast‐milk calcium concentrations and infant birth weight, growth, and bone mineral accretion in the first year of life. American Journal of Clinical Nutrition2006;83(3):657‐66. JarjouLMA , BennettJ , LaidlawA , GoldbergGR , PrenticeA . Changes in bone turnover and calcitrophic hormones in lactating Gambian women supplemented with calcium during pregnancy. Journal of Human Lactation2007;23(1):86‐7. JarjouLMA , SawoY , GoldbergGR , LaskeyMA , ColeTJ , PrenticeA . Persistent effects of calcium supplementation during pregnancy on maternal bone mineral content: a follow‐up study in Gambian women. Proceedings of the 16th ISRHML Conference "Breastfeeding and the Use of Human Milk. Science and Practice"; 2012 September 27th ‐ October 1st; Trieste, Italy. 2012:Abstract no.:105. JarjouMA , YankubaS , GoldbergR , LaskeyMA , ColeJ , PrenticeA . Unexpected long‐term effects of calcium supplementation in pregnancy on maternal bone outcomes in women with a low calcium intake: a follow‐up study. American Journal of Clinical Nutrition2013;98(3):723‐30. PrenticeA , GoldbergGR , JarjouLMA . The effects of pregnancy calcium supplementation on calcium metabolism after lactation in Gambian women with a low calcium intake. Breastfeeding Medicine2016;11(2):A‐20‐A‐21, Abstract no: P‐8. PrenticeA , ISRCTN72582014 . Effects on birth weight and perinatal mortality of maternal dietary supplements in rural Gambia: 5 year randomised controlled trial. isrctn.com/ISRCTN72582014 (first received 27 March 2013). PrenticeA , ISRCTN96502494 . Calcium requirements of pregnant women in The Gambia. isrctn.com/ISRCTN96502494 (first received 6 November 2007). PrenticeA , JarjouLM , GoldbergGR , BennettJ , ColeTJ , SchoenmakersI . Maternal plasma 25‐hydroxyvitamin D concentration and birthweight, growth and bone mineral accretion of Gambian infants. Acta Paediatrica2009;98(8):1360‐2. WardKA , JarjouL , PrenticeA . Maternal calcium supplementation and offspring growth. Osteoporosis International2016;27(1 Suppl 1):S327‐8. WardKA , PrenticeA , JarjouL . Long‐term effects of maternal calcium supplementation on childhood growth differ between males and females in a population accustomed to a low calcium intake. Bone2017;103:31‐8. '>Jarjou 2004</a>) found no significant difference in systolic blood pressure in 64% of the original trial offspring at between five and 10 years of age. This analysis was restricted to children born at term and the relevant data were not available for our meta‐analysis. </p> </section> <section id="CD001059-sec-0118"> <h5 class="title">(18) Childhood diastolic blood pressure &gt; 95th percentile</h5> <p>Data were available only from one study (<a href="./references#CD001059-bbs2-0005" title="BelizanJM . Prevention of hypertensive disorders of pregnancy with calcium supplementation. 8th World Congress on Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires. 1992:93. BelizanJM , VillarJ , BergelE , delPinoA , DiFulvioS , GallianoSV , et al. Long term effect of calcium supplementation during pregnancy on the blood pressure of offspring: follow up of a randomised controlled trial. BMJ1997;315:281‐5. BelizanJM , VillarJ , GonzalezL , CampodonicoL , BergelE . Calcium supplementation to prevent hypertensive disorders of pregnancy. New England Journal of Medicine1991;325:1399‐405. BergelE , GibbonsL , RasinesMG , LuetichA , BelizanJM . Maternal calcium supplementation during pregnancy and dental caries of children at 12 years of age: follow‐up of a randomized controlled trial. Acta Obstetricia et Gynecologica Scandinavica2010;89(11):1396‐402. StephensIF . Effect of calcium supplementation during pregnancy on blood pressure of offspring. Authors cannot be sure of effect's generalisability to all children aged 5‐9 [letter; comment]. BMJ1998;316(7126):234. VillarJ , BelizanJM , RepkeJ . The effect of calcium supplementation on the incidence of hypertensive disorders of pregnancy and prematurity. 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy. 1990:54. VillarJ , BelizanJM , RepkeJT . Does calcium supplementation reduce pregnancy‐induced hypertension and prematurity?. Proceedings of the International Symposium on advances in the prevention of low birthweight; 1988 May 8‐11; Cape Cod, Massachusetts. 1988:187‐95. ">Belizan 1991</a>). There was no difference between groups (<a href="./references#CD001059-fig-0030" title="">Analysis 1.18</a>). </p> </section> <section id="CD001059-sec-0119"> <h5 class="title">(19) Dental caries in childhood</h5> <p>In one study (<a href="./references#CD001059-bbs2-0005" title="BelizanJM . Prevention of hypertensive disorders of pregnancy with calcium supplementation. 8th World Congress on Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires. 1992:93. BelizanJM , VillarJ , BergelE , delPinoA , DiFulvioS , GallianoSV , et al. Long term effect of calcium supplementation during pregnancy on the blood pressure of offspring: follow up of a randomised controlled trial. BMJ1997;315:281‐5. BelizanJM , VillarJ , GonzalezL , CampodonicoL , BergelE . Calcium supplementation to prevent hypertensive disorders of pregnancy. New England Journal of Medicine1991;325:1399‐405. BergelE , GibbonsL , RasinesMG , LuetichA , BelizanJM . Maternal calcium supplementation during pregnancy and dental caries of children at 12 years of age: follow‐up of a randomized controlled trial. Acta Obstetricia et Gynecologica Scandinavica2010;89(11):1396‐402. StephensIF . Effect of calcium supplementation during pregnancy on blood pressure of offspring. Authors cannot be sure of effect's generalisability to all children aged 5‐9 [letter; comment]. BMJ1998;316(7126):234. VillarJ , BelizanJM , RepkeJ . The effect of calcium supplementation on the incidence of hypertensive disorders of pregnancy and prematurity. 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy. 1990:54. VillarJ , BelizanJM , RepkeJT . Does calcium supplementation reduce pregnancy‐induced hypertension and prematurity?. Proceedings of the International Symposium on advances in the prevention of low birthweight; 1988 May 8‐11; Cape Cod, Massachusetts. 1988:187‐95. ">Belizan 1991</a>), dental caries was assessed at 12 years of age in a subset of those enrolled. It is was not specified how this subset was randomly selected. As this was a post hoc outcome for this review, the data should be interpreted with caution. The study found a significant reduction in dental caries, defined as at least one decayed, filled or missing tooth (one trial, 195 children: RR 0.73, 95% CI 0.62 to 0.87; <a href="./references#CD001059-fig-0031" title="">Analysis 1.19</a>). </p> <p><b>(20) Non‐prespecified outcomes (comparison 5)</b> </p> <p>Sub‐studies of <a href="./references#CD001059-bbs2-0027" title="AbalosE , MerialdiM , WojdylaD , CarroliG , CampodónicoL , YaoSE , et al. Effects of calcium supplementation on fetal growth in mothers with deficient calcium intake: a randomised controlled trial. Paediatric and Perinatal Epidemiology2010;24(1):53‐62. Abdel‐AleemH , MerialdiM , ElsnosyED , ElsedfyGO , Abdel‐AleemMA , VillarJ . The effect of calcium supplementation during pregnancy on fetal and infant growth: a nested randomized controlled trial within WHO calcium supplementation trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2009;22(2):94‐100. CarroliG , MerialdiM , WojdylaD , AbalosE , CampodonicoL , YaoSE , et al. Effects of calcium supplementation on uteroplacental and fetoplacental blood flow in low‐calcium‐intake mothers: a randomized controlled trial. American Journal of Obstetrics and Gynecology2010;202(1):45.e1‐45.e9. HofmeyrGJ , MlokotiZ , NikodemVC , MangesiL , FerreiraS , SingataM , et al. Calcium supplementation during pregnancy for preventing hypertensive disorders is not associated with changes in platelet count, urate, and urinary protein: a randomized control trial. Hypertension in Pregnancy2008;27(3):299‐304. VillarJ , Abdel‐AleemH , MerialdiM , MathaiM , AliM , ZavaletaN , et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. American Journal of Obstetrics and Gynecology2006;194:639‐49. VillarJ , AleemHA , MerialdiM , MathaiM , AliM , ZavaletaN , et al. WHO randomized trial of calcium supplementation among low calcium intake pregnant women [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S2. VillarJ , ISRCTN37214165 . Calcium supplementation during pregnancy in low‐intake populations. isrctn.com/ISRCTN37214165 (first received 19 March 2014). ZhangJ , VillarJ , SunW , MerialdiM , Abdel‐AleemH , MathaiM , et al. Blood pressure dynamics during pregnancy and spontaneous preterm birth. American Journal of Obstetrics and Gynecology2007;197(2):162.e1‐6. ">WHO 2006</a> found no effect of calcium supplementation on uterine or umbilical artery resistance index or ultrasound estimates of fetal growth at 32 weeks; or platelet count, uric acid or urine protein/creatinine ratio at 35 weeks. </p> </section> <section id="CD001059-sec-0120"> <h5 class="title">Sensitivity analysis</h5> <p>One study contributing data to this analysis was assessed to be at high risk of attrition bias (<a href="./references#CD001059-bbs2-0015" title="Lopez‐JaramilloP , NarvaezM , WeigelRM , YepezR . Calcium supplementation reduces the risk of pregnancy‐induced hypertension in an Andes population. British Journal of Obstetrics and Gynaecology1989;96:648‐55. Lopez‐JaramilloP , NarvaezM , YepezR . Effect of calcium supplementation on the vascular sensitivity to angiotensin II in pregnant women. American Journal of Obstetrics and Gynecology1987;156:261‐2. NarvaezM , Lopez‐JaramilloP , WeigelM . Calcium (Ca++) supplementation reduces the risk for pregnancy induced hypertension (PIH). World Congress of Gynecology and Obstetrics; 1988 October 23‐28; Brazil. 1988:180‐1. ">L‐Jaramillo 1989</a>). Removing these study data from the analyses for high blood pressure (with or without proteinuria) (<a href="./references#CD001059-fig-0013" title="">Analysis 1.1</a>; <a href="./references#CD001059-fig-0032" title="">Analysis 2.1</a>; <a href="./references#CD001059-fig-0037" title="">Analysis 3.1</a>); pre‐eclampsia (<a href="./references#CD001059-fig-0014" title="">Analysis 1.2</a>; <a href="./references#CD001059-fig-0033" title="">Analysis 2.2</a>; <a href="./references#CD001059-fig-0038" title="">Analysis 3.2</a>; <a href="./references#CD001059-fig-0042" title="">Analysis 4.1</a>); stillbirth or death before discharge from hospital (<a href="./references#CD001059-fig-0017" title="">Analysis 1.5</a>; <a href="./references#CD001059-fig-0036" title="">Analysis 2.5</a>; <a href="./references#CD001059-fig-0041" title="">Analysis 3.5</a>); and low birthweight (<a href="./references#CD001059-fig-0027" title="">Analysis 1.15</a>) made little or no difference to the overall effect estimates. </p> </section> </section> <section id="CD001059-sec-0121"> <h4 class="title">Low‐dose calcium supplementation with or without cointerventions, versus no calcium supplementation </h4> <p>We included nine studies with 2234 participants. The risk of bias was variable, and studies included those with and without co‐interventions. </p> <p>Data were not available for the following secondary outcomes: maternal death or serious morbidity; proteinuria; HELLP syndrome; intensive care unit admission; mother's hospital stay seven days or more: neonate in intensive care unit seven days or more; death or severe neonatal morbidity; childhood disability; systolic blood pressure greater than 95th percentile during childhood; diastolic blood pressure greater than 95th percentile during childhood; dental caries in childhood. </p> </section> <section id="CD001059-sec-0122"> <h4 class="title">Primary outcomes</h4> <section id="CD001059-sec-0123"> <h5 class="title">(1) High blood pressure with or without proteinuria</h5> <p>Calcium supplementation was associated with a reduction in high blood pressure in five studies (665 women, RR 0.53, 95% CI 0.38 to 0.74; heterogeneity: Chi² = 2.55, df = 4 (P = 0.64); I² = 0%; test for subgroup differences: Chi² = 2.11, df = 2 (P = 0.35), I² = 5.2%; <a href="./references#CD001059-fig-0051" title="">Analysis 6.1</a>), including three studies of calcium supplementation alone (558 women, RR 0.57, 95% CI 0.39 to 0.82) and one of calcium plus linoleic acid (48 women, RR 0.20, 95% CI 0.05 to 0.82). </p> </section> <section id="CD001059-sec-0124"> <h5 class="title">(2) Pre‐eclampsia</h5> <p>Pre‐eclampsia was reduced with low‐dose calcium supplementation (nine studies, 2234 women, RR 0.38, 95% CI 0.28 to 0.52; I² = 0%; <a href="./references#CD001059-fig-0052" title="">Analysis 6.2</a>). The reduction was also consistent across the following subgroups: calcium alone (four studies, 980 women, RR 0.36, 95% CI 0.23 to 0.57); calcium plus linoleic acid (two studies, 134 women, RR 0.23, 95% CI 0.09 to 0.60); calcium plus vitamin D, (two studies, 1060 women: RR 0.49, 95% CI 0.31 to 0.78; 1060 women; I² = 17%) and in one trial of calcium plus antioxidants with low risk of bias (60 women, RR 0.24, 95% CI 0.06 to 1.01). Test for subgroup differences: Chi² = 2.55, df = 3 (P = 0.47), I² = 0%. </p> </section> <section id="CD001059-sec-0125"> <h5 class="title">(3) Preterm birth</h5> <p>Overall, there was little or no effect on preterm birth for calcium with other supplements (six studies, 1290 women: average RR 0.83, 95% CI 0.34 to 2.03; I² = 64%; <a href="./references#CD001059-fig-0053" title="">Analysis 6.3</a>). Preterm birth was reduced in the experimental arm of one study of calcium supplementation alone (422 women, average RR 0.40, 95% CI 0.21 to 0.75; <a href="./references#CD001059-fig-0053" title="">Analysis 6.3</a>), but as it was not reported in the other three studies of calcium supplementation alone, the possibility of publication bias needs to be considered. For calcium plus vitamin D, the risk of preterm birth seemed to be increased with supplements (three studies, 760 women: RR 1.59, 95% CI 1.03 to 2.45; I² = 0%; <a href="./references#CD001059-fig-0053" title="">Analysis 6.3</a>). </p> </section> <section id="CD001059-sec-0126"> <h5 class="title">(4) Admission to neonatal intensive care unit (ICU)</h5> <p>Admission to neonatal ICU was reported in only one trial of calcium supplementation alone, so the reduction in the calcium group may be due to publication bias (422 women: RR 0.44; 95% CI 0.20 to 0.99; <a href="./references#CD001059-fig-0054" title="">Analysis 6.4</a>). </p> </section> <section id="CD001059-sec-0127"> <h5 class="title">(5) Stillbirth or death before discharge from hospital</h5> <p>There was no overall effect on the RR of a stillbirth or the baby dying before discharge from hospital (five trials, 1025 women: RR 0.48, 95% CI 0.14 to 1.67; heterogeneity: Chi² = 0.99, df = 4 (P = 0.91); I² = 0%; <a href="./references#CD001059-fig-0055" title="">Analysis 6.5</a>). </p> </section> </section> <section id="CD001059-sec-0128"> <h4 class="title">Secondary outcomes</h4> <section id="CD001059-sec-0129"> <h5 class="title">(6) Placental abruption</h5> <p>Three studies reported this outcome and the event rates were too small for meaningful analysis (160 participants: RR 1.00, 95% CI 0.14 to 6.90; <a href="./references#CD001059-fig-0056" title="">Analysis 6.6</a>). </p> </section> <section id="CD001059-sec-0130"> <h5 class="title">(7) Caesarean section</h5> <p>Caesarean section was reduced in two studies of calcium plus linoleic acid (134 women: average RR 0.55; 95% CI 0.35 to 0.87; heterogeneity: Tau² = 0.00; Chi² = 0.03, df = 1 (P = 0.86); I² = 0%), but not overall (four studies, 521 women, average RR 0.73; 95% CI 0.46 to 1.15; heterogeneity: Tau² = 0.13; Chi² = 7.48, df = 3 (P = 0.06); I² = 60%); <a href="./references#CD001059-fig-0057" title="">Analysis 6.7</a>. </p> </section> <section id="CD001059-sec-0131"> <h5 class="title">(8) Severe pre‐eclampsia</h5> <p>Four trials reported severe pre‐eclampsia and there was no clear difference between the groups (246 participants: RR 0.40, 95% CI 0.14 to 1.15; I<sup>2</sup> = 0%; <a href="./references#CD001059-fig-0058" title="">Analysis 6.8</a>). </p> </section> <section id="CD001059-sec-0132"> <h5 class="title">(9) Eclampsia</h5> <p>One trial of calcium supplementation alone reported eclampsia. There was no clear difference between the groups (168 women: RR 0.17, 95% CI 0.01 to 4.06; <a href="./references#CD001059-fig-0059" title="">Analysis 6.9</a>). </p> </section> <section id="CD001059-sec-0133"> <h5 class="title">(10) Miscarriage (non‐prespecified)</h5> <p>An unexpected finding in one small trial of calcium plus antioxidants, commencing at eight to 12 weeks of pregnancy, was a reduction in miscarriage in the calcium plus antioxidant group (60 women: RR 0.06, 95% CI 0.00 to 1.04; <a href="./references#CD001059-fig-0060" title="">Analysis 6.10</a>). </p> </section> <section id="CD001059-sec-0134"> <h5 class="title">(11) Low birthweight (birthweight less than 2500 g)</h5> <p>The risk of having a baby with birthweight less than 2500 g was reduced with calcium supplementation plus linoleic acid (two studies, 134 women: RR 0.20, 95% CI 0.05 to 0.88; heterogeneity: Chi² = 0.00, df = 1 (P = 1.00); I² = 0%; <a href="./references#CD001059-fig-0061" title="">Analysis 6.11</a>). </p> </section> <section id="CD001059-sec-0135"> <h5 class="title">(12) Neonate small‐for‐gestational age</h5> <p>There was no overall effect on the risk of the baby being born small‐for‐gestational age (four trials, 854 women: RR 0.81, 95% CI 0.54 to 1.21; heterogeneity: Chi² = 2.06, df = 3 (P = 0.56); I² = 0%; <a href="./references#CD001059-fig-0062" title="">Analysis 6.12</a>). </p> </section> <section id="CD001059-sec-0136"> <h5 class="title">Sensitivity analysis</h5> <p>We had planned to exclude studies assessed to have inadequate allocation concealment or high risk of attrition bias, or both. However, five studies either did not conceal allocation (<a href="./references#CD001059-bbs2-0018" title="MaryaRK , RatheeS , ManrowM . Effect of calcium and vitamin D supplementation on toxaemia of pregnancy. Gynecologic and Obstetric Investigation1987;24:38‐42. ">Marya 1987</a>), had high levels of attrition (<a href="./references#CD001059-bbs2-0002" title="AsemiZ , IRCT201212105623N3 . Comparison of effectiveness of multivitamin, multivitamin‐mineral supplements, probiotic and normal Gaz on pregnancy outcomes in pregnant women. en.search.irct.ir/view/11730 (first received 26 December 2012). AsemiZ , TabassiZ , HeidarzadehZ , KhorammianH , SabihiSS , SamimiM . Effect of calcium‐vitamin D supplementation on metabolic profiles in pregnant women at risk for pre‐eclampsia: a randomized placebo‐controlled trial. Pakistan Journal of Biological Sciences2012;15(7):316‐24. ">Asemi 2012</a>; <a href="./references#CD001059-bbs2-0003" title="AsemiZ , SamimiM , SiavashaniMA , MazloomiM , TabassiZ , KaramaliM , et al. Calcium‐vitamin D co‐supplementation affects metabolic profiles, but not pregnancy outcomes, in healthy pregnant women. International Journal of Preventive Medicine2016;7:49. ">Asemi 2016</a>; <a href="./references#CD001059-bbs2-0004" title="BassawB , RoopnarinesinghS , RoopnarinesinghA , HomerH . Prevention of hypertensive disorders of pregnancy. Journal of Obstetrics and Gynaecology1998;18(2):123‐6. ">Bassaw 1998</a>), or both (<a href="./references#CD001059-bbs2-0021" title="RogersMS , FungHYM , HungCY . Calcium and low‐dose aspirin prophylaxis in women at high risk of pregnancy‐induced hypertension. Hypertension in Pregnancy1999;18(2):165‐72. ">Rogers 1999</a>) and we did not feel that removing these would result in a meaningful analysis. If further studies are added in future updates we will perform the sensitivity analysis. </p> </section> </section> <section id="CD001059-sec-0137"> <h4 class="title">High‐dose (=/&gt; 1 g) versus low‐dose (&lt; 1 g) calcium supplements (one trial with 262 women) </h4> <p>Only a single trial with 262 women is included in this dose comparison and results were reported for only four of our prespecified outcomes. The risk of <b>pre‐eclampsia</b> appeared to be reduced in the high‐dose group compared to the low‐dose group (RR 0.42, 95% CI 0.18 to 0.96; <a href="./references#CD001059-fig-0063" title="">Analysis 7.1</a>); for other outcomes, although results were in the same direction, there was insufficient evidence to demonstrate any clear difference between groups (<b>preterm birth</b>: RR 0.31, 95% CI 0.09 to 1.08, <a href="./references#CD001059-fig-0064" title="">Analysis 7.2</a>; <b>eclampsia</b>: RR 0.32, 95% CI 0.07 to 1.53, <a href="./references#CD001059-fig-0065" title="">Analysis 7.3</a>; <b>stillbirth</b>: RR 0.48, 95% CI 0.13 to 1.83, <a href="./references#CD001059-fig-0066" title="">Analysis 7.4</a>). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD001059-sec-0138" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD001059-sec-0138"></div> <section id="CD001059-sec-0139"> <h3 class="title" id="CD001059-sec-0139">Summary of main results</h3> <section id="CD001059-sec-0140"> <h4 class="title">High‐dose calcium supplementation</h4> <p>Our meta‐analysis showed that calcium supplementation with at least 1 g of calcium approximately halved the risk of pre‐eclampsia compared to placebo, with the confidence intervals estimating the true effect to be a risk reduction of between 35% and 69%. Women with an adequate dietary intake of calcium were the only subgroup where the confidence interval crossed the line of no effect. Nevertheless, the point estimate for this subgroup of women was a 38% risk reduction. The greatest risk reduction was for women at high risk of pre‐eclampsia (variably defined; 78% reduction). The meta‐analysis may be an over‐estimate, as funnel plot asymmetry suggested a small‐study effect or publication bias. In the largest study, the 8% reduction in pre‐eclampsia had a confidence interval that crossed the line of no effect. </p> <p>There was also a 35% reduction in the risk of gestational hypertension, with the greatest effect also amongst women with low calcium diets. These data should be interpreted with caution because of the possibility of small‐study effects or publication bias. </p> <p>The risk of having the composite outcome 'maternal death or severe morbidity' was reduced by 20% with calcium supplementation and there was a 24% reduction in the risk of preterm birth. </p> <p>The risk of haemolysis, elevated liver enzymes and low platelets (HELLP) syndrome was increased; however the absolute number of events was low (2.5/1000 versus 0.9/1000). There were no clear effects on other relevant outcomes at discharge from hospital. There were no clear differences between calcium supplementation and placebo for any other outcomes, although for several outcomes the confidence intervals approach statistical significance, e.g. for caesarean section a small (5%) reduction in risk associated with calcium supplementation is possible. For stillbirth and death before discharge from hospital, the point estimate is for a reduction of 10%, although no effect or a small increase in risk has not been excluded. </p> </section> <section id="CD001059-sec-0141"> <h4 class="title">Low‐dose calcium supplementation</h4> <p>The results with low‐dose calcium supplementation alone are similar to those of the smaller studies with high‐dose supplementation, showing a reduction in pre‐eclampsia of about 60% which was consistent between studies with low and high risk of bias. High blood pressure with or without proteinuria was reduced by about 50%. Results for calcium plus other interventions were similar to those for calcium alone, but the possibility that the cointerventions contributed to the effect on pre‐eclampsia needs to be considered. For antioxidants, this is unlikely as antioxidants have not been found to reduce the risk of pre‐eclampsia (<a href="./references#CD001059-bbs2-0113" title="RumboldA , DuleyL , CrowtherCA , HaslamRR . Antioxidants for preventing pre‐eclampsia. Cochrane Database of Systematic Reviews2008, Issue 1. [DOI: 10.1002/14651858.CD004227.pub3] ">Rumbold 2008</a>). For vitamin D there is as yet inadequate evidence regarding its effect on pre‐eclampsia (<a href="./references#CD001059-bbs2-0087" title="De‐RegilLM , PalaciosC , AnsaryA , KulierR , Peña‐RosasJP . Vitamin D supplementation for women during pregnancy. Cochrane Database of Systematic Reviews2012, Issue 2. [DOI: 10.1002/14651858.CD008873.pub2] ">De‐Regil 2012</a>); for linoleic acid there is also insufficient evidence. There were no other differences, other than a reduction in neonatal intensive care admission and low birthweight in the low‐dose calcium supplementation groups. These outcomes were reported only by one or two studies, suggesting reporting bias. </p> </section> <section id="CD001059-sec-0142"> <h4 class="title">High‐dose versus low‐dose calcium supplementation</h4> <p>One small study, which had limitations, found a reduction in pre‐eclampsia with 2 g calcium daily versus 500 mg daily. </p> </section> </section> <section id="CD001059-sec-0143"> <h3 class="title" id="CD001059-sec-0143">Overall completeness and applicability of evidence</h3> <p>We consider the evidence in favour of high‐dose calcium supplementation with respect to reducing the risk of pre‐eclampsia to be complete, particularly in women with low calcium diets and those at high risk. Although there were not individually significant reductions in the risk of death, severe pre‐eclampsia, eclampsia, or admission to intensive care, the point estimates for these outcomes favoured calcium supplementation, and so moderate reductions in these outcomes remain possible. The compound outcome death or severe morbidity was significantly reduced by 20%. </p> <p>Few side effects were recorded in the included trials. In two trials, the risk of HELLP syndrome was increased with calcium supplementation. A possible explanation for this apparently anomalous finding is that calcium supplementation in the second half of pregnancy may only reduce blood pressure rather than the underlying pre‐eclamptic process. Lower blood pressures in the calcium group may have reduced the diagnosis of pre‐eclampsia and, thus, medical interventions to curtail pregnancy, allowing more time for the pre‐eclampsia to progress to HELLP syndrome (<a href="./references#CD001059-bbs2-0096" title="HofmeyrG , DuleyL , AtallahA . Dietary calcium supplementation for prevention of pre‐eclampsia and related problems: a systematic review and commentary. BJOG: an international journal of obstetrics and gynaecology2007;114(8):933‐43. ">Hofmeyr 2007</a>). </p> <p>There remains little information about the long‐term follow‐up of children exposed to calcium in utero. One study evaluated childhood systolic hypertension and dental caries. The risk of both of these outcomes was significantly reduced, however, the latter effect was observed in a small subset of the children and the study was not originally designed to assess this outcome. These effects therefore need corroboration. </p> <p>There is no information about any possible changes in the use of healthcare resources associated with calcium supplementation. It would seem plausible that a reduction in gestational hypertension and pre‐eclampsia might lead to fewer antenatal visits, less antepartum hospital admissions and fewer inductions of labour. However, the included trials do not provide data on these outcomes. </p> <p>This 2018 update has included data from trials using less than 1 g calcium daily (mostly 500 mg to 600 mg). Over half of these studies were at high risk of bias and combined calcium with other supplements. However, the evidence seems to indicate that lower doses of calcium may be effective in reducing hypertensive disorders of pregnancy. The results of the low‐dose studies is therefore incomplete and need corroboration by larger high‐quality studies. </p> </section> <section id="CD001059-sec-0144"> <h3 class="title" id="CD001059-sec-0144">Quality of the evidence</h3> <p>We consider the evidence for the effect of high‐dose calcium supplementation on pre‐eclampsia and preterm birth to be low, due to heterogeneity and small study effects. We deemed the evidence for HELLP syndrome to be of high quality (see <a href="./full#CD001059-tbl-0001">summary of findings Table for the main comparison</a>). The quality of evidence for the large studies subgroup was also high. </p> <p>In general, heterogeneity of findings seemed to be largely associated with study size, with the small studies having the most positive results (see <a href="#CD001059-fig-0004">Figure 4</a> to <a href="#CD001059-fig-0012">Figure 12</a>). These small‐study effects may indicate publication bias or other biases, or be caused by differences between small and large studies. As the small studies tended to recruit high‐risk women, at least some of the heterogeneity may be explained by calcium having a greater effect for high‐risk women. These data on heterogeneity related to sample size should be interpreted with caution however, as the sensitivity analysis was post‐hoc, and the cut‐off point for sample size (400) was arbitrary. </p> </section> <section id="CD001059-sec-0145"> <h3 class="title" id="CD001059-sec-0145">Potential biases in the review process</h3> <p>We sought to minimise potential biases in the review process by having clearly‐defined criteria for inclusion of studies, and by excluding members of the review team from decisions regarding studies in which they were involved. Post hoc inclusions are clearly identified, and acknowledged as a potential source of bias. </p> </section> <section id="CD001059-sec-0146"> <h3 class="title" id="CD001059-sec-0146">Agreements and disagreements with other studies or reviews</h3> <p>This evidence of a modest risk reduction in gestational hypertension and 'maternal deaths and serious morbidity' contrasts with the large epidemiological differences previously identified between populations with adequate and low dietary calcium intake (<a href="./references#CD001059-bbs2-0077" title="BelizanJM , VillarJ . The relationship between calcium intake and edema, proteinuria, and hypertension‐gestosis: an hypothesis. American Journal of Clinical Nutrition1980;33:2202‐10. ">Belizan 1980</a>; <a href="./references#CD001059-bbs2-0090" title="HamlinRHJ . The prevention of eclampsia and pre‐eclampsia. Lancet1952;i:64‐8. ">Hamlin 1952</a>; <a href="./references#CD001059-bbs2-0091" title="HamlinRHJ . Prevention of pre‐eclampsia. Lancet1962;1:864‐5. ">Hamlin 1962</a>). Possible explanations include the following. </p> <p> <ol id="CD001059-list-0018"> <li> <p>Dietary calcium may be a marker for other aetiological factors.</p> </li> <li> <p>Starting supplementation in the middle trimester of pregnancy may be too late to be fully effective. </p> </li> </ol> </p> <p>The finding of reduced childhood hypertension needs replication but, if corroborated, has far‐reaching implications for public health. Although based on only a partial follow‐up in one study (<a href="./references#CD001059-bbs2-0005" title="BelizanJM . Prevention of hypertensive disorders of pregnancy with calcium supplementation. 8th World Congress on Hypertension in Pregnancy; 1992 November 8‐12; Buenos Aires. 1992:93. BelizanJM , VillarJ , BergelE , delPinoA , DiFulvioS , GallianoSV , et al. Long term effect of calcium supplementation during pregnancy on the blood pressure of offspring: follow up of a randomised controlled trial. BMJ1997;315:281‐5. BelizanJM , VillarJ , GonzalezL , CampodonicoL , BergelE . Calcium supplementation to prevent hypertensive disorders of pregnancy. New England Journal of Medicine1991;325:1399‐405. BergelE , GibbonsL , RasinesMG , LuetichA , BelizanJM . Maternal calcium supplementation during pregnancy and dental caries of children at 12 years of age: follow‐up of a randomized controlled trial. Acta Obstetricia et Gynecologica Scandinavica2010;89(11):1396‐402. StephensIF . Effect of calcium supplementation during pregnancy on blood pressure of offspring. Authors cannot be sure of effect's generalisability to all children aged 5‐9 [letter; comment]. BMJ1998;316(7126):234. VillarJ , BelizanJM , RepkeJ . The effect of calcium supplementation on the incidence of hypertensive disorders of pregnancy and prematurity. 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy. 1990:54. VillarJ , BelizanJM , RepkeJT . Does calcium supplementation reduce pregnancy‐induced hypertension and prematurity?. Proceedings of the International Symposium on advances in the prevention of low birthweight; 1988 May 8‐11; Cape Cod, Massachusetts. 1988:187‐95. ">Belizan 1991</a>), this finding is supported by a very limited follow‐up in two other studies (<a href="./references#CD001059-bbs2-0007" title="HabliM , LevineRJ , QianC , SibaiB . Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. American Journal of Obstetrics and Gynecology2007;197(4):406.e1‐406.e7. HattonDC , Harrison‐HohnerJ , CosteS , RellerM , McCarronD . Gestational calcium supplementation and blood pressure in the offspring. American Journal of Hypertension2003;16:801‐5. Levine RJ for the CPEP Study Group. Calcium for preeclampsia prevention (CPEP): a double‐blind, placebo‐controlled trial in healthy nulliparas. American Journal of Obstetrics and Gynecology1997;176:S2. Levine RJ for the CPEP Study Group. The trial of calcium for preeclampsia prevention (CPEP). 8th World Congress on Hypertension in Pregnancy ‐ Protagonists and Presentations; 1992 November 8‐12; Buenos Aires, Argentina. 1992:94. LevineRJ , EsterlitzJR , RaymondEG , DerSimonianR , HauthJC , Ben CuretL , et al. Trial of calcium for preeclampsia prevention (CPEP): rationale, design, and methods. Controlled Clinical Trials1996;17:442‐69. LevineRJ , HauthJC , CuretLB , SibaiBM , CatalanoPM , MorrisCD , et al. Trial of calcium to prevent preeclampsia. New England Journal of Medicine1997;337(2):69‐76. NCT00000534 . Calcium for pre‐eclampsia prevention (CPEP). clinicaltrials.gov/ct2/show/record/NCT00000534 (first received 27 October 1999). ">CPEP 1997</a>; <a href="./references#CD001059-bbs2-0008" title="CrowtherC , HillerJ , PridmoreB , BryceR , DugganP , HagueW , et al. Calcium supplementation in nulliparous women for the prevention of pregnancy included hypertension, pre‐eclampsia and preterm birth: an Australian randomised trial. 2nd Annual Congress of the Perinatal Society of Australia &amp; New Zealand; 1998 March 30‐April 4; Alice Springs, Australia. 1998:101. CrowtherCA , HillerJE , PridmoreB , BryceR , DugganP , HagueWM , et al. Calcium supplementation in nulliparous women for the prevention of pregnancy‐induced hypertension, preeclampsia and preterm birth: an Australian randomized trial. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(1):12‐8. HillerJE , CrowtherCA , MooreVA , WillsonK , RobinsonJS . Calcium supplementation in pregnancy and its impact on blood pressure in children and women: follow up of a randomised controlled trial. Australian and New Zealand Journal of Obstetrics and Gynaecology2007;47(2):115‐21. ">Crowther 1999</a>), as well as observational (<a href="./references#CD001059-bbs2-0107" title="McGarveyST , ZinnerSH , WillettWC , RosnerB . Maternal prenatal dietary potassium, calcium, magnesium and infant blood pressure. Hypertension1991;17:218‐24. ">McGarvey 1991</a>), and animal (<a href="./references#CD001059-bbs2-0080" title="BergelE , BelizanJM . A deficient maternal calcium intake during pregnancy increases blood pressure of the offspring in adult rats. BJOG: an international journal of obstetrics and gynaecology2002;109:540‐5. ">Bergel 2002</a>) studies. </p> <p>There are concerns regarding possible adverse effects of calcium supplementation, which may be dose‐related. Long‐term calcium use in later life has been associated with myocardial infarction, however the association may not be causal (<a href="./references#CD001059-bbs2-0106" title="LiK , KaaksR , LinseisenJ , RohrmannS . Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPIC‐Heidelberg). Heart2012;98(12):920‐5. ">Li 2012</a>). In addition, in a 2010 publication of the Gambia study in which women received calcium supplementation of 1.5 g during pregnancy (<a href="./references#CD001059-bbs2-0011" title='GoldbergG , YinJ , JarjouL , PrenticeA . Maternal calcium supplementation during pregnancy and blood pressure in rural Gambian children at 3 and 9 years old. Annals of Nutrition &amp; Metabolism2013;63(Suppl 1):728, Abstract no: PO982. GoldbergGR , JarjouLM , ColeTJ , PrenticeA . Randomized, placebo‐controlled, calcium supplementation trial in pregnant Gambian women accustomed to a low calcium intake: effects on maternal blood pressure and infant growth. American Journal of Clinical Nutrition2013;98(4):972‐82. HawkesworthS , SawoY , FulfordAJ , GoldbergGR , JarjouLM , PrenticeA , et al. Effect of maternal calcium supplementation on offspring blood pressure in 5‐ to 10‐y‐old rural Gambian children. American Journal of Clinical Nutrition2010;92(4):741‐7. HawkesworthS , WalkerCG , SawoY , FulfordAJ , JarjouLM , GoldbergGR , et al. Nutritional supplementation during pregnancy and offspring cardiovascular disease risk in The Gambia. American Journal of Clinical Nutrition2011;94(6 Suppl):1853S‐1860S. JarjouLM , LaskeyMA , SawoY , GoldbergGR , ColeTJ , PrenticeA . Effect of calcium supplementation in pregnancy on maternal bone outcomes in women with a low calcium intake. American Journal of Clinical Nutrition2010;92(2):450‐7. JarjouLM , PrenticeA , BennettJ . Impact of calcium supplementation in the preceding pregnancy on the human milk calcium concentration of Gambian women. Advances in Experimental Medicine and Biology2004;54:347‐9. JarjouLM , PrenticeA , SawoY , LaskeyMA , BennettJ , GoldbergGR , et al. Randomized, placebo‐controlled, calcium supplementation study in pregnant Gambian women: effects on breast‐milk calcium concentrations and infant birth weight, growth, and bone mineral accretion in the first year of life. American Journal of Clinical Nutrition2006;83(3):657‐66. JarjouLMA , BennettJ , LaidlawA , GoldbergGR , PrenticeA . Changes in bone turnover and calcitrophic hormones in lactating Gambian women supplemented with calcium during pregnancy. Journal of Human Lactation2007;23(1):86‐7. JarjouLMA , SawoY , GoldbergGR , LaskeyMA , ColeTJ , PrenticeA . Persistent effects of calcium supplementation during pregnancy on maternal bone mineral content: a follow‐up study in Gambian women. Proceedings of the 16th ISRHML Conference "Breastfeeding and the Use of Human Milk. Science and Practice"; 2012 September 27th ‐ October 1st; Trieste, Italy. 2012:Abstract no.:105. JarjouMA , YankubaS , GoldbergR , LaskeyMA , ColeJ , PrenticeA . Unexpected long‐term effects of calcium supplementation in pregnancy on maternal bone outcomes in women with a low calcium intake: a follow‐up study. American Journal of Clinical Nutrition2013;98(3):723‐30. PrenticeA , GoldbergGR , JarjouLMA . The effects of pregnancy calcium supplementation on calcium metabolism after lactation in Gambian women with a low calcium intake. Breastfeeding Medicine2016;11(2):A‐20‐A‐21, Abstract no: P‐8. PrenticeA , ISRCTN72582014 . Effects on birth weight and perinatal mortality of maternal dietary supplements in rural Gambia: 5 year randomised controlled trial. isrctn.com/ISRCTN72582014 (first received 27 March 2013). PrenticeA , ISRCTN96502494 . Calcium requirements of pregnant women in The Gambia. isrctn.com/ISRCTN96502494 (first received 6 November 2007). PrenticeA , JarjouLM , GoldbergGR , BennettJ , ColeTJ , SchoenmakersI . Maternal plasma 25‐hydroxyvitamin D concentration and birthweight, growth and bone mineral accretion of Gambian infants. Acta Paediatrica2009;98(8):1360‐2. WardKA , JarjouL , PrenticeA . Maternal calcium supplementation and offspring growth. Osteoporosis International2016;27(1 Suppl 1):S327‐8. WardKA , PrenticeA , JarjouL . Long‐term effects of maternal calcium supplementation on childhood growth differ between males and females in a population accustomed to a low calcium intake. Bone2017;103:31‐8. '>Jarjou 2004</a>), investigators reported reduced bone density in the women postpartum. They suggest that high‐dose calcium during pregnancy might reverse metabolic adaptation to long‐term low calcium diets, resulting in a rebound effect when withdrawn. This finding was based on a selected follow‐up and was opposite to the prior hypothesis and therefore needs confirmation in a prospective study. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD001059-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD001059-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/full#CD001059-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD001059-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/full#CD001059-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD001059-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/full#CD001059-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 2 Routine high‐dose calcium supplementation in pregnancy by hypertension risk, outcome: 2.1 High blood pressure (with or without proteinuria)." data-id="CD001059-fig-0004" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Funnel plot of comparison: 2 Routine high‐dose calcium supplementation in pregnancy by hypertension risk, outcome: 2.1 High blood pressure (with or without proteinuria). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/full#CD001059-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, outcome: 1.1 High blood pressure (with or without proteinuria)." data-id="CD001059-fig-0005" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, outcome: 1.1 High blood pressure (with or without proteinuria). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/full#CD001059-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 3 Routine high‐dose calcium supplementation in pregnancy by study sample size, outcome: 3.1 High blood pressure (with or without proteinuria)." data-id="CD001059-fig-0006" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Funnel plot of comparison: 3 Routine high‐dose calcium supplementation in pregnancy by study sample size, outcome: 3.1 High blood pressure (with or without proteinuria). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/full#CD001059-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-AFig-FIG07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-AFig-FIG07.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, outcome: 1.2 Pre‐eclampsia." data-id="CD001059-fig-0007" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, outcome: 1.2 Pre‐eclampsia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/full#CD001059-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-AFig-FIG08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-AFig-FIG08.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 2 Routine high‐dose calcium supplementation in pregnancy by hypertension risk, outcome: 2.2 Pre‐eclampsia." data-id="CD001059-fig-0008" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p>Funnel plot of comparison: 2 Routine high‐dose calcium supplementation in pregnancy by hypertension risk, outcome: 2.2 Pre‐eclampsia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/full#CD001059-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-AFig-FIG09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-AFig-FIG09.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 4 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium and study sample size (not pre‐specified), outcome: 4.1 Pre‐eclampsia." data-id="CD001059-fig-0009" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 9</div> <div class="figure-caption"> <p>Funnel plot of comparison: 4 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium and study sample size (not pre‐specified), outcome: 4.1 Pre‐eclampsia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/full#CD001059-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-AFig-FIG10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-AFig-FIG10.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, outcome: 1.3 Preterm birth." data-id="CD001059-fig-0010" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 10</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, outcome: 1.3 Preterm birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/full#CD001059-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-AFig-FIG11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-AFig-FIG11.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 2 Routine high‐dose calcium supplementation in pregnancy by hypertension risk, outcome: 2.3 Preterm birth." data-id="CD001059-fig-0011" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 11</div> <div class="figure-caption"> <p>Funnel plot of comparison: 2 Routine high‐dose calcium supplementation in pregnancy by hypertension risk, outcome: 2.3 Preterm birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/full#CD001059-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-AFig-FIG12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-AFig-FIG12.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 3 Routine high‐dose calcium supplementation in pregnancy by study sample size, outcome: 3.3 Preterm birth." data-id="CD001059-fig-0012" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 12</div> <div class="figure-caption"> <p>Funnel plot of comparison: 3 Routine high‐dose calcium supplementation in pregnancy by study sample size, outcome: 3.3 Preterm birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/full#CD001059-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-AFig-FIG12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 1 High blood pressure (with or without proteinuria)." data-id="CD001059-fig-0013" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 1 High blood pressure (with or without proteinuria). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-001-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 2 Pre‐eclampsia." data-id="CD001059-fig-0014" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 2 Pre‐eclampsia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-001-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 3 Preterm birth." data-id="CD001059-fig-0015" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 3 Preterm birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 4 Admission to neonatal intensive care unit." data-id="CD001059-fig-0016" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 4 Admission to neonatal intensive care unit. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 5 Stillbirth or death before discharge from hospital." data-id="CD001059-fig-0017" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 5 Stillbirth or death before discharge from hospital. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 6 Maternal death/serious morbidity." data-id="CD001059-fig-0018" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 6 Maternal death/serious morbidity. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 7 Placental abruption." data-id="CD001059-fig-0019" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 7 Placental abruption. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 8 Caesarean section." data-id="CD001059-fig-0020" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 8 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 9 Proteinuria (gestational with no proteinuria)." data-id="CD001059-fig-0021" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 9 Proteinuria (gestational with no proteinuria). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 10 Severe pre‐eclampsia." data-id="CD001059-fig-0022" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 10 Severe pre‐eclampsia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 11 Eclampsia." data-id="CD001059-fig-0023" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 11 Eclampsia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 12 HELLP syndrome." data-id="CD001059-fig-0024" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 12 HELLP syndrome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 13 Intensive care unit admission." data-id="CD001059-fig-0025" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 13 Intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 14 Maternal death." data-id="CD001059-fig-0026" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 14 Maternal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 15 Low birthweight (birthweight &lt; 2500 g)." data-id="CD001059-fig-0027" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 15 Low birthweight (birthweight &lt; 2500 g). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 16 Neonate small‐for‐gestational age as defined by trial authors." data-id="CD001059-fig-0028" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 16 Neonate small‐for‐gestational age as defined by trial authors. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 17 Systolic blood pressure &gt; 95th percentile during childhood." data-id="CD001059-fig-0029" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 17 Systolic blood pressure &gt; 95th percentile during childhood. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 18 Diastolic blood pressure &gt; 95th percentile during childhood." data-id="CD001059-fig-0030" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 18 Diastolic blood pressure &gt; 95th percentile during childhood. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 19 Dental caries in childhood." data-id="CD001059-fig-0031" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium, Outcome 19 Dental caries in childhood. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-002-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Routine high‐dose calcium supplementation in pregnancy by hypertension risk, Outcome 1 High blood pressure (with or without proteinuria)." data-id="CD001059-fig-0032" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Routine high‐dose calcium supplementation in pregnancy by hypertension risk, Outcome 1 High blood pressure (with or without proteinuria). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-002-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Routine high‐dose calcium supplementation in pregnancy by hypertension risk, Outcome 2 Pre‐eclampsia." data-id="CD001059-fig-0033" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Routine high‐dose calcium supplementation in pregnancy by hypertension risk, Outcome 2 Pre‐eclampsia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-002-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Routine high‐dose calcium supplementation in pregnancy by hypertension risk, Outcome 3 Preterm birth." data-id="CD001059-fig-0034" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Routine high‐dose calcium supplementation in pregnancy by hypertension risk, Outcome 3 Preterm birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Routine high‐dose calcium supplementation in pregnancy by hypertension risk, Outcome 4 Admission to neonatal intensive care unit." data-id="CD001059-fig-0035" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Routine high‐dose calcium supplementation in pregnancy by hypertension risk, Outcome 4 Admission to neonatal intensive care unit. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Routine high‐dose calcium supplementation in pregnancy by hypertension risk, Outcome 5 Stillbirth or death before discharge from hospital." data-id="CD001059-fig-0036" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Routine high‐dose calcium supplementation in pregnancy by hypertension risk, Outcome 5 Stillbirth or death before discharge from hospital. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-003-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Routine high‐dose calcium supplementation in pregnancy by study sample size, Outcome 1 High blood pressure (with or without proteinuria)." data-id="CD001059-fig-0037" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Routine high‐dose calcium supplementation in pregnancy by study sample size, Outcome 1 High blood pressure (with or without proteinuria). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Routine high‐dose calcium supplementation in pregnancy by study sample size, Outcome 2 Pre‐eclampsia." data-id="CD001059-fig-0038" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Routine high‐dose calcium supplementation in pregnancy by study sample size, Outcome 2 Pre‐eclampsia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-003-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Routine high‐dose calcium supplementation in pregnancy by study sample size, Outcome 3 Preterm birth." data-id="CD001059-fig-0039" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Routine high‐dose calcium supplementation in pregnancy by study sample size, Outcome 3 Preterm birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Routine high‐dose calcium supplementation in pregnancy by study sample size, Outcome 4 Admission to neonatal intensive care unit." data-id="CD001059-fig-0040" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Routine high‐dose calcium supplementation in pregnancy by study sample size, Outcome 4 Admission to neonatal intensive care unit. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Routine high‐dose calcium supplementation in pregnancy by study sample size, Outcome 5 Stillbirth or death before discharge from hospital." data-id="CD001059-fig-0041" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Routine high‐dose calcium supplementation in pregnancy by study sample size, Outcome 5 Stillbirth or death before discharge from hospital. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-004-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium and study sample size (not prespecified), Outcome 1 Pre‐eclampsia." data-id="CD001059-fig-0042" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium and study sample size (not prespecified), Outcome 1 Pre‐eclampsia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Routine high‐dose calcium supplementation in pregnancy by other outcomes (not prespecified), Outcome 1 Uterine artery RI at 32 weeks." data-id="CD001059-fig-0043" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Routine high‐dose calcium supplementation in pregnancy by other outcomes (not prespecified), Outcome 1 Uterine artery RI at 32 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Routine high‐dose calcium supplementation in pregnancy by other outcomes (not prespecified), Outcome 2 Umbilical artery RI at 32 weeks." data-id="CD001059-fig-0044" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Routine high‐dose calcium supplementation in pregnancy by other outcomes (not prespecified), Outcome 2 Umbilical artery RI at 32 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Routine high‐dose calcium supplementation in pregnancy by other outcomes (not prespecified), Outcome 3 Low platelet count at 35 weeks." data-id="CD001059-fig-0045" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Routine high‐dose calcium supplementation in pregnancy by other outcomes (not prespecified), Outcome 3 Low platelet count at 35 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Routine high‐dose calcium supplementation in pregnancy by other outcomes (not prespecified), Outcome 4 High serum uric acid at 35 weeks." data-id="CD001059-fig-0046" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Routine high‐dose calcium supplementation in pregnancy by other outcomes (not prespecified), Outcome 4 High serum uric acid at 35 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Routine high‐dose calcium supplementation in pregnancy by other outcomes (not prespecified), Outcome 5 High urine protein/creatinine ratio at 35 weeks." data-id="CD001059-fig-0047" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 Routine high‐dose calcium supplementation in pregnancy by other outcomes (not prespecified), Outcome 5 High urine protein/creatinine ratio at 35 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Routine high‐dose calcium supplementation in pregnancy by other outcomes (not prespecified), Outcome 6 Ultrasound estimate of fetal growth at 32 weeks: femur length (cm)*." data-id="CD001059-fig-0048" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 Routine high‐dose calcium supplementation in pregnancy by other outcomes (not prespecified), Outcome 6 Ultrasound estimate of fetal growth at 32 weeks: femur length (cm)*. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-005-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-005-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Routine high‐dose calcium supplementation in pregnancy by other outcomes (not prespecified), Outcome 7 Ultrasound estimate of fetal growth at 32 weeks: biparietal diameter (cm)*." data-id="CD001059-fig-0049" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-005-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5 Routine high‐dose calcium supplementation in pregnancy by other outcomes (not prespecified), Outcome 7 Ultrasound estimate of fetal growth at 32 weeks: biparietal diameter (cm)*. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-005-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-005-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-005-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Routine high‐dose calcium supplementation in pregnancy by other outcomes (not prespecified), Outcome 8 Ultrasound estimate of fetal growth at 32 weeks: abdominal circumference (cm)*." data-id="CD001059-fig-0050" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-005-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.8</div> <div class="figure-caption"> <p>Comparison 5 Routine high‐dose calcium supplementation in pregnancy by other outcomes (not prespecified), Outcome 8 Ultrasound estimate of fetal growth at 32 weeks: abdominal circumference (cm)*. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-005-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Low‐dose calcium supplementation (&lt; 1 g/day) with or without co‐supplements vs placebo or no treatment, Outcome 1 High blood pressure (with or without pre‐eclampsia)." data-id="CD001059-fig-0051" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Low‐dose calcium supplementation (&lt; 1 g/day) with or without co‐supplements vs placebo or no treatment, Outcome 1 High blood pressure (with or without pre‐eclampsia). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Low‐dose calcium supplementation (&lt; 1 g/day) with or without co‐supplements vs placebo or no treatment, Outcome 2 Pre‐eclampsia." data-id="CD001059-fig-0052" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Low‐dose calcium supplementation (&lt; 1 g/day) with or without co‐supplements vs placebo or no treatment, Outcome 2 Pre‐eclampsia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Low‐dose calcium supplementation (&lt; 1 g/day) with or without co‐supplements vs placebo or no treatment, Outcome 3 Preterm birth." data-id="CD001059-fig-0053" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Low‐dose calcium supplementation (&lt; 1 g/day) with or without co‐supplements vs placebo or no treatment, Outcome 3 Preterm birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-006-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-006-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Low‐dose calcium supplementation (&lt; 1 g/day) with or without co‐supplements vs placebo or no treatment, Outcome 4 Admission to neonatal intensive care unit." data-id="CD001059-fig-0054" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-006-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6 Low‐dose calcium supplementation (&lt; 1 g/day) with or without co‐supplements vs placebo or no treatment, Outcome 4 Admission to neonatal intensive care unit. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-006-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-006-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-006-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Low‐dose calcium supplementation (&lt; 1 g/day) with or without co‐supplements vs placebo or no treatment, Outcome 5 Stillbirth or death before discharge." data-id="CD001059-fig-0055" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-006-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6 Low‐dose calcium supplementation (&lt; 1 g/day) with or without co‐supplements vs placebo or no treatment, Outcome 5 Stillbirth or death before discharge. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-006-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-006-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-006-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Low‐dose calcium supplementation (&lt; 1 g/day) with or without co‐supplements vs placebo or no treatment, Outcome 6 Placental abruption." data-id="CD001059-fig-0056" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-006-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.6</div> <div class="figure-caption"> <p>Comparison 6 Low‐dose calcium supplementation (&lt; 1 g/day) with or without co‐supplements vs placebo or no treatment, Outcome 6 Placental abruption. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-006-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-006-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-006-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Low‐dose calcium supplementation (&lt; 1 g/day) with or without co‐supplements vs placebo or no treatment, Outcome 7 Caesarean section." data-id="CD001059-fig-0057" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-006-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.7</div> <div class="figure-caption"> <p>Comparison 6 Low‐dose calcium supplementation (&lt; 1 g/day) with or without co‐supplements vs placebo or no treatment, Outcome 7 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-006-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-006-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-006-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Low‐dose calcium supplementation (&lt; 1 g/day) with or without co‐supplements vs placebo or no treatment, Outcome 8 Severe pre‐eclampsia." data-id="CD001059-fig-0058" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-006-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.8</div> <div class="figure-caption"> <p>Comparison 6 Low‐dose calcium supplementation (&lt; 1 g/day) with or without co‐supplements vs placebo or no treatment, Outcome 8 Severe pre‐eclampsia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-006-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-006-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-006-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Low‐dose calcium supplementation (&lt; 1 g/day) with or without co‐supplements vs placebo or no treatment, Outcome 9 Eclampsia." data-id="CD001059-fig-0059" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-006-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.9</div> <div class="figure-caption"> <p>Comparison 6 Low‐dose calcium supplementation (&lt; 1 g/day) with or without co‐supplements vs placebo or no treatment, Outcome 9 Eclampsia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-006-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-006-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-006-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Low‐dose calcium supplementation (&lt; 1 g/day) with or without co‐supplements vs placebo or no treatment, Outcome 10 Miscarriage." data-id="CD001059-fig-0060" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-006-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.10</div> <div class="figure-caption"> <p>Comparison 6 Low‐dose calcium supplementation (&lt; 1 g/day) with or without co‐supplements vs placebo or no treatment, Outcome 10 Miscarriage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-006-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-006-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-006-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Low‐dose calcium supplementation (&lt; 1 g/day) with or without co‐supplements vs placebo or no treatment, Outcome 11 Low birthweight (birthweight &lt; 2500 g)." data-id="CD001059-fig-0061" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-006-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.11</div> <div class="figure-caption"> <p>Comparison 6 Low‐dose calcium supplementation (&lt; 1 g/day) with or without co‐supplements vs placebo or no treatment, Outcome 11 Low birthweight (birthweight &lt; 2500 g). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-006-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-006-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-006-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Low‐dose calcium supplementation (&lt; 1 g/day) with or without co‐supplements vs placebo or no treatment, Outcome 12 Neonate small‐for‐gestational age." data-id="CD001059-fig-0062" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-006-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.12</div> <div class="figure-caption"> <p>Comparison 6 Low‐dose calcium supplementation (&lt; 1 g/day) with or without co‐supplements vs placebo or no treatment, Outcome 12 Neonate small‐for‐gestational age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-006-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 High‐dose (=/&gt; 1 g) vs low‐dose (&lt; 1 g) calcium supplements, Outcome 1 Pre‐eclampsia." data-id="CD001059-fig-0063" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 High‐dose (=/&gt; 1 g) vs low‐dose (&lt; 1 g) calcium supplements, Outcome 1 Pre‐eclampsia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 High‐dose (=/&gt; 1 g) vs low‐dose (&lt; 1 g) calcium supplements, Outcome 2 Preterm birth." data-id="CD001059-fig-0064" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 High‐dose (=/&gt; 1 g) vs low‐dose (&lt; 1 g) calcium supplements, Outcome 2 Preterm birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 High‐dose (=/&gt; 1 g) vs low‐dose (&lt; 1 g) calcium supplements, Outcome 3 Eclampsia." data-id="CD001059-fig-0065" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 High‐dose (=/&gt; 1 g) vs low‐dose (&lt; 1 g) calcium supplements, Outcome 3 Eclampsia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001059-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/urn:x-wiley:14651858:media:CD001059:CD001059-CMP-007-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_t/tCD001059-CMP-007-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 High‐dose (=/&gt; 1 g) vs low‐dose (&lt; 1 g) calcium supplements, Outcome 4 Stillbirth." data-id="CD001059-fig-0066" src="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-007-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7 High‐dose (=/&gt; 1 g) vs low‐dose (&lt; 1 g) calcium supplements, Outcome 4 Stillbirth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/media/CDSR/CD001059/image_n/nCD001059-CMP-007-04.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD001059-tbl-0001"> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Calcium supplementation compared with placebo for preventing hypertensive disorders and related problems in pregnancy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population: pregnant women</b> </p> <p><b>Settings: outpatient</b> </p> <p><b>Intervention: high‐dose calcium (≥ 1 g/day)</b> </p> <p><b>Comparison: placebo</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>No calcium</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Calcium</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Pre‐eclampsia</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Overall</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 0.45</b> (0.31 to 0.65) </p> <p><b>RR 0.36</b> (0.20 to 0.65) </p> <p><b>RR 0.22</b> (0.12 to 0.42) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>15,730<br/> (13) </p> <p>10,678</p> <p>(8)</p> <p>587</p> <p>(5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>1</sup> </p> <p>⊕⊕⊝⊝<br/> low<sup>1</sup> </p> <p>⊕⊕⊝⊝<br/> low<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>65 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>29 per 1000</b><br/> (20 to 42) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Low‐calcium diet</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>57 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>21 per 1000</b><br/> (11 to 37) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High‐risk women</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>176 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>38 per 1000</b><br/> (21 to 74) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Preterm birth</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Overall</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.76</b> (0.60 to 0.97) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>15,275<br/> (11) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>104 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>79 per 1000</b><br/> (62 to 101) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>HELLP syndrome</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>1 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>3 per 1000</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 2.67</b> (1.05 to 6.82) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12,901</p> <p>(2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊕<br/> high </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded two levels due to heterogeneity and small study effects (‐2) </p> <p>CI: confidence interval<br/> HELLP: haemolysis, elevated liver enzymes and low platelets<br/> RR: risk ratio </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-title"></span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/full#CD001059-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001059-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 High blood pressure (with or without proteinuria) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>15470</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.53, 0.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Adequate calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5022</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.81, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Low calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10418</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.28, 0.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Dietary calcium not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.57, 1.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Pre‐eclampsia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>15730</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.31, 0.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Adequate calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5022</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.32, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Low calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10678</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.20, 0.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Dietary calcium not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.02, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Preterm birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>15275</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.60, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Adequate calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.26, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Low calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10242</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.64, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Admission to neonatal intensive care unit <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13406</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.94, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Adequate calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4336</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.95, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Low calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9070</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.81, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Stillbirth or death before discharge from hospital <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>15665</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.74, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Adequate calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.66, 1.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Low calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10632</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.70, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Maternal death/serious morbidity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9732</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.66, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Low calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9732</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.66, 0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Adequate calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Placental abruption <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14336</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.55, 1.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Adequate calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4830</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.39, 1.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Low calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9506</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.51, 1.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>15234</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.89, 1.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Adequate calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4981</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.84, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Low calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.88, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Proteinuria (gestational with no proteinuria) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.86, 1.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Adequate calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Low calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.86, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Severe pre‐eclampsia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8302</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.48, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Adequate calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 Low calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8302</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.48, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Eclampsia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13425</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.41, 1.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Adequate calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4589</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.25, 3.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 Low calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8836</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.37, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 HELLP syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>12901</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.67 [1.05, 6.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Adequate calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4589</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.50 [0.73, 16.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 Low calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.26 [0.70, 7.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.66, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Adequate calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 Low calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.66, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Maternal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.02, 1.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 Adequate calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 Low calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.02, 1.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Low birthweight (birthweight &lt; 2500 g) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14883</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.72, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 Adequate calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.31, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 Low calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9850</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.85, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Neonate small‐for‐gestational age as defined by trial authors <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13615</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.86, 1.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 Adequate calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4589</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.92, 1.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2 Low calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9026</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.60, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Systolic blood pressure &gt; 95th percentile during childhood <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>514</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.39, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1 Adequate calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.2 Low calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>514</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.39, 0.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Diastolic blood pressure &gt; 95th percentile during childhood <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>514</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.50, 1.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1 Adequate calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.2 Low calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>514</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.50, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Dental caries in childhood <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.62, 0.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.1 Low calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.62, 0.87]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001059-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Routine high‐dose calcium supplementation in pregnancy by hypertension risk</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 High blood pressure (with or without proteinuria) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>15470</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.53, 0.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Low‐risk women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>15143</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.57, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 High‐risk women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>327</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.22, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Pre‐eclampsia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>15730</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.31, 0.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Low‐risk women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>15143</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.41, 0.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 High‐risk women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>587</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.12, 0.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Preterm birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>15275</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.60, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Low‐risk women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14707</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.67, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 High‐risk women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>568</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.24, 0.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Admission to neonatal intensive care unit <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13406</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.94, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Low‐risk women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13343</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.94, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 High‐risk women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.03, 2.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Stillbirth or death before discharge from hospital <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>15665</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.74, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Low‐risk women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>15153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.74, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 High‐risk women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>512</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.02, 9.20]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Routine high‐dose calcium supplementation in pregnancy by hypertension risk</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001059-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Routine high‐dose calcium supplementation in pregnancy by study sample size</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 High blood pressure (with or without proteinuria) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>15470</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.53, 0.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Studies with &lt; 400 participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>675</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.21, 0.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Studies with =/&gt; 400 participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14795</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.70, 0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Pre‐eclampsia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>15730</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.31, 0.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Studies with &lt; 400 participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>935</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.12, 0.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Studies with =/&gt; 400 participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14795</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.52, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Preterm birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>15275</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.60, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Studies with &lt; 400 participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>810</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.24, 0.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Studies with =/&gt; 400 participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14465</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.69, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Admission to neonatal intensive care unit <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13406</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.94, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Studies with &lt; 400 participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.03, 2.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Studies with =/&gt; 400 participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13343</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.94, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Stillbirth or death before discharge from hospital <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>15665</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.74, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Studies with &lt; 400 participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.02, 9.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Studies with =/&gt; 400 participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14819</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.74, 1.09]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Routine high‐dose calcium supplementation in pregnancy by study sample size</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001059-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium and study sample size (not prespecified)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Pre‐eclampsia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>15730</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.31, 0.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Adequate calcium/small study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>230</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.04, 1.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Adequate calcium/large study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4792</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.33, 1.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Low calcium/small study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>675</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.12, 0.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Low calcium/large study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.35, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Dietary calcium not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.02, 1.02]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Routine high‐dose calcium supplementation in pregnancy by baseline dietary calcium and study sample size (not prespecified)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001059-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Routine high‐dose calcium supplementation in pregnancy by other outcomes (not prespecified)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Uterine artery RI at 32 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>372</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.02, 0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Umbilical artery RI at 32 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>373</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.02, 0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Low platelet count at 35 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>667</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.63, 2.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 High serum uric acid at 35 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>664</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.64, 1.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 High urine protein/creatinine ratio at 35 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>637</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.76, 1.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Ultrasound estimate of fetal growth at 32 weeks: femur length (cm)* <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>377</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.04, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Ultrasound estimate of fetal growth at 32 weeks: biparietal diameter (cm)* <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>377</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.06, 0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Ultrasound estimate of fetal growth at 32 weeks: abdominal circumference (cm)* <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>377</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.26, 0.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Routine high‐dose calcium supplementation in pregnancy by other outcomes (not prespecified)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001059-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Low‐dose calcium supplementation (&lt; 1 g/day) with or without co‐supplements vs placebo or no treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 High blood pressure (with or without pre‐eclampsia) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>665</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.38, 0.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Calcium supplementation alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>558</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.39, 0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Calcium plus vitamin D</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.24, 1.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Calcium plus linoleic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.05, 0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Pre‐eclampsia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2234</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.28, 0.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Calcium supplementation alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>980</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.23, 0.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Calcium plus vitamin D</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1060</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.31, 0.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Calcium plus linoleic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [0.09, 0.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 Calcium plus antioxidants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [0.06, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Preterm birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1290</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.34, 2.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Calcium supplementation alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>422</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.21, 0.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Calcium plus vitamin D</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>760</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.59 [1.03, 2.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Calcium plus linoleic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [0.05, 5.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 Calcium plus antioxidants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.04, 3.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Admission to neonatal intensive care unit <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>422</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.20, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Calcium supplementation alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>422</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.20, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Calcium plus vitamin D</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Calcium plus linoleic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Stillbirth or death before discharge <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1025</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.14, 1.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Calcium supplementation alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>171</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.07, 16.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Calcium plus vitamin D</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>660</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.01, 4.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Calcium plus linoleic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.6 [0.08, 4.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4 Calcium plus antioxidants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.02, 8.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Placental abruption <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.14, 6.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Calcium plus antioxidants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Calcium plus vitamin D</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.14, 6.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>521</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.46, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Calcium supplementation alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>387</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.40, 2.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Calcium plus vitamin D</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 Calcium plus linoleic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.35, 0.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Severe pre‐eclampsia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>246</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.14, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Calcium supplementation alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Calcium plus vitamin D</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.6 [0.08, 4.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 Calcium plus linoleic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.07, 1.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.4 Calcium plus antioxidants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.04, 3.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Eclampsia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>168</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.01, 4.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Calcium supplementation alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>168</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.01, 4.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Calcium plus vitamin D</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3 Calcium plus linoleic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Miscarriage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [0.00, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Calcium plus antioxidants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [0.00, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Low birthweight (birthweight &lt; 2500 g) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.05, 0.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Calcium supplementation alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 Calcium plus vitamin D</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.3 Calcium plus linoleic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.05, 0.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Neonate small‐for‐gestational age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>854</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.54, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Calcium supplementation alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 Calcium plus vitamin D</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>660</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.58, 1.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.3 Calcium plus linoleic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.06, 1.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.4 Calcium plus antioxidants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.07, 16.31]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Low‐dose calcium supplementation (&lt; 1 g/day) with or without co‐supplements vs placebo or no treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001059-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">High‐dose (=/&gt; 1 g) vs low‐dose (&lt; 1 g) calcium supplements</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Pre‐eclampsia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>262</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.18, 0.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Preterm birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>262</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.09, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Eclampsia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>262</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.07, 1.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Stillbirth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>262</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.13, 1.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">High‐dose (=/&gt; 1 g) vs low‐dose (&lt; 1 g) calcium supplements</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001059.pub5/references#CD001059-tbl-0008">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD001059.pub5&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD001059-note-0002">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD001059-note-0009">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD001059-note-0015">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD001059-note-0007">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD001059-note-0006">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD001059-note-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD001059-note-0008">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD001059-note-0004">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD001059-note-0001">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD001059-note-0003">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001059\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001059\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001059\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001059\x2epub5"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001059\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001059\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001059\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001059\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001059\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001059\x2epub5"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001059\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001059\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001059\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001059\x2epub5"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001059\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001059\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001059\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001059\x2epub5"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=IYhCEbRn&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001059.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001059.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD001059.pub5/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD001059.pub5/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001059.pub5%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740715090642"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001059.pub5/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740715090646"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001059.pub5/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d7e9a7d4c1bde',t:'MTc0MDcxNTA5MS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 